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ABSTRACT 
The material presented in this thesis examines the observation 
that some simple sugars inhibit immune r esponses and attempts to 
analyse the mechanisms underlying the inhibition. 
In chapter 1, a survey of the literature relevant to T cell 
dependent antibody responses is presented, discussing the involvement 
of macrophages, T cells and B cells in antibody formation and high-
lighting the role of the H-2 complex and that of soluble "helper" 
factors. 
Chapter 2 contains a description of the materials and methods 
used in the thesis. 
Chapter 3 is the first experimental chapter and describes 
the initial observation that some sugars selectively inhibit immune 
responses in vi:tJr.o. N-acetyl-D-galactosamine (Gal NAc), L-fucose (Fuc) 
and N-acetyl-D-glucosamine (Glu NAc) inhibited secondary IgG responses 
to hapten carrier conjugates in CBA/H cultures, but had no effect on 
the primary and secondary IgM responses to hapten-carrier conjugates, 
mixed lymphocyt e reactions or on the generation of cytotoxic T (Tc) 
cells to alloantigens. Gal NAc inhibited the ability of a T cell 
replacing factor (TRF) to restore IgG responses to T cell-depleted 
cultures. 
In chapter 4, the observation that some sugars selectively 
inhibit IgG responses in certain mouse strains was analysed. Inhibition 
of IgG responses to hapten carrier conjugates was H-2 haplotype 
dependent; hence Fuc inhibited H-2k but not H-2d or H-2b haplotypes 
whereas -acetyl-D- mannosamine (~an Ac) and D- g alactose (Gal) 
. h.b. d b k . b" in i ited H-2 and H- 2 but not H-2 haplotypes. Using recom inant 
V 
mouse strains, inhibition by Fuc was mapped to the I-J subregion and 
the inhibition by Man NAc and Gal to the I-C subregion of the H-2 
complex. Although Gal NAc inhibited IgG responses in all mouse strains 
tested, its structural similarity to Man NAc and Gal suggested that 
the inhibition by Gal NAc is also under I-C subregion control. 
In chapter 5, the nature of the sugar-inhibitable TRF was 
investigated . The TRF was not antigen specific, was active across 
H-2 barriers and was active when added late to the cultures of T cell-
depleted spleen cells. The sugar inhibition pattern of TRF activity 
was analogous to that seen in chapter 4, i.e. 
k 
Fuc inhibited H-2 but not 
b d b H-2 or H-2 TRF activity whereas Man NAc and Gal inhibited H-2 and 
d k . . l . . . . H-2 but not H-2 TRF activity; Ga NAc inhibited TRF from all strains. 
Moreover, the TRF molecule was shown to be an H-2 controlled lectin 
which recognised a carbohydrate-defined receptor on its target cell. 
Inhibition of immune responses by D-mannose was examined in 
chapter 6. D-mannose inhibited all immune responses tested in all 
mouse strains. Hence unlike the other sugars discussed, it was 
nonspecific in its action and appeared to interfere with cellular 
matabolism. 
Finally, chapter 7 contains a summary and concluding r emarks 
of all the experimental chapters. 
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1. INTRODUCTION 
For many years the immune system has appealed to biologists 
as it represents a unique system of differentiation, the administration 
of endogenous antigen resulting in the rapid differentiation of resting 
lymphocytes to highly specialized antibody-forming cells or plasma 
cells. An additional attraction of the immune system is its ability to 
respond and produce specific antibodies against an almost infinite 
number of molecular structures, a property that poses intriguing 
questions for both biochemists and cell biologists. 
Interest in immunology has been further stimulated 1.n the last 
decade by the realisation that the immune system represents a complex 
network of interacting subpopulations of lymphoid cells. Furthermore, 
the major histocompatibility complex (MHC), which was for many years 
thought to be a biological curiosity that frustrated transplantation 
e2I\ 
surgeons, has now Ashown to play a fundamental role in cell to cell 
communication. 
The antibody response to T-cell dependent antigens clearly 
expresses the unique features of the immune system outlined above. 
This thesis deals with T-cell dependent antibody responses. 
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2 . HISTORICAL OVERVIEW 
2.1 Early Evidence for T cell- B cell collaboration 
Following the pioneering experiments of Gowans ~t al.. (1964) 
which clearly showed that lymphocytes mediated immune responses, the 
first evidence for lymphocyte collaboration came from an analysis by 
Claman and coworkers (1966) of the cellular basis of the humoral 
response to sheep red blood cells (SRBC). In these experiments, 
lethally irradiated mice were injected intravenously with varying doses 
of either spleen, thymus, bone marrow or thymus plus bone marrow cells 
from normal or imune syngeneic donors. The results clearly showed 
that at least two classes of immunocompetent cells were needed for 
optimal antibody responses. Thus neither bone marrow nor thymus cells 
alone produced anti-SRBC antibodies, whereas a mixture of the two 
populations resulted in a substantial antibody response. On the basis 
of these observations, the authors proposed that the bone marrow 
contained "effector" cells capable of producing antibody but only 1n 
the presence of "auxilliary" cells present 1n the thymus. 
Support for collaboration between different cell populations 
came from Davies ~t a£., (1967), whose work showed that antibody was 
produced by cells originating from bone marrow and not from thymus. 
Moreover, they showed that the highest antibody response occurred when 
both thymus and bone marrow cells were preprimed to the antigen. 
Perhaps the clearest evidence for thymus-derived (T) cell -
Bursa-equivalent (B) cell collaboration came from Miller and Mitchell 
(1967) who showed that bone marrow of neonatally thymectomized mice 
was as effective as that of normal mice in restoring innnunological 
3 
responsiveness to irradiated mice with an intact thymus. Furthermore, 
giving neonatally thymectomized mice allogeneic thoracic duct or 
thymus lymphocytes restored their responsiveness to SRBC. The resultant 
antibody forming cells could be destroyed by antisera against host 
cell alloantigens but not by antisera against donor thymus cells. 
These observations and their subsequent work (Miller and Mitchell, 1968; 
Mitchell and Miller, 1968; Nossal et a£., 1968) established that 
antibody forming cell precursors are derived from bone marrow and that, 
as first proposed by Claman, thymus cells recognise and specifically 
react to antigen, but perform an auxilliary role in the activation of 
antibody forming cell precursors. 
Subsequent studies by a number of workers (Chan et al.,1970; 
Schimpl and Wecker, 1970, 1971; Hartmann, 1970, 1971; Hirst and Dutton, 
1970; Munro and Hunter, 1970) have documented, either by the use of 
anti-theta (Thy-1) antisera for T cell depletion or by the use of 
specifically primed T cell populations, that the development of both 
primary and secondary anti-SRBC responses -<J1 vi:tAo requires the 
participation of both T and B lymphocytes in a manner analogous to 
that postulated from ~n vivo experiments. 
2.2 Early Evidence for Macrophage Involvement 
The development of in vibr..o methodologies by Mishell and 
Dutton (1967) and Marbrook (1967), provided a highly useful approach 
for studying cell - cell interactions in antibody responses. Of 
particular importanc e was the ability to analyse the participation of 
other cells, notably nonlyrnphoid "accessory" cells, in the development 
of such responses. The first studies of this type were made by Mosier 
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and colleagues (Mosier and Coppleson, 1968; Mosier ~t al.., 1970) who 
separated mouse spleen cells into subpopulations based on their relative 
abilities to adhere to plastic or glass surfaces. The separation of 
spleen cells into adherent and nonadherent fractions resulted in cell 
populations that were unable to develop primary in vi:t.Jr.o antibody 
responses. However, the antibody responses could be restored by 
recombining the two cell populations. The adherent cell was shown to 
be a macrophage (m¢) and the nonadherent cell population contained 
both T and B lymphocytes. 
2.3 Early Analyses with hapten-carrier Conjuqates 
Shortly after the initial studies demonstrating the requirement 
for T cell-B cell-macrophage interactions in the antibody response to 
SRBC, analogous interactions were demonstrated in the ~n vivo humoral 
responses to protein antigens and to hapten-carrier conjugates (Taylor, 
1969; Chiller ~t al.., 1970; Miller and Sprent, 1971). Furthermore, 
with the use of hapten-carrier antigens it has been possible to further 
analyse cell-cell interactions in antibody responses. Since it is 
this system that is used extensively in this thesis, a more detailed 
analysis of it will be undertaken here. 
The ability to couple hapten onto protein carriers, originally 
described by Landsteiner (1962), has provided a powerful tool for 
analysing the interaction between hapten-specific and carrier-specific 
subpopulations of lymphoid cells. Initially it was found that a 
hapten only elicited an anti-hapten antibody response when it was 
coupled to a carrier which was itself immunogenic (Benacerraf ~ta!., 
1963; Levine ~t al.., 1963; Green ~t al.., 1966). Optimal secondary 
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hapten-specific antibody responses only occurred when animals were 
challenged with the same hapten-carrier conjugate used for priming, 
a phenomenon that was subsequently termed the "carrier effect". 
Since the antibodies produced by such immunizations were highly 
specific for the hapten and, since it was assumed that the serum 
antibody represented the specificity of irnrnunoglobulin receptors on 
antibody-forming cell precursors, it was postulated that another cell 
recognised determinants on the carrier molecule. 
The first direct evidence, with an antibody response to a 
hapten-carrier conjugate, for co-operative participation of two cells 
with distinct determinant specificities was obtained by Mitchison (1969). 
In this study it was demonstrated that syngeneic spleen cells primed 
to 4 - hydroxy - 5 - iodo - 3 - nitrophenacetyl ovalbumin (NIP-OVA) when 
injected into irradiated recipients, made a seconday anti-NIP antibody 
response to the homologous conjugate NIP-OVA but failed to respond 
to a heterologous conjugate, NIP-bovine serum albumin (BSA). However, 
when spleen cells from donors immunized with NIP-OVA were injected 
together with spleen cells from donors immunized with bovine serum 
albumin (BSA), a good secondary anti-NIP response was elicited by the 
heterologous conjugate NIP-BSA. This basic in vivo observation has been 
confirmed repeatedly by other workers. 
On the basis of these findings it was postulated that for the 
induction of an anti-hapten antibody response, carrier-specific T cells 
initially interact with the hapten-carrier conjugate and induce hapten-
specific B cells to differentiate into antibody forming cells. The 
similarities between this system and the observed thymus-bone marrow 
co-operation in anti-SRBC responses was immediately obvious, a point 
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that was further established by Raff (1970), who showed, with the use 
of anti-Thy-1 and complement that the carrier-specific co-operating cells 
or "helper" cells were indeed thymus-derived, whereas the anti-hapten 
antibody forming cells were not. 
The capacity to analyse in vi:tJr.o responses to hapten-carrier 
conjugates was greatly facilitated by the development of a simple 
method for coupling the chemical hapten trinitrophenyl (TNP) directly 
onto red cell membranes (Rittenberg and Pratt, 1969). Based on this 
method, Kettman and Dutton (1970) obtained a primary anti-TNP antibody 
response in vi:tJr.o by culturing mouse spleen cells with TNP-SRBC. 
Using this system, a number of other laboratories soon obtained evidence 
for co-operation between carrier-specific and hapten-specific cells 
in the in vi:tJr.o primary antibody response (Katz ~t al., 197 0; 
Trowbridge ~t al., 1970; Kettman and Dutton, 1971). Furthermore, 
the carrier-specific cells were shown to be T cells as helper activity 
was eliminated by anti-Thy-1 and complement treatment (Dutton ~t al., 
1 971 ) . 
At about the same time ~n vitfr.o responses to soluble hapten-
protein conjugates were reported (Bullock and Rittenberg, 1970a, b). 
Spleen cells from mice primed previously to TNP-KLH (keyhole limpet 
haemocyanin) were shown to develop TNP-specific IgM and IgG plaque-
forming cells (PFC) when challenged in vi:tJr.o with TNP-KLH. The in vi:tJr.o 
response to soluble hapten-carrier conjugates also involved co-operative 
cell interactions since spleen cells only gave secondary responses 
, 
when the same conjugate was used for ~n v~vo priming and stimulation, 
thus demonstrating that these responses were analogous to the ~n v~vo 
co-operation model (Cheers ~t al., 1971). 
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As a general rule, the most effective T-B collaboration was 
observed when both T cells and B cells recognised distinct determinants on 
the same molecule (Rajewsky et al., 1969; Mitchison, 1971). This important 
point was clearly demonstrated by Mitchison (1971) in adoptive transfer 
studies in mice where recipients of hapten-primed and carrier-primed 
spleen cell populations failed to respond when they were simultaneously 
challenged with the relevant hapten and the unconjugated carrier 
protein. Such a result was interpreted to mean that close contact 
between carrier-specific T cells and hapten-specific B cells is required 
for successful collaboration and this proximity cannot be achieved 
when the relevant hapten cand carrier are on separate molecules. This 
basic observation has been confirmed by other workers both in vivo 
and in vibe.a (Hamaoka et al., 1971; Unanue and Katz, 1973; Askonas and 
Roelants, 1974) supporting the concept that close proximity of 
collaborating T and B cells is required, although the regulatory signal 
may be mediated either by direct cell-cell contact or via elaboration 
of short-range factor(s). 
Although experiments such as these show that in many systems 
the most efficient T cell-B cell interaction occurs when the respective 
determinants are present on the same molecule, there are exceptions to 
this rule. A number of workers have reported substantial secondary 
anti-hapten antibody responses both in vivo (Hamaoka et al., 1973) 
and in vibr.o ( Sul ica et al., 1971; Kishimoto and Ishizaka, 1973a) wh en 
the hapten and the relevant carrier were present as separate molecules. 
The most likely explanation for these differences in the ability to 
elicit antibody responses to linked or nonlinked determinants is anti gen 
concentration. Hence at high concentrations of hapten and unconjugated 
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carrier, there is a greater probability of close proximity between 
these two molecules in the membranes of accessory cells, a situation 
that could facilitate T-B collaboration. In the case of ~n vitJc.o 
antibody responses an additional factor is that short range and/or 
unstable T cell factors could accumulate in the culture medium and 
allow T-B collaboration to occur at a distance. 
3 . CELLULAR REQUIREMENTS FORT-DEPENDENT ANTIBODY RESPONSES 
At least three cell types are required for the induction of 
an antibody response to a T cell-dependent antigen. They are 
a) thymus-derived (T) lymphocytes, b) bone marrow derived (bursa 
equivalent) antibody-forming cell precursors, (B) lymphocytes, and 
c) accessory cells. These three cell types are physically and 
functionally distinct, T cells being classically characterised in the 
mouse by the Thy-1 cell surface antigen, B cells being characterised 
by a high density of surface immunoglobulin (Ig) and accessory cells 
being distinguished from lymphoid cells by their adherent properties. 
A brief description of these cell types is presented below. 
3.1 Accessory Cells 
The regulatory role of accessory cell in immune induction has 
been reviewed in detail by Unanue (1972, 1981) and therefore will only 
be briefly outlined here. As mentioned above (section 2.2), the active 
participation of an adherent, non-lymphoid cell is necessary for the 
generation of antibody responses, and since this cell is frequently 
only defined by its adherent properties it is usually termed "acc essory 
cell". Classically, cells of the mononuclear phagocyte lineage have been 
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considered to be the maJor accessory cell population in most immune 
responses (Feldmann, 1972a). However, ~n vibt.o studies indicate that 
several members of the mononuclear phagocyte system can function as 
accessory or antigen-presenting cells, namely peripheral blood monocytes 
(Rosenberg and Lipsky, 1979), peritoneal macrophages (Rosenthal et al., 
1976), Kupffer cells of the liver (Lipsky and Rogoff, 1980), splenic 
adherent cells (Cowing et al., 1978a) and alveolar macrophages 
(Lipscomb et al., 1981). Furthermore, cells that are not part of 
the mononuclear phagocyte system, such as dendridic cells and 
Langerhans cells, may also function as accessory cells. It should be 
noted, however, that in many cases the assay for accessory cell function 
has been the ability to support antigen-specific T cell proliferation 
rather than initiation of antibody responses. 
Within these accessory cell populations it has been shown 
that only those cells expressing I-region associated (Ia) antigens 
can act as accessory cells (Yamashita and Shevach, 1977; Cowing et al., 
1978 b). For example, the primary in vibt.o antibody response to TNP-KLH 
was shown to be strongly dependent upon phagocytic accessory cells 
bearing both I-A and I-E/I-C subregion controlled determinants (Hodes 
et al . , 1978; Dickler et al.., 1980), a point that is discussed in more 
detail in section 4.3. In a separate study, Niederhuber and coworkers 
(1978, 1980) reported that a primary in vibt.o anti-SRBC response was 
inhibited when accessory cells were pretreated with anti-I-J sera. 
By contrast, pretreatment of accessory cells with anti I-A and/or 
anti I-E/I-C sera had no effect: these latter antisera were only 
effective when added in the presence of complement (Hodes et al., 1978; 
Dickler et al.., 1980). Such data suggest that macrophage Ia determinants 
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play a key role in immune induction, an interpretation discussed more 
extensively in section 4.3. 
In vibto experiments have also indicated that accessory cells 
not only act as antigen-presenting cells but can accomplish additional 
functions. For example, it has been reported that they maintain 
lymphocyte viability and functional integrity in the absence of antigen 
activation (Chen and Hirsch, 1972; Ellner ~t cu., 1976). This may 
involve the production of soluble factors essential for cell growth 
or viability. 
Direct physical contact between lymphocytes and macrophages 
also appears to be essential for these cells to express many of their 
biological activities (Lipsky and Rosenthal, 1973, 1975). Thus, 
macrophage-lymphocyte clusters provide a focus for collaboration between 
T cells and B cells (Katz and Unanue, 1973), allow the direct 
presentation of immunologically relevant determinants by antigen-bearing 
macrophages (Lipsky and Rosenthal, 1975) and may regulate the 
transmission of information between T and B cells (Ptak ~t al., 1977). 
Furthermore, macrophages may also modify lymphocyte reactivity throu gh the 
action of secreted immunoregulatory molecules, in particular interleukin-1 
(IL-1) (see section 5.3). The secretion of soluble factors may be increased 
or even tri gge red by the developme nt of physical contact between macrophages 
and lymphocytes, thus explaining the importance of direct macrophage-
lymphocyte contact in lymphocyte activation. In turn, the factors may be 
at optimal concentrations in close proximity to th e cell secreting them. 
In summary, the rol e of macrophages in immune induction is served 
by two distinct yet inter r e lated functions: handling and presentation of 
antigen in association with l region products to l ymphocy t es, and secretion 
of lymphostimulatory molecules. 
11 
3. 2 Lymphocytes 
As reviewed in section 2, the past two decades have seen the 
recognition of two distinct classes of lymphocytes that are required for 
immune responses. It is generally accepted that one class of lymphoid 
stem cell from yolk sack, foetal liver or bone marrow migrates to the 
thymus, acquires immuno-competence in the thymic microenvironment and 
then migrates to spleen and lymph nodes as mature T cells. The second 
lymphoid cell class, referred to as B cell, originates in the bone marrow 
in mammals, although these cells have been shown to originate from a 
separate lymphoid organ in chickens, namely the Bursa of Fabricius. 
These cells also migrate to peripheral lymphoid organs such as spleen and 
lymph nodes and become antibody-forming cell precursors (Claman and 
Chaperon, '1969; Davies, 1969; Miller and Mitchell, 1969; Katz and 
Benaceraff, 1972). The general properties of the T and B lymphocytes 
r equired for T-dependent antibody responses will be discussed below. 
3. 2. 1 T lymphocytes 
The functional subdivision of lymphocyt e populations has been 
greatly assisted by the development of antisera against cell surface 
antigens (reviewed by McKenzie and Potter, 1979; McKenzie ~t af.., 1981 ) . 
+ Thy-1 was the first alloantigen used to distinguish T cells (Thy-1 ) from 
B cells (Thy-1 ) in the mouse and is now used as a standard cell surface 
marker for murine T cells (Raff, 1971; McKenzie and Potter, 1979). 
Following these early studies, additional alloantigens have been described 
that discriminate betwee n functional subsets of lymphoid cells (McKenzie 
and Potter, 1979). On th e basis of these studies it has become apparent 
that T lymphocyt es represent a highly complex mixture of functional 
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subsets of cells. Not only can T cells act as "helper cells" for antibody 
responses, but they can mediate such diverse phenomena as delayed-type 
hypersensitivity (DTH), lysis of target cells and suppression of immune 
responses; effects that are usually mediated by different subsets of 
T cells. Of particular relevance to antibody responses was the realisation 
that T cell subsets exist that can either "help" or "suppress" antibody 
formation (Katz and Benacerraf, 1972, Eardley et al., 1978). Although 
superficially these observations added additional complexity to the system, 
they were consistent with the notion that T cells re gulate antibody 
production by B cells. 
There are a number of excellent reviews and monographs on 
functional T cell subsets (Cantor and Boyse, 1975; Katz, 1977), particularly 
suppressor T cells (Parks and Weigle, 1979; Cantor et al., 1978; 
Asherson et al., 1980) and consequently this discussion will touch on 
these only briefly. Furthermore, subsequent sections of this review will 
concentrate on the induction of antibody formation by helper T (TH) cells 
rather than the inhibition of humoral immunity by suppressor T (Ts) cells, 
as the helper function is more relevant to the experimental chapters of 
the thesis. 
In functional terms, T cells may be broadly categorised as either 
regulatory cells or effector cells, each of these having a number of 
subcategories. The effector cells are T cells mediating graft versus host 
(GVH) reactions, cytotoxic killing (Tc) and delayed-type hypersensitivity 
(TDTH) (review in Katz, 1977). Regulatory cells consist of helper (TH) 
and suppressor (Ts T cells that can modify both humoral and cell-mediated 
irrrrnunity. 
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Helper T lymphocytes have been differentiated from other T cells 
by both functional and cell surface characteristics. The most useful cell 
surface antigens for differentiating functional T cells subsets are the 
Ly-1 and Ly-2/3 alloantigens (Boyse et al.., 1968, 1971), although the 
use of other antigens such as Ly-6 and Ly-7 is also becoming important 
(McKenzie et al., 1977a, b). 
+ -
It was originally believed that TH and TDTH cells were Ly-1 2/3 
- + 
whereas Ts and Tc cells were Ly-1 2/3 . However, it appears now that all 
T cells express the Ly-1 antigen, but Ly-1 density varies greatly between 
T cell subsets: Ly-2/3 cells expressing the highest quantity of Ly-1 and 
+ Ly2/3 cells expressing the lowest amounts (Mathieson et al., 1979; 
Ledbetter et al., 1980; Hogarth et al., 1980). Nonetheless, the Ly 
alloantigens have been used extensively to discriminate between functional 
subpopulations of T cells. For example, the Ly phenotype of TH cell 
precursors has been examined by some workers and been shown to be either 
+ - + + Ly-1 , 2/3 (Feldmann et al.., 1977) or Ly-1 2/3 (Shen et al., 1981), 
depending upon the experimental system used. One explanation for this 
+ + discrepancy is that the Ly-1 2/3 cells are not TH precursors but aid 
in the development of TH cells. 
Although the Ly antigens cannot be used to distinguish between 
Tc and Ts cells, the expression of I-J subregion controlled determinants 
on Ts cells has become a particularly useful method of differentiating 
these two activities (Murphy et al.., 1976). It should be noted however, 
+ 
that I-J TH cells have been reported (Tada et al., 1978). An additional 
method of separating Ts cells has been described by Shearer et al., (1972) 
based on the affinity of these cells for histamine . 
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+ -While both TH and TDTH cells are Ly-1 2/3 , they can be different-
iated functionally. The use of selective irmnunization regimens by a 
number of investigators have suggested that the induction of TH cells may 
be inversely related to the induction of cells mediating DTH reactions 
(Parish, 1972). In a typical experiment, immunization with low doses 
of SRBC induced DTH but failed to induce antibody (Gordon and Yu, 1973). 
These observations were supported by others (Liew and Parish, 1974; 
Silver and Benacerraf, 1974) and functionally dissociated TH from TDTH cells. 
Similarly, Dennert and Lennox (1974) developed a system for 
selective stimulation of Tc or TH cells. Their findings indicated an 
inverse relationship between the generation of Tc and TH cells. Comparable 
observations by Janeway et al., (1975) clearly demonstrated that T cells 
mediating helper activity for humoral irmnune responses are distinct from 
those participating in cytotoxic reactions as well as those mediating DTH 
responses. 
Thus TH cells for antibody responses appear to be in many cases 
physically and functionally distinct from Tc, TDTH and Ts cells. However, 
even TH lymphocytes are not a homogeneous class of cells (see section 4.4.1). 
+ -Heterogeneity within the Ly-1 2/3 TH cells for antibody responses has 
been demonstrated by a number of laboratories (Marrack and Kappler, 1976; 
Tada et al.,1978; Janeway, 1979; Bottomly et al., 1980; Takatsu et al ., 
1980). In these studies two helper T cells which may act independently 
or synergistically were identified: Th 1 which 
+ - -is Ly-1 2/3 , 1-J , 1-A 
+ - + + 
and is nylon wool nonadherent and Th 2 which is Ly-1 2/3 , 1-J , 1-A and 
nylon wool adherent. 
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3.2.2 B lymphocytes 
B cells are the precursors of antibody forming cells, and like 
T cells, they are diverse in terms of physical properties, display of 
cell surface markers and responsiveness to various stimuli. This 
heterogeneity is due in part to cells differing in terms of maturity and 
antigen experience. In addition, differences in responsiveness may also 
reflect functional specialisation of B cell subsets (reviewed by Katz, 
1977). 
Surface imrnunoglobulin (Ig) is the most widely used marker for 
identifying B cells. B cell subsets expressing one or more of the known 
lg classes, namely IgM, IgD, IgG, IgA and IgE have been identified. IgM 
is the first lg class expressed on immature cells, subsequently followed 
by IgD and then other classes. This differentiation is probably 
antigen driven, although there is some evidence that differentiation can 
occur in absence of exogenous antigens (reviewed by Kincaide, 1981). 
Usually the lg specificity for antigen expressed on B cell surface 
represents the specificity it will synthesise following antigenic 
stimulation. However, B cells do have an ability to switch lg class they 
synthesise, whilst maintaining the same specificity for antigen. The 
manner in which lg genes are rearrange d is now well documented, although 
the actual mechanisms of gene splicing and the factors which regulate 
this process remain unknown (Cory and Adams, 1980; Weigert~~ al., 1980). 
In addition to lg, B cells express a vari e ty of cell surface 
markers (reviewed in Katz, 1977). Some of these are found only on B cells, 
namely (a) alloantigens such as Lyb - 4, 5, 6, 7, 8 (b) heteroantigens 
such as mouse-specific B cell antigen (MBLA) and mouse specific plasma cell 
antigen (MSPCA) (revi e wed by Katz, 1977). Examples of other surface 
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structures found on B cells but not exclusive to them are Fe receptors 
for different lg classes (Basten et ai.., 1972), receptors for the third 
component of complement (CR) and antigens of the major histocompatibility 
complex. 
Functional subsets of B lymphocyt e s have been identified on the 
basis of some of the cell surface markers listed above. Thus Parish and 
Chilcott (1975) demonstrated that antigens vary in their ability to 
+ 
activate CR and CR B cells to synthesise specific antibody. Polyme ric 
antigens such as DNP-POL and horse red blood cells were found to activat e 
+ both CR and CR B cells to secrete antibody where as soluble antige ns 
+ 
such as DNP-MON triggered only CR B cells. It was concluded that polyme ric 
nature rather than T cell dependence is the factor that determines 
whether an antigen can provoke CR B cells to secrete antibody since the 
response to HRBC is T cell dependent while the response to DNP-POL 
is not. Complement receptors may facilitate T-B interaction by stabilizing 
+ 
the antigen on irnrnunoglobulin receptors on CR B cells. Polymeric anti gens, 
on the other hand, bind avidly to lg rece ptors without such a mechani sm . 
The CBA/N mouse strain has been particularly useful in delineating 
B cell subpopulations as it lacks a functional subset of B cells carrying 
the Lyb 5 alloantigen. Asano et a£., (1981) and Singer et ai.., (1981) 
+ -have shown that both Lyb 5 and Lyb 5 subs e ts r e spond to T c e ll 
dependent antigens in vivo and in vitlr.o; howe ver, while the activation 
of the Lyb 5+ subset did not require th e T cell r e co gnition of MHC 
determinants on its cell surface , the Lyb 5 subse t can only be activat e d 
by T cells which do int e ract with MHC anti ge ns on it s me mbran e . 
A subset of B ce lls can be activat e d to antibody s e cretion with-
out T cell help (Playfair and Purve s, 1971) to hapt e nat e d "T c e ll 
17 
independent antigens" such as Fico 11, T4, Bttuc.e.lla aboktu/2, and LPS. 
Whether responses to these antigens are truly T cell independent or 
whether they are very efficient inducers of TH cells is still a 
contentious . issue (Letvin e.t al., 1981) discussed in detail by Katz (1977). 
4. CENTRAL ROLE OF THE MHC IN HUMORAL IMMUNITY 
4.1 General Considerations 
The general requirements for cell-cell int e raction in the 
development and regulation of immune responses have been extensively 
investigated during the past 10-12 years. During this time a large 
amount of evidence has been obtained which indicates that gene products 
of the major histocompatibility complex (MHC) play an important role in 
lymphocyte function (reviewed by Katz and Benacerraf, 1975, 1976; 
Rosenthal and Shevach, 1976; Solliday-Rich and Rich, 1976). The original 
studies which implicated the MHC, suggested that the interaction of 
macrophages with T cells (Rosenthal and Shevach, 1973) and T cells with 
B cells (Kindred and Shreffler, 1972; Katz e.t al., 1973) occurred only if 
these cells shared MHC determinants. These observations led to the 
proposition that cell-cell collaboration in immune responses is controlled 
by MHC-linked cell interaction (CI) genes coding for cell surface 
molecules which mediate these interactions (Katz and Benacerraf, 1975). 
Initially, CI genes were though t to serve a pure ly physiological 
role, enabling T cells. and B cells to interact. The role of the MHC in 
immune responses became more clear cut wh en Zinkernage l and Doherty (1974) 
demonstrated that virus-specific cytotoxic T cells only lysed virus-
infected target cells which were MHC compatible. This phenomenon became 
known as "MHC (H-2 in the mouse) restriction". Subsequent work established 
an immunologically important role for MHC antigens, showing that T cell 
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recognised a foreign antigen in association with a self-MHC antigen 
(Zinkernagel and Doherty, 1979). 
4.2 The Murine MHC 
The phenomenon of "MHC restriction" has been studied most 
extensively in the mouse due to the well characterised MHC of this species. 
Before discussing MHC involvement in the humeral immunity, the general 
properties of the murine MHC will be considered. 
4. 2. 1 Genetic Arrangement 
The MHC, known in the mouse as the histocompatibility 2 complex 
(H-2), (originally defined by Corer, 1936), is known to affect a spectrum 
of immune functions such as cell-mediated immunity, collaborative 
interactions between T cells and B cells and proliferative responses to 
various antigens (reviewed by Klein, 1975, McKenzie et al., 1980). The 
H-2 complex also controls a variety of nonirnrnunological functions such as 
serum testosterone levels, mating preference and cortisone-induced cleft 
palat e (Klein, 1978). 
The analysis of this gene complex has been greatly advanced by 
the availability of H-2 congenic and intra-H-2 recombinant strains of 
mice (Klein, 1975) which have enabled the division of the H-2 complex into 
distinct regions and subregions, each defined by a marker locus. The 
H-2 complex can be divided into four maJor regions, namely H-2K, H-21, 
H-2S, and H-2D (see Figure 1). 
The H-2K and H-2D regions code for serologically defined H-2K 
and H-2D antigens which serve as strong transplantation anti gens and are 
involved in the activation of T cells in GVH reactions, and in the 
induction of cell-mediated cytotoxicity (Klein, 1975). More recently, 
FIGURE 1 
Genetic map of the murine MHC 
Regions K I s u D 
Subregions N A B J E C 
I l l J I t l 
Gene products H-2K Ia Aa ? Ia Ea Ia Ss H-2U H-2D 
AB Slp H-21 
EB H-2R 
H-2M 
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a sixth sub-region I-N has been assigned on the basis of serological and 
MLR data (Hayes and Bach, 1980). Also, a new region termed H-2U has 
been recently defined at the D end of the H-2 complex that appears to 
control Ia-like antigens and may have arisen from gene duplication of 
a primordial I region (O'Neill and Parish, 1981a). 
Finally, the S re gion codes for the Ss and Slp serum proteins, 
one of which has been shown to be functionally the fourth component of 
complement (Demant e.t al.., 1973; Curman e.t al., 1975). 
The entire H-2 system has been extensively discussed in many 
excellent reviews and monographs (Shreffler and David, 1975; Klein, 1975, 
1978; Benacerraf and Germain, 1978; McKenzie e.t al.., 1980; Murphy, 1980a) 
consequently the section below will only briefly describe the H-2K and 
H-2D antigens and will focus largely on the I region encoded antigens. 
4.2.2 H-2K and H-2D Antigens 
The H-2K and H-2D region coded antigens are expressed on virtually 
all tissues. Some 70 antigenic specificities are controlled by these 
regions indicating the high degree of complexity and polymorphism of this 
antigenic system (Kleine.ta£., 1978; Morgan e.t al.., 1980). Biochemical 
studies have shown that both molecules are glycoproteins with a molecular 
wei ght of 45,000 daltons and, in contrast to the Ia antigens, associate 
with S2 microglobulin (11,500 daltons). While studies on the chemical 
composition and biochemical properties suggest that the Kand D gene 
products are proteins, evidence for carbohydrate-defined specificities 
for H-2K antigens also exists, suggesting the existence of two types of 
antigenic determinants (O'Neill e.t a£ ., 1981; O'Neill and Parish, 198lb;. 
As mentioned earlier, there is now good evidence that the H-2K 
and H-2D antigens can act as strong transplantation antigens and 
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lymphocyte activating determinants and, also, represent the "self" 
structures involved in the "H-2 restricted" recognition of target cells 
by Tc cells. 
4.2.3 Ia Antigenic System 
The I-region associated (Ia) antigens of the mouse are a highly 
polymorphic system of antigens which are controlled by a cluster of genes 
locat ed within the H-2 complex (Shreffler and David, 1975; David, 1976). 
Whether these Ia antigens represent the products of Ir genes is at present 
controversial, although recent studies with an I-region mutant mouse strain 
suggests that this is indeed the case (McKenzie ~ta£., 1981). The Ia 
antigens undoubtedly play a role in MLR (Schwartz ~t cu.., 1976a; Okuda 
and David, 1978) and T-m~ interactions (Schwartz ~t al., 1976b; 1978). 
They are also associated with several irnrnunoregulatory molecules such 
as helper factors (Armerding ~t al ., 1974; Munro and Taussig, 1975), and 
suppressor factors (Tada ~t al ., 1976; Theze ~ta£., 1977) of antibody 
forrna t ion. 
It is generally accepted that the Ia antigens are glycoprotein 
molecules of molecular weight 58,000 daltons, which dissociate into two 
polypeptide chains of mol. wt. 33,000 ( a chain) and 25,000 daltons 
( B chain) (Cullen ~t cu.., 1976). The antigenic determinants of these 
molecules appear to reside in their protein portion. However, 
considerable evidence has now been obtained which suggests that Ia 
antigenicity can also r es ide in carbohydrate determinants (reviewed by 
Parish and McKenzie, 1980). The carrie rs of these antigens appear to be 
gangliosides (Parish ~t cu. ., 1976a, b, c), and they have been detected 
on cell surfaces as well as on soluble T cell factors. Together, the 
evidence suggests that two classes of Ia antigens exist, one whose anti-
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genie determinants are defined by protein, the other by carbohydrate. 
Unlike the H-2 antigens, Ia antigens have a restricted cellular 
distribution, possibly reflecting their different functional role. They 
are expressed in highest concentration on B cells and macrophages, but can 
also be detected on T cells especially when these cells become activated 
(reviewed by McKenzie and Potter, 1979). 
Genetic control of the expression of Ia antigens can involve 
interaction between more than one l subregion. Recent studies by Jones 
et ai. : (1978) suggest that the Ia molecules controlled by the I-E sub-
region arise by complementation between gene mapping in both the I-A 
and I-E subregions. Subsequently, Cook et al. (1979) demonstrated 
considerable heterogeneity in the S chains of I-E molecules detected 
in recombinant strains differing at the I-A subregion. Since no 
heterogeneity was found in the a chains of the recombinants, these results 
suggest that the I-E controlled molecules are hybrids, the a chain being 
the product of I-E and the S chain being coded for by the I-A subregion. 
The S chain also appears to be essential for insertion of the molecule 
into the plasma membrane (Jones et al., 1978). 
As already mentioned, the I-region can be subdivided into six 
genetic regions, I-N, I-A, I-B, I-J, I-E, I-C which will be considered here 
separately. Each subregion is associated with one or more genes which 
control different immunological phenomena, although whether some of these 
phenome na are effects of one or several genes mapping to a particular 
subregion is not yet known. 
1-N subregion 
The I-N subregion maps between H-2K and I-A and has been only 
recently identified by serologically defined Ia specificity and MLR 
stimulating determinants (Hayes and Bach, 1980). 
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I-A subregion 
The I-A subregion contains the Ia-1 locus coding for Ia specificities 
found mainly on B cells (Hammerling, 1976; Abbas et ai., 1976) and less 
often on T cells (Murphy et al., 1976b; Stout et al., 1977; Fujimoto 
1978; Marrack et al., 1980), splenic macrophages (Cowing et al., 1978b), 
epidermal cells and Langerhans cells (Frelinger et al., 1978). However, 
current evidence suggests that some of the Ia specificities on T cells 
differ from those on B cells (Stout et ai., 1977; Hammerling et al., 1979; 
Marrack et al., 1980), suggesting that at least two Ia loci exist in the 
I-A subregion. 
I-A subregion antigens have also been found on several innnuno-
regulatory factors such as helper (Thf) and augmenting (Taf) T cell 
factors (Taussig et al., 1975; Tokuhisa et ai., 1978; Howie et al., 1979), 
allogeneic effect factor (Armerding et al., 1974) and macrophage helper 
cell inducing fuctor (Erb et ai., 1976). The I-A subregion also codes 
for antigens on B cells acting as acceptor sites for some of these Ia-
bearing factors (Taussig et cu.., 1976), thus implying that Ia antigens 
can mediate cell-cell communication. 
A great deal of evidence suggests that products of the I-A 
subregion (probably the I-A antigens) play an important role in the 
induction and regulation of immune responses. Some of this evidence is 
listed below briefly. 
Cellular interactions between T cells and B cells (Sprent and 
Alpert, 1981; Asano et al., 1981) and T cells and macrophages (Erb and 
Feldmann, 1975) are genetically restricted, requiring I-A subregion 
compatibility for successful interaction. 
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Genes mapping in the I-A subregion code for lymphocyte-
activating determinants (Lad-1) which induce strong MLR (Klein, 1975; 
Lonai and McDevitt, 1977). Furthermore, anti-I-A sera that react with 
the stimulator cells can specifically block the induction of the MLR. 
A locus leading to graft rejection maps to the I-A subregion 
(Klein, 1975). As with the MLR above, a positive graft rejection response 
correlates with the presence of an Ia antigenic difference (McKenzie 
and Henning, 1977). Anti-Ia sera enhance graft survival. 
Anti I-A subregion sera and anti I-A subregion monoclonal 
antibodies can specifically block antigen-induced T cell proliferation 
(Schwartz et al., 1978; Nepom et al., 1981) and T-dependent antibody 
responses (McDevitt et al., 1976; Sprent, 1980a). 
Taken together, th ese points suggest that the I-A subregion 
controlled antigens play a major role in the induction and regulation of 
immune responses, a point of view strongly supported by the I-A subregion 
B6.c-H-2bml 2 , h. h . 1 1 d'f· d I . mutant w ic simu taneous y express mo i ie a antigens, 
transplantation antigens, Lad determinants and Ir genes (McKenzie et al ., 
1979; Michaelides et al., 1981). 
I-B subregion 
This r egion was initially defined by the presence of immune 
response (Ir) genes controlling responsiveness to an IgG protein (Klein, 
1975). One other Ir gene effect controlled solely by this subregion is 
r ecorded: it controls responsiveness to the male - specific H-Y antigen 
for DTH and graft rejection (Hurme et al., 1978; Liew and Simpson, 1980). 
So far, no Ia antigens are known to be associated with I-B. 
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I-J subregion 
This region, containing the Ia-4 locus, was originally defined by 
alloantisera which, in combination with complement, remove d suppressor 
T cells for antibody responses (Murphy ~t al., 1976b). the I-J subregion 
antigens are difficult to detect serologically, possibly because only a 
small number of lymphoid cells bear this marker (Parish and McKenzie, 1977). 
Initially, the I-J antigens were associated with suppressor 
function in a range of irrnnune responses. Thus, I-J determinants were 
demonstrated on carrier-specific, idiotype-specific and tumour-specific 
suppressor T cells, since treatment of the cell populations with anti-I-J 
sera and complement, removed these activities (Murphy, 1980). Additionally, 
the I-J antigens have bee n detected on T cell derived, antigen specific 
suppressor factors for humoral (Tada ~t al., 1976) and cellular (Greene 
~t al . , 1977) immunity as well as being associated with the acceptor 
sites for suppressor factors on T cells (Tada ~t al., 1977). 
Although I - J determinants are widely used as a marker for Ts 
cells, they have been detected on other cell types. A macrophage sub-
population required in the generation of primary ~n v~Uo antibody 
responses is I-J+, and anti I-J sera also blocks its activity (Niederhuber 
and Allen, 1980). Furthermore, a subpopulation of TH cells has also been 
shown to carry I-J determinants (Tada ~t al., 1978) although whether this 
antigen is directly involved in mediating helper function remains to be 
determined. to date, all B cells are apparently I-J In addition it 
appears that the I-J de t erminants found on accessory cells and helper 
T cells are distinct from those found on suppressor T cells (Murphy 
~t al., 1981), suggesting that at l eas t two loci exist in the I-J 
subre g ion, an assumption supported by the observation that th e I-J subregion 
codes for determinants expressed on suppressor factors as well as for 
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the acceptor site on target cells for these factors. 
Thus, as with I-A subregion anti gens, the I-J determinants 
appear to be regulatory structures used for cell communication both 
in a positive and negative mode. 
I - E subregion 
The I - E subregion is defined by the Ia. 7, Ia.22 and Ia.23 
specificities, all of which are present on one Ia molecule and are 
the r efore controlled by the one locus (Shreffle r et al . , 1977; Cullen 
et a£ ., 1980) . I - E determinants are found on most B cells (Abbas et a£ . , 
1976; Shreffler et al ., 1977), on some spl e nic macrophages (Cowin g 
et a£ ., 1978b) but not on resting T cells. Recent studies have demonstrat ed 
t he p r esence of a second locus in the I - E subre g ion, codin g for 
de t erminants found on Con A- activated T cells but not on B cells (Hayes 
and Bach , 19 7 8) . 
As mentioned above, the 6 chain of the I-E molecule is coded 
for by t he I - A subregion where as the a chain is an I-E subregion product. 
The I - E subregion coded part appears to r egulate the cel l surface 
expression of the I - A subregion product (David and Cullen, 197 8) . Mo r e 
recently, it has been shown that a gen e mapping in I-A-I-J r egulat es the 
quantitative expression of the I - E subregion controlled a chain (Murphy 
et a£ ., 1980). These findin gs demonstrate that I r egio n ge n e interactions 
may be essential for the expression of some Ia antigens and provide a 
rational explanation for complementing Ir ge n es in t he I-A and I-E/C 
subregions (Benacerraf and Germain, 1978) . 
I - C subregion 
This r egion is defined by th e Ia.6 specificity which is only 
found in two haplotypes (David and Shreffler, 1974). Some difficulty 
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has been encountered in demonstrating the existence of the I-C subregion 
and for a long time the I-C and I-E subregions were considered to be a 
single subregion I-E/C (Murphy, 1980). However, recent work of 
Sandrin et al . , (1981) has confirmed the original obs ervations of David & 
Shreffler (1974) and provided good evidence for the existence of an Ia.6 
specificity and hence a distinct I-C subregion. 
The I-C subregion has been detected on a subpopulation of T cells 
and mitogen-stimulated T cell blasts (David et al., 1976; McKenzie et al., 
1980). Ia specificities controlled by a gene mapping in the I-C 
subregion have also been detect ed with the us e of xenogeneic antisera. 
These de terminants represent carbohydrate-defined specificities and have 
been detected mainly on B cells (McKenzie et al., 1980), suggesting the 
existence of a second locus in the I-C subregion. In addition, the I-C 
subregion codes for Lad determinants expressed on stimulator T c e lls in 
the MLR (Okuda and David, 1978), and antigens on suppressor factors 
generated in a MLR (Rich et a£., 1979). 
In summary, the different I subregions appear to control a variety 
of related effects such as determinants on helper and suppressor cells 
or factors, Lad de terminants and Ir gene action. The ability of the 
appropriat e anti-Ia r eagents to block these various func tions suggests 
a direct rol e for Ia antigens in thes e effects. 
As me ntioned above, it is now generally accepted that MHC 
anti gens (H-2K, H-2D, and Ia) play a key rol e in the presentation of 
for e i gn antigens to the immune system, T cell recognising an association 
of anti ge n with MHC gen e products. In the case of virus-specific Tc 
cells it has bee n suggested that H-2K and H-2D restricted r ecognition 
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ensures that Tc cells identify and kill virus-infected cells while 
ignoring an excess of free virus (Howard, 1980). On the other hand, 
since Ia antigens have a limited cellular distribution, I-region 
r estricted recognition may control cell-cell collaboration in immune 
responses. Nonetheless, of all immune responses, the role of MHC gene 
products in antibody responses remains the most controversial. The sum 
of evidence suggests however, that MHC restriction in responses to T-
dependent antigens applies at two different levels: first, during 
activation of T helper cells (a manifestation of T-macrophage interaction) 
and second, during T cell-B cell collaboration per se. 
4.3 MHC involvement in T cell-macrophage interaction 
There is general agreement that the macrophage presentation of 
antigen to T lymphocytes in a range of systems is H-2 restricted 
(Ros entha l and Shevach, 1973; Erb and Feldmann, 1975; Paul ~t al ., 1977; 
Sprent, 1980). Although little is known of the exact role of macrophages 
in the antigen presentation, it seems that small fragments of antige n 
become associated with macrophage MHC determinants (usually Ia antigens). 
T cells then recognise this association, are stimulated, and henceforth 
can only be restimulated by antigen presented in association with the same 
MHC determinants. 
A number of workers have demonstrated that the respons e in primary 
m v~tAo antibody responses to hapten-carrier required that T cells and 
macrophages share the I-A subregion of the H-2 complex (Singe r ~t al., 
1977, 1978). Using a somewhat different approach, Kappler and Marrack 
(1976, 1978) reach e d the same conclusion: in thei r system it was found 
that F 1 (P1 x P2 ) TH cells primed to antigen on parent 1 macrophage could 
subsequently only be activated by antigen on P 1 but not P2 macrophage. 
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Analysis of a range of recombinant macrophages revealed that the I-A 
subregion of P 1 was required for antigen presentation. The demonstration 
+ 
that Ia macrophages are required for .m V~VlO antibody responses 
(Yamashita and Shevach, 1977; Cowing ~t al.., 1978a) is consistent with Ia 
involvement in these responses (see section 3.1). However, using a 
primary anti-SRBC response, Niederhuber (1978, 1980) reported that 
although macrophages carrying I-A, I-E/C and I-J determinants were 
required, treatment of macrophages with anti-I-J but not anti-I-A or 
I-E/C antibodies, completel y blocked their ability to present antigen to 
T cells. This result appears to be inconsistent with those mentioned 
above, since it implies that the I-J, not the I-A, determinant is the 
restricting element in I-macrophage interactions. One possible differene 
is that Singer ~t al.., Kappler and Marrack tested the restriction in 
a secondary (primed) situation whereas Niederhuber examined a primary 
response. 
It should be noted that in some studies, I region restricted 
interactions between lymphocytes and macrophages were not found (Katz 
and Unanue, 1973; Unanue, 1978). In these experiments allogeneic 
macrophages were used to present TNP-KLH to carrier-primed spleen cells. 
However, the primed spleen cells were unfractionated and therefore 
contained syngeneic macrophages. Unanue (1978) raised the possibility 
of antigen transfer from allogeneic to syngeneic macrophages, a possibility 
with is supported by the work of Pierce and Malek (1980). 
In v~vo evidence for MHC-restricted interaction between helper 
T cells and macrophages has been elegantly demonstrated by Sprent (1978a, b). 
In his system, purified F1 (P 1 x P2 ) T cells were primed to antigen in an 
irradiated parent 1 strain. The resultant TH cells were shown subsequently 
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to only be activated when exposed to antigen in the presence of 
P
1 
but not P
2 
accessory cells. Furthermore, the priming process could 
be blocked by the injection of monoclonal anti Ia P
1 antibodies (1980b). 
4 . 4 MHC Involvement in T cell-B cell interaction 
While it is generally believed that the T cell-macrophage 
interaction in antibody responses is I- region restricted, the unresolved 
question until very recently was whether T cell clones which respond to 
antigen in association with a particular macrophage Ia antigen will only 
collaborate with B cells bearing the same Ia antigens. 
Thus, cellular interactions between TH cells and B cells in the 
generation of primary and secondary IgM and IgG responses both m vivo 
and m vitfc.o have variously been reported as being restricted by the 
MHC (Katz et a.1.. , 1973; Sprent, 1978b, c; Swierkosz et a.1.., 1978) or not 
being MHC restricted (McDougal and Cort, 1978; Erb et a.1. . , 1979; Singer 
et a1. . , 1 9 7 9 , 1 9 81 ; sh i h et a1. . , 1 9 8 o ) . 
The explanation for these differences has not been apparent. 
Variables such as the antigen-primed status of the responding population 
of cells, the predominant lg isotype of the response and the use of 
.{YL vivo or ,{,Y!. vitJr..o response systems have failed to correlate with the 
presence or absence of a requirement for H-2 restricted recognition of 
B cells. 
Although a large number of workers have tried to resolve the 
question of MHC restriction between T and B cells since Katz 
et al . , (1973), first reported it, much of the early work is difficult 
to evaluate, either because the reported lack of H-2 restriction may 
have been due to allogeneic effects between H-2 incompatible cell 
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populations or, the apparent presence of restriction could have been 
due to the absence of the appropriate H-2 bearing macrophages, thus 
preventing helper T cells from being~ reactivated. 
Possibly the two best experiments resolving this issue were 
done by Sprent ,{J1 v~va (1978c) and by Asano e;t al. (1981) and Singer 
e;t al. (1981) both ,tYL v~va and ~n v~:ur.o. Sprent used F
1 
(P
1 
x P
2
) 
into parent (P 1 ) chimeric TH cells primed to SRBC in the context of 
P1 MHC antigens. He injected these TH cells into irradiated 
F1 (P1 x P2 ) hosts (which therefore contained radioresistant macrophages 
able to present antigen in the context of either the P 1 or P2 H-2 type) 
together with either P 1 or P 2 derived B cells and antigen and 
demonstrated that such T cells could help only P
1 
B cells but not P2 
B cells. His system avoided the allogeneic effect and supplied the 
appropriate antigen-presenting cells for reactivation of primed T cells 
thus unequivocally demonstrating that T-B interaction during a secondary 
antibody response to SRBC is H-2 restricted. 
Asano ~t al. (1981) used F1 (P 1 x P2 ) into P1 chimeric TH cells 
which were cultured ,{J1 V~Vl.O with appropriate F 1 or P 1 strain macrophages) 
in the presence of either P1 or P2 B cells and TNP-KLH. It was 
demonstrated that for responses to low concentrations of antigen the TH 
cells only collaborated with B cells of the P1 H-2 haplotype. In contrast, 
at higher antigen concentrations, the TH cells were unrestricted, 
collaborating with both P
1 
and P2 B cells. 
In contrast to the findings of Sprent, Singer ~t al. (1981), usin g 
a cell transfer system to examine a primary ,{J1 v~va antibody r esponse to 
SRBC demonstrated that in normal animals the respons e was restricted by 
the I-A subregion at the T cell-B cell level whereas in CBA/N mice no 
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H-2 restriction occurred, although both of these responses were 
restricted by the I-A subregion at the T cell-macrophage level. 
Underlying the controversy of H-2 restriction at the T cell-
B cell level is the possibility that both TH cells and B cell populations 
are functionally heterogeneous. Indeed, it has been suggested that two 
distinct subpopulations of TH cells exist, one of which is H-2 
restricted at the T-B level while the other is not (Janeway, 1975; 
Marrack and Kappler, 1976; Tada ~t al., 1978; Takatsu ~t al., 1980, etc.). 
Similarly, some reports suggest that at least two distinct subpopulations 
of B cells with identical antibody repertoires but different activation 
requirements exist (Asano ~t al., 1981; Singer ~t al . , 1981). One of 
these B cell subpopulations interacts in an MHC-restricted manner with TH 
cells whereas the other B cell subpopulation does not. 
4 . 4 . 1 Heterogeneity in T helper cells 
A number of laboratories have now shown that more than one kind 
of TH cell is required for B cell responses to protein-coupled antigens 
(Feldmann, 1972b; Schimpl and Wecker, 1972; Waldmann ~t al., 1976; 
McDougal and Gordon, 1977; Woodland and Cantor, 1978). This is in direct 
contrast to reports that B cell responses to red cell bound antigens 
probably only require one helper T cell activity (Schimpl and Wecker, 
1972; Harwell ~t al . , 1976), although there may also be a role for 
macrophage-derived factors in these responses (Hoffmann ~t al., 1979). 
It is quite possible that different forms of antigen have different T 
cell requirement, since some antigens are thought to be able to induce 
antibody responses in the absence of TH cells. 
The involvement of two TH cells in the anti-TNP, antibody response 
to TNP-protein conjugates has been demonstrated in a number of ways. 
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Janeway (1975) obtained unexpected slopes on log-log plots of antibody 
obtained versus T cells of transferred in in vivo cell transfer 
experiments which indicated that responses to hapten-carrier conjuga t e s 
indeed two T cell populations and one B cell population. More recently, 
Tada et al . (1978) showed that two types of T cells were involved in 
. H 
. + these responses, one of which was I-J and nylon wool adhe rent whereas 
the other lacked these characteristics. Marrack et al. (1980) also 
reported the existence of two TH subsets, one of which expressed I-A 
subregion antigens while the other did not. the T cell subset carrying 
I-A determinants was resistant to lysis by conventionally raised anti-Ia 
sera plus complement, but was depleted with sera raised against the Ia 
antigens on Con A blasts (Marrack et al., 1980). 
The two sets of TH cells were designated Th1 and Th2 by Tada 
et al. (1978). Marrack and coworkers defined the two classes of TH cells 
in the following expe riment: F1 (P 1 x P2 ) into P 1 chimeric T cells, 
when antigen primed, could only help P 1 but not P2 B cells even wh e n 
the appropriate macrophage type was present, thus demonstrating that an 
essential TH cell can only interact with H-2 compatible B c e lls. In 
the second part of the experiment it was shown that the TH cells could 
collaborate with both P 1 and P2 B cells in the presenc e of a con A-
induced supernatant, but only if P 1 strain macrophages we r e also present. 
The ability of the Con A supe rnatant to over-ride the H-2 restricted 
interaction of TH cells with B cells but not with macrophages sugges ted 
that two helper activities wer e r e quired for an anti-TNP antibody r esponse , 
one involving the MHC-restricted int e raction of T cells with macrophages 
and the other resulting from a MHC-restricted T-B interaction. 
An attempt will be made here to summarise the different 
characteristic of the two t ypes of TH cells, i.e. Th 1 and Th2 (see Table 1). 
TABLE 1 
CHARACTERIZATION OF TH SUBSETS 
Trait tested Thl Th 2 
Ly antigenic phenotype + Ly-1 , 2/3 Lyl + 2/3 
antigens + Ia I-A I-A 
nylon wool adherence No Yes 
Antigen specificity Yes Yes 
Requires an antigen bridge Yes No 
Requires lg for priming No Yes 
Required for in V,tVO antibody responses Yes No? 
Required in anti-SRBC antibody response No Yes 
MHC restricted at T cell-macrophage level Yes Yes 
MHC restricted at T-B level No? Yes? 
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+ -The Th 1 subset of TH cells is Lyl 2/3 , 1-A, I-J and nylon 
wool nonadherent and acts early in the B cell r esponse to TNP-protein 
conjugate (Marrack and Kappler, 1976; Tada et al.,1978; Kappler et al., 1979; 
Marrack et al., 1979). It recognises macrophage bound carrier molecules 
in an H-2 r estricted manner and requires a hapten-carrier bridge in order 
to activate B cells (Tada et al., 1978; Janeway et al., 1980), suggesting 
that this T cell subset must be physically close to a hapten-specific B 
cell to activate it either directly or by release of close-range T cell 
factor(s). Whereas the Th 1-macrophage interaction is H-2 restricted, 
the Th 1-B cell interaction is not (Marrack et al., 1980). It is this 
subset of TH cell which is active in the ~n v~vo adoptive cell transfer 
experiments to hapten-carrier conjugates, but is absent in anti -S RBC 
respons es (Janeway et al., 1980; Marrack et al., 1979). 
+ - + + The Th 2 subset is Ly-1 2/3 , I-A , I-J and nylon wool adherent 
(Tada et al., 1978; Marrack et al ., 1980). It is required late in the 
response to hapten-carrier and is the only TH cell needed in anti - SRBC 
responses ( 1arrack et al ., 1980). Th 2 is antigen-specific at the level 
of the T cell-macrophage interaction, but does not appear to need an 
antigen bridge to activate B cells, i.e. the relevant hapten and carrier 
need not be on the same molecule (Marrack and Kappler, 1975; Tada et al ., 
1978). Like Th 1 , Th 2 recognises the carrier in association with Ia 
on the macrophage membrane in an H- 2 restricted manner (Marrack et al ., 
1980). However, unlike Th 1 , Th 2 cell interacts with hapten-specific 
B cell in an H-2 restricted manner, this interaction resulting in the 
secretion of a nonspecific helper factor from Th 2 akin to those factors 
found in Con A supernatants C1arrack et al ., 1980 ). 
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Do Th 1 and Th 2 act independently or in unison in responses to 
hapten-carrier? The answer appears to vary: Janeway ~t al. (1980) 
and Bottomly ~t al . (1980) claim that Th 1 subset alone is sufficient 
for these responses both in vivo and in viVLo. In contrast, Marrack 
~t al.. (1979) and Kappler ~t al. (1979) suggested that both types of TH 
cells can act independently, but best responses occur when these two 
cells synergise . 
The existence of two TH cell subsets can resolve a number of 
apparently contradictory observations in the literature: namely, the 
genetic restriction observed between T cells and B cells and the ability 
to obtain responses to linked and unlinked hapten-carrier conjugates. 
Hence when responses were obtained only to a hapten linked to the 
relevant carrier, or in the absence of histocompatibility between T 
and B cells, the authors must have dealt with the Th
1 
subset. On the 
other hand, responses requiring strict histocompatibility between T 
cells and B cells or triggering of hapten-specific B cells by unlinked 
carrier involved the action of Th 2 subset. 
In addition to characteristics ascribed to the Th
2 
subset, 
Bottomly ~t al. (1980) showed that Th 2 cells cannot be induced in mice 
depleted since birth of B cells (and lg), suggesting that the induction 
of Th 2 is lg-dependent. Although this was interpreted to mean that Th 2 
has receptors for lg, it would mean that Th 2 cells must have at least 
3 separate recognition capabilities: one for antigen, one for self-MHC 
and another for lg. Alternatively it may be postulated that an inducer 
of Th 2 rnust recognise lg: this "third" cell may be involved in 
regulating lg class secreted by B cells as postulated by Rosenberg (1980). 
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A possible model for the role of the two T cell subsets in H 
an antibody response to a TNP-protein conjugate is as follows: Th1 cell 
interacts with carrier - Ia antigen complexes on macrophages in an l-region 
restricted manner and become activated. In turn, the Th
1 
cells activate 
the linked, TNP-specific B cells that have bound antigen, either through 
cell contact (not H-2 restricted) or by short-range T cell factors. 
Once these B cells are activated, they become capable of interacting 
with Th 2 cells in an H- 2 restricted fashion. The Th 2 cells, like Th 1 , 
are initially activated by the recognition of carrier- Ia antigen complexes . 
Possibly another lg - recognising cell regulates Th2 activation. The 
activated Th
2 
cells then interact with B cells through recognition of 
H- 2 molecules and may release nonspecific T cell factors which support 
the differentiation of B cells into plasma cells. 
How then, are anti-SRBC antibody responses activated? Evidence 
suggests that the Th 1 subset 
sufficient help . If this is 
is not needed, Th 2 cells alone providing 
true, then the B cells in an anti-SRBC 
response obviously must either not need the first signal from the Th 1-
macrophage-B cell complex or the nature of this signal must be 
different . For example, there may be a role for macrophage derived 
factors in this response (Hoffman ~t al . , 1979). 
4 . 4 . 2 B lymphocyte heterogeneity 
In addition to the existence of heterogeneous TH cell subpopulations 
which differ in their requirements for reco gnition of MHC determinants 
on B cells, recent findings have demonstrated that B lymphoc y tes differ 
in their inductive requirements, some requirin g r ecognit ion of surface 
MHC antigens by T cells for activation wh e r eas others being induced by 
T cells without MHC involvement. The following section deals with the 
existence of such B cell subpopulations and discusses their role in T c e ll-
dependent antibody responses. 
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The existence of distinct B cell populations has been established 
on the basis of their expression of a number of cell surface markers 
including Ia, Ig, Fe receptors, complement receptors and most recently 
by the differentiation antigens Lyb-3, Lyb-5 and Lyb-7 (Huber ~t al., 
1 9 7 7 ; Ahmed ~t a£ . , 1 9 7 7 ; Sub bar o ~t a£ . , 1 9 7 9 ) . ( see s e ct ion 3 . 2 . 2 ) . 
B cells can be separated into two equally sized subpopulations based on 
their expression of the Lyb-5 antigen, which is a cell surface antigen 
encoded by a single locus with two allelic forms. B cells expressing the 
Lyb - 5 antigen are a late - appearing subpopulation in mice and are 
virtually absent in mutant CBA/N mice. + The Lyb-5 and Lyb-5 B cell 
subpopulations may represent two distinct B cell lineages or two functionally 
distinct differentiation stages of the same B cell. 
Using CBA/N or Lyb - 5 - depleted B cells as a source of the Lyb-5 
B cell population and normal B cells containing both populations, Singer 
and coworkers (Singer ~ta£ ., 1981; Asano ~ta£., 1981) demonstrated 
- + that Lyb - 5 and Lyb - 5 B cells differ, both in vivo and in vitJr.o, in 
their MHC requirements for activation by TH cells. In an adoptive cell 
transfer system similar to that used by Sprent (1978c) chimeric T cells 
(F
1 (P1 x P 2 • P 2 ) restricted to see P1 MHC were assayed for their ability 
to activate unprimed SRBC-specific P
2 B cells in an irradiated P 2 host 
containing F
1 
(P
1 
x P
2
) macrophages. When the B cells consisted of both 
+ Lyb-5 and Lyb-5 subpopulations, no H-2 restricted interaction between 
T cells and B cells were observed, i.e. T cells restrict ed to see P
1 MHC 
determinants delivered help to P 2 B cells. However, when th e B cell 
population contained only Lyb-5 cells, the restrict ed TH cells could 
no longer help P
2 
B cells even in the presence of P 1 macrophages. This 
implies that for TH cells to activate Lyb-5 B cells, recognition of B 
+ cell MHC antigens is essential, whereas Lyb-5 B cells do not r equire such 
an ~BC-restricted interaction for activation. 
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A similar experiment in vitft.o produced comparable findings 
(Asano et al., 1981). At low concentrations of hapten-carrier, H-2 
restricted interaction between chimeric T cells and normal B cells was 
observed. In contrast, at higher antigen concentrations, T-B 
collaboration was not H-2 restricted. It was then demonstrated that low 
concentrations of antigen induced Lyb-5 B cells, but at high concentrations, 
+ Lyb-5 B cells were activated. These findings were consistent with the 
in vivo experiments indicating that the activation of Lyb-5 B cells 
requires direct TH cell recognition of B cell H-2 antigens, whereas such 
a recognition does not occur when TH cells interact with Lyb-5+ cells. 
In conclusion, the controversy over the MHC requirement for T cell-
B cell collaboration can probably be explained by the B cell subpopulations 
that differ in their MHC requirements. Restriction at delivery level 
occurs in responses which activate Lyb-5 B cells; lack of restriction 
+ 
reflects the induction of Lyb-5 B cells. In this context, it may be 
suggested that the in vivo experiment of Sprent (1978c) in which the 
induction of an anti-SRBC antibody response was, unlike Singer's et al. 
(1981), MHC restricted, induced Lyb-5 B cells, whereas Sin ge r induced 
+ 
Lyb-5 B cells. A key difference between the two experimental syst ems 
was that Singer examined a primary response, whereas Sprent analysed a 
secondary response. This diffe rence could have r es ult e d in different 
B cell subsets being activated. 
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5 ROLE OF SOLUBLE HELPER FACTORS INT CELL DEPENDENT ANTIBODY 
RESPONSES 
Ever since it was established that immune responses involve 
complex interactions between T cells, B cells and macrophages a lar ge 
number of workers have been attracted to the idea that such interactions 
are mediated by soluble factors that act as communication signals between 
the cells producing them and other cells carrying relevant acceptor 
sites. 
Evidence for the existence of such mediators came initially from 
the demonstration by Dutton ~ta£. (1971) that supernatants obtained from 
short term cultures of histoincompatible mouse cells contained a nonspecific 
biologically active mediator capable of markedly affecting ,{_YI, viuo antibody 
responses to T-dependent antigens. Since this observation, a number of 
different factors that appear to have biological relevance to T-B cell 
collaboration have been described by a plethora of investigators 
(Feldmann and Basten, 1972; Schimpl and Wecker, 1972; Rubin and Coons, 
1972; Watson 1973; Armerding and Katz, 1974a; Munro ~t al., 1974; 
Marrack and Kappler, 1976 ). 
A multitude of soluble helper factors can be generated by 
stimulation with specific antigens or mitogens. They are produced by 
T cells or macrophages and may be antigen-specific or nonspecific, bear 
or lack MHC determinants and are either MHC restricted or unrestrict ed 
in their action. The bewildering array of factors in the literature is 
in part a 1 reflection of the methods which have been used to identify and 
classify lymphokines over the past decade: each has been defined by its 
biolo gical activity in a particular in viuo assay and many have been 
given acronyms. The factors are difficult to purify due to their lability 
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and very low starting concentrations in biological preparations. As 
a result, the term "factor" is not a clear definition, merely 
designating a heterogeneous group of molecules whose molecular identity 
is not yet known. Many of the factors discussed here have not been 
isolated or characterized beyond localization of activity in column 
effluents . 
Soluble mediators exerting a positive effect on antibody 
responses will be considered here in three separate sections: 
(i) antigen-specific T cell derived helper factors 
(ii) antigen-nonspecific T c e ll factors, and finally 
(iii) macrophage-de rived factors. 
It should be emphasized at the outset that a variety of 
different molecules are capable of exerting virtually indistinguishable 
biological effects . Hence the expression of a g iven bi ological activity 
cannot be taken as an identification of any one fact or ; the ultimate 
proof of ide ntity requires biochemi ca l and immunological characterization. 
It should also be noted that soluble mediators, as a rule, serve the rol e 
of a "second signal" in c e ll activation and exe rt activity only when 
anti gen-spe cific r eceptors on l ymphocy t es have bound antigen ("first 
signal") . 
A summary of factors discussed in this chapter is presented in 
Table 2 . 
AUTHOR 
(1) IgT 
Feldman and 
Basten, 1972 
Tamaguchi and 
Tada, 1974 
(2) Ia 
Taussig and 
Munro, 1974 
Isac and 
Mozes, 1974 
TABLE 2 
DERIVATION 
In vivo education with 
protein antigens followed 
by culture with antigen. 
In vivo education with 
carrier, in vitJc.o culture 
with antigen . 
In V,tVO education to 
synthetic polypeptides, 
In vitJc.o 8 hr culture with 
antigen . 
In vivo education to 
synthetic polypeptides 
In vitJc.o culture with 
antigen. 
AS SAY SY STEM 
PROPERTIES 
PHYSIOCHEMICAL TARGET 
In v,i;tJr,o IgE 
response to 
hapten carrier 
DNP-KLH or 
DNP-FGG 
180,000 daltons Macrophage 
monomeric IgM 
In V,tVO IgE 
response to 
ascaris 
+ + 
k ' µ 
100-200, 000 
daltons 
monomeric IgM? 
In v~vo IgM 1.50,000 daltons 
& TGAL response 2.Two subunits 
45,000 and 
70,000 daltons 
In V,tVO & ~50,000 daltons 
PGAL, HGAL 
B ce 11 s 
B cell 
B cell 
(absorbed) 
CARRIES H-2 
H-2 ANTIGENS RESTRICTED 
+ I-A 
+ I-A 
NO 
NO 
(Table 2 continued) 
AUTHOR 
Howie and 
Feldmann, 1977 
Howie 
. ' 
1979 
Tokuhisa 
(3) Nonspecific 
AEF (Armerding 
and Katz , 1 9 7 4 ) 
Delovitch 
DERIVATION 
In vitJr.o education with 
proteins or synthetic 
polypeptides, m v~VLO 
24 hr culture with 
antigen. 
In vivo education with 
TGAL, m vitJt.o culture 
In vivo education with 
antigen, m vitJr.o culture 
with antigen . 
In v~vo education with 
irradiated allogeneic 
cells, )._n v~VLO culture 
with target. 
" 
ASSAY SYSTEM 
In vilioigM 
to KLH or TGAL 
In vJ.bc.o anti-
GAT response 
In vil.Jr.o anti-
KLH response 
In vitJr.o anti-
hapten response 
" 
PROPERTIES 
PHYSIOCHEMICAL 
50-60,000 daltons 
reacts with 
anti-lg 
50,000 
40,000 
12,000 - B2 
35,000 
68,000 
TARGET 
B cell or 
macrophage 
B cell 
T cell 
B cell 
B cell 
CARRIES 
H-2 ANTIGEN 
I-A 
I-J 
+ I-A 
+ I-A 
+ I-A 
+ 
+ 
H-2 
RESTRICTED 
NO 
NO 
YES 
I-A 
NO 
YES 
I-A 
(Table 2 continued) 
AUTHOR 
TRF (Schimpl 
and Wecker, 
197 
(4) Monokines 
K-1 
Hoffmann, etc . 
GRF 
Erb and 
Feldnwnn 
DERIVATION 
Antigen, alloantigen 
or mitogen-induced 
T cells 
In VWLO activation 
with LPS, activated 
T cells 
ASSAY SYSTEM 
In vilio anti-
SRBC or anti-
hapten response 
In vilio IgM 
and IgG 
response s 
In vilAo 
response to 
KLH, TGAL 
PROPERTIES 
PHYS roe llEMICAL 
30-35,000 
'vl6,000 daltons 
55,000 + 3,000 
complex 
including 
antigen 
TARGET 
B cell 
T cells 
B cells? 
T cell 
CARRIER H-2 
H-2 ANTIGEN RESTRICTED 
NO NO 
NO NO 
NO NO 
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5.1 Antigen-specific helper factors 
One of the key questions in T-B collaboration is how an 
antigen-specific TH cell can successfully activate rare clones of 
antigen-specific B cells. One means of explaining this dilemma is that 
the TH cells secrete antigen-specific helper factors. Theoretically, 
such factors have the advantage that they only interact with B cells 
that have bound the relevant antigen (particularly if MHC restrict ed 
r ecogni tion is involved) and therefore greatly increase the probability 
of an interaction between rare antigen-specific TH and B cells. Work 
during the last decade has, in fact, resulted in the identification and 
characterisation of such antigen-specific helper factors produced by 
T cells. These factors can bind antigen (or idiotype in some cases) 
and are capable of activating other cells. Besides helper factors, 
T cell.shave been shown to secrete antigen-specific suppressor molecules 
for both humoral and cellular immunity, but these will not be discussed 
here (reviewed by Tada and Okumura, 1979; Rocklin ~t al.., 1980). 
The antigen-specific helper factors, released by primed T cells 
upon challenge with specific antigen, induce B cells and plasma cells 
to produce immunoglobulin that is directed exclusively against the 
antigen used to elicit the helper factor. In experimental systems where 
hapten-carrier conjugates have been used to induce a secondary antihapten 
antibody response, these factors have been shown to possess specificity 
for the carrier component. 
Antigen-specific helper factors for antibody responses may be 
subdivided into two separat e groups: those that carry Ig determinants 
and those which bear Ia antigens. 
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5 . 1 . 1 Helper factors bearing Iq-like determinants 
The first demonstration of an antigen specific helper factor 
with biological activity was made by Feldmann and coworkers (reviewed 
by Feldmann and Nossal, 1972; Feldmann, 1974a, b) using Marbrook 
cul t ure vessels . These authors separated T cells from B cells with a 
nucleopore membrane and showed that carrier primed T cells, when 
i ncubated with a hapten- carrier conjugate, released a mediator that 
passed through the nucleopore membrane and activated hapten-primed B 
cells . The effect was carrier-specific, since antibody responses to _ 
unrelated antigens were not seen. Furthe rmore, the soluble mediator 
could be removed by anti-µ-chain and anti-K-chain antibody absorbents 
( Feldmann, 1972a, b) and its molecular weight was about 180,000 daltons, 
which is close to that of monomeric IgM (Feldmann e.:t CU., 1973'). 
Together, these results were taken to mean that the factor was T cell 
released Ig ("IgT") and thc1t "IgT" had similarities to monomeric IgM . 
This hypothesis was strong ly supported by the coinciding demonstration 
of monomeric IgM on T cells (Marchalonis e.;t CU., 1972). Subsequent 
studies revealed that the factor was cytophilic for macrophages: the 
factor - antigen complex bound to macrophages and could subsequently 
trigger B cells without T cells (Feldmann, 1972b). 
It has been hypothesised that this T cell-derived mediator 
may have a number of functions in cell cooperation. Thus (i) when bound 
to macrophages and antigen it triggers B cells, (ii) when the factor 
occupies the receptor for IgT on macrophages, responses to unrelated 
antigens are abrogated explaining "antige nic compe tition" and finally 
(iii) in the absence of macrophages, factor-anti gen complexe s may 
interact directly with B lymphocytes, resulting in specific T cell 
suppression (Feldmann, 1973, 1974c, Feldmann and Schrader, 1974). 
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Besides these ,U1 v~Vl.O experiments, some reports suggested that 
IgT-like molecules enhance ~n v~vo antibody responses (Taniguchi and 
Tada, 1974). In these studies thymocyte extracts from hyperimmunized 
animals reconstituted the antibody response of T cell deficient animals 
against the relevant antigen. The active molecule in the thymocyte 
extract carried Fab andµ chain determinants and had a molecular weight 
of between 100-200,000 daltons, thus resembling IgT. However, it is not 
known whether this mediator is T cell derived, and, in fact, there is 
some evidence that carrier-specific B cells produce the "IgT" molecule 
(Kirov and Parish, 1976a, b). 
The validity of the IgT molecule ~n v~vo and ~n v~Vl.o is yet to 
be established. A number of other workers have had great difficulty 
in de tectingµ and K chain determinants on T cell factors. Moreover, 
the presence of lg determinants on T cells is also unresolved 
(Marchalonis and Warr, 1979; Vitetta and Uhr, 1975). 
5.1.2 Helper factors bearing Ia antigens 
Th e first antigen-specific TH cell factor not bearing Ig 
determinants was described by Taussig (1974). Spleen cells from 
irradiated recipients reconstituted with thymocytes and challenged with 
synthetic copolymer antigens elaborated soluble mediators when cultured 
for 6 hours with the relevant antigen . This supernatant could replace 
antigen specific T cells when injected with unprimed bone marrow cells 
and antigen into irradiated mice, an IgM response being generated. 
The factor was a T cell product (Taussig ~t ai. ., 1976) with a mol e cular 
weight of 35,000-60,000 daltons. The activity could not be removed by 
an anti-mouse Ig immuno-absorbent, but was completely removed by absorbents 
coupled with the specific antigen (Munro ~t ai. ., 1974). The most 
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important feature of this factor is that it contains antigenic 
determinants coded for by genes in the H-2 complex. Specifically, the 
activity of this factor was removed by anti-I-A subregion immuno-absorbents, 
indicating that I-A subregion controlled determinants are carried by 
this antigen-specific helper factor (Taussig et a£., 1975). 
Similar antigen-specific T cell factors were generated against 
three other multichain synthetic polypeptides to which responses in 
mice are controlled by Ir-1 genes (Taussig et a£., 1974; Isac and Mozes, 
1977). These factors have a very similar physiochemical and immuno-
chemical properties to the factor first described by Taussig (1974), 
and are all products of the I-A subregion. 
The putative B cell receptor for these factors appears to be 
coded for by genes in the l region, since treatment of B cells with 
anti-Ia antisera prevented the cells from absorbing the mediator (Munro 
and Taussig, 1975). However, Munro et a£. (1974) using crossreactive 
anti-Ia antisera, demonstrated that the I-region determinants on the 
helper factors were different from B cell Ia antigens. It should be 
emphasized, however, the despite the fact that these antigen-specific 
TH cell factors carry I-A subregion controlled determinants, they are 
capable of cooperating with allogeneic B cells, i.e. they are not H-2 
restricted in their action (Taussig and Munro, 1976). 
These helper factors probably act directly on B cells sinc e 
they can be absorbed by bone marrow cells even in the absence of antigen . 
However, B cells of nonresponder strains were unable to absorb th e factor 
suggesting a lack of the I-A subre gion acceptor in these mice (Munro 
and Taussig, 1975). B cells trea t ed with this factor and antigen 
-<.Yl. v~:tAo mounted a good antibody response ,(Yl, v~vo when they are 
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injected into lethally irradiated recipients with additional antigen. 
If antigen was ommitted ,m vi:tlr.o, no re sponse was obtained, suggesting 
that B cell triggering is initiated by Ig receptors on the B cell binding 
antigen followed by factor-acceptor interaction, th e antigen-specific 
factor binding antigen on the B cell surface as well as interacting 
with its I-A subregion controlled acceptor. This latter interaction 
provides the second signal for B cell differentiation. 
The generation of Ia-bearing antigen specific helper factors has 
also been demonstrated ,01 vit.Jr.o (Howie and Feldmann, 1977). In vit.Jr.o 
induced TH cells specific for the synthetic polypeptide (T,C)-A-L 
elaborated a factor which could help B cells to secrete antibody against 
the relevant antigen. Interestingly, while this factor shared 
characteristics with Munro and Taussig's factor, it had some properties 
of Ig T as well. Like Munro and Taussig's factor, this molecule was 
between 50-60,000 daltons in molecular weight, could be absorbed by 
columns coupled with homologous antigen (Howie ~t al., 1977) and by 
immuno-absorbents coupled with anti-I-A subregion antibodies against 
the haplotype of the donor of th e T cell factor (Howie ~t al., 1979). 
Like IgT, the activity of this factor r equired the presence of 
macrophages and, more importantly, was removed by a chicken anti - mouse 
Ig immuno-absorbent, suggesting that the T cell factors may bear 
structures r esembling Ig. 
In an additional study, Howie and coworkers (1979) analysed an 
,01 vi:tlr.o generated antigen-specific factor against another synthetic 
polypeptide, CAT. TLe basic properties of this factor are the same as 
of the one described above. However, whereas the TCAL-specific factor 
carried I-A subregion controlled determinants, the CAT-specific factor 
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was only absorbed by anti-I-J subregion immuno-absorbents. Furthermore 
both the TGAL-specific and CAT-specific helper factors were shown to be 
removed by immuno-absorbents against the carbohydrate-defined Ia antigens 
(see section 4.2.3), indicating that these factors carry carbohydrate 
Ia specificities. 
Whereas the studies mentioned above were performed using synthetic 
polypeptide antigens whose antibody responses are under Ir gene control, 
a number of workers have demonstrated antigen-specific T cell factors 
against protein antigens that augment the antibody responses to haptens 
coupled to these antigens (Gordon and Yu, 1973; Tokuhisa ~t al., 1978; 
Howie and Feldmann, 1977). Thus, using the same procedure as making 
helper factors against synthetic polypeptides, Howie and Feldmann (1977) 
produced a KLH-specific helper factor that specifically augmented the 
B cell response to DNP-KLH-in vit.Jr.o. This factor has properties identical 
to tho se of the (T,G)-A-L specific helper factor. 
Tokuhisa ~ta£. (1978) also reported a carrier-specific T c e ll 
factor capable of enhancing a T-cell dependen t antihapten antibody 
+ -
response. Their factor is secreted by Ly-1 2/3 T c e ll and carries I-A 
subregion controlled antigens which are different from the I-a determinants 
on B cells. However, this factor is clearly different from that described 
by Taussig ~t al . and Feldmann ~t al. Firstly, the factor was isolat ed 
from T cell extracts. Secondly, the target for th e factor is a T cell 
rather than a B cell. Thirdly, the enhancing molecule is not capable 
of replacing T cells since addition of the factor to T cell depleted 
spleen cells did not induce an anti-hapten antibody r esponse. Fourthly, 
a very important characteristic of this factor is the v ery strict H-2 
requirement for its action: a factor derived from one strain of mice 
46 
could only augment the response of another strain if there was I-A 
subregion identity. 
In conclusion, the majority of these T cell factors carry Ia 
antigens, have a molecular weight of about 50,000 daltons, interact with 
B cells and, despite bearing Ia determinants and probably interacting 
with an I-region controlled acceptor, are not I-region restricted in 
their action. IgT is the exception to the rule, but some similarities 
with the above factors exist, such as the targe t of IgT being a B cell 
and some Ia bearing factors may express Ig-like determinants. On the 
other hand, Tokuhisa's factor may be more appropriately classed with 
antigen-specific factors which augment T cells rather than being termed 
an antigen-specific helper factor for B cells. 
5.2 Antigen nonspecific helper factors 
Since Dutton's first demonstration that non-antigen specific 
T cell replacing supernatants can be obtained from cultures of histo-
incompatibl e cells (Dutton ~t al ., 1971), nume rous studies have shown 
that such supernatants can augment them vitlto antibody responses 
unfractionated spleen or can reconstitut e them v~o response of T 
cell depleted spleen to T-dependent antigens. These helper supernatants 
could be generated by (i) stimulation of primed T cells with specific 
antigen (Rubin and Coons, 1971; Geha ~t al., 1973; Kishimoto and 
Ishizaka,1973b; Rosenthal ~t al., 1973; Waldmann and Munro, 1975; 
Harwell ~t al ., 1976; Harrack and Kappler, 1976; Takatsu ~t al., 1980 ), 
(ii) stimulation of lymphoid cells with alloantigen (Andersson ~t al., 
1972; Katz, 1972; Schimpl and Wecker, 197 2; Gorzinski ~t al ., 1973; 
Watson, 1973; Armerding and Katz, 1974; Hunter and Kettman, 1974; Farrar, 
1975) or (iii) simulation of lymphoid cells with T cell mitogens 
(\\a t son ~t al., 1973; Rich and Pierce, 1974). 
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Culture supernatants from activated T cells have multiple 
biological functions. Besides augmenting antibody responses, they 
can facilitate the response of thymocytes to mitogens, expand Tc 
cell responses and, under certain conditions, suppress humoral responses 
(Chen and Di Sabata, 1976; Pierce and Tadakuma, 1977). Hence two 
possibilitie~ exist: either all of these activities are mediated by a 
family of closely related molecules, or supernatants of activated T 
cells contain a large number of different factors mediating different 
activities. 
Non-antigen-specific T cell helper factors may be divided into 
three groups: The allogeneic effect factors (AEF), early acting T cell 
replacing factors (TRF) and late acting TRF's. 
5.2.1 AEF 
The AEF's have been implicated in a range of immunological 
phenomena such as augmenting (Armerding and Katz, 1974) and suppressing 
(Gisler and Fridman, 1975) antibody respons es, suppressing MLR (Rich 
and Rich, 1975), and in inducing self reactive cells (Altman and Katz, 
1980). The factors are obtained from culture supernatants of short 
t erm hi V~VT.O MLR between ~n v~vo alloantigen-activated T cells and 
irradiated stimulator cells. So far AEF is the only non-anti gen -specific 
factor described that expresses Ia determinants (Reviewed by Katz, 1977; 
Altman and Katz, 1980). Furthermore, like many antigen-specific factors, 
AEF substitutes for T cells in primary anti-SRBC antibody responses and 
in secondary IgG anti-hapten responses by acting directly on B cells 
(Armerding and Katz (1974). 
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AEF is a protein molecule which is devoid of lg determinants 
but carries Ia antigens and B2 microglobulin (Armerding et al., 1977). 
While some workers showed these Ia determinants to be of responder cell 
origin (Armerding et al., 1974b) others demonstrated that they were 
derived from stimulator cells (McDevitt et al., 1976), suggesting that 
stimulator cells release biologically active molecules as well. 
Controversy also exists over whether AEF action is H-2 restricted. 
While AEF showed no H-2 restricted action in primary m vil.fr.o antibody 
responses (Kat z et al., 1976), strict restriction to the I-A or I-J 
subregions of the stimulator haplotype was reported by Delovitch's 
group for secondary IgG responses ,i_n viVLo (Delovitch and McDevitt, 
1977; Delovitch et al., 1978; Delovitch and Sohn, 1979). 
The molecular weight of AEF has been reported to be 30,000-
40,000 daltons, and it is associated with B2 microglobulin (10-12,000 
daltons) which is an integral part of the active moiety (Armerding 
et al., 1977). However, Delovitch and coworkers (1981) were able to 
resolve the ir AEF activity into two active components. One component, 
of about 30,000-35,000 molecular weight, possesses identical biochemical 
and biolo gical properties to murine T cell growth factor (TCGF or Il-2) 
and is not genetically restricted in its activity. The other component 
has a molecular weight of about 68,000 daltons, differ both biochemically 
and biologically from TCGF and is I-A subregion restricted in its helper 
activity for B cells of the stimulator haplotype. Delovitch suggested 
that this second component is a T cell receptor molecule that recognises 
the I-A subregion antigens of the stimulator cells . Furthermore, he 
found that the purified 68,000 dalton AEF lacked Ia determinants and he 
proposed that culture supernatant AEF represents a complex of T cell 
receptor- Ia antigen and this complex is disrupted during AEF fractionation. 
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Hence obvious differences exist between the AEF described 
by Armerding and Katz and that of Delovitch. Delovitch ~t al. (1981) 
suggested that the AEF of Armerding is a TCGF molecule. However, TCGF 
molecules do not carry Ia determinants and, therefore, a more likely 
possibility is that the two groups are looking at different molecules. 
5.2.2 Early Acting TRF 
·Factors which replace T cells in antibody r esponses are called 
T cell replacing factors (TRF). They may be generated by antigen, 
alloantigen or mitogen-stimulated Ly-1+2/3- T cells and although not 
unequivocally demonstrated, all seem to act directly on B cells. 
TRFs do not carry Ia det erminants and do not appear to be H-2 restricted 
in their action on B cells. 
Two kinds of TRFs have been described that differ from each 
other in their time of action: one TRF must be present at the initiation 
of an ,<.n vi:Uto antibody response to exert its action whereas the other 
TRF appears to act late in the differentiation of B cells into plasma 
cells. 
Initially, early acting TRF will be considered. Supernatants 
obtained from cultures of KLH-primed T cells or splenocytes, after 
reexposure of these cells ,i_n. vi:ltto to KLH, were shown to be capable of 
facilitating B cell responses to SRBC (Waldmann and Munro, 1973, 1974, 
1975; Marrack and Kappler, 1976; and Harwell ~t al., 1976). The factor 
had a molecular weight of between 25,000 and 60,000 daltons (Waldmann 
and Munro, 1975; Harwell ~t cu. ., 1976) and was most effective biologically 
when added at the beginning of the culture, in contrast to the late TRF 
(s ee section 5.2.3) which had optimal activity when added later. 
I 
so 
Subsequent studies indicated that while this factor could 
reconstitute antibody responses to SRBC or TNP-erythrocytes, it could 
not resture responses to soluble TNP-protein conjugates (Waldmann, 1975; 
Harwell ~t al., 1976). From these data it was proposed that the 
nonspecific factor analyzed could not be the sole mediator of T-B cell 
collaboration since it was unable to enhance the antibody response to 
hapten-carrier conjugates. It was therefore proposed that this factor 
cannot activate hapten-specific B cells unless a carrier-specific helper 
factor derived from carrier-specific TH cells is also present. This 
theory in fact agrees with the observation (see section 4.4.1) that only one 
T cell subpopulation (Th2 ) is required for anti-SRBC antibody responses 
whereas responses to soluble hapten-carrier conjugates require two T 
cell subpopulations, i.e. Th1 and Th2 . Furthermore, it is conceivable 
that the Th
1 
cells could secrete antigen-s pecific helper factors. 
However, the relationship between early and late actin g TRF is still not 
clear . 
5.2.3 Late acting TRF 
The majority of workers, when discussing TRF, refer to the TRF 
described by Schimpl and Wecker and associates (reviewed by Schimpl 
~d Wecker, 1975). This TRF is a T cell product, produced within 24 hrs 
of T cell stimulation. The optimal enhancing effect on both the IgM 
~d IgG responses to SRBC is observed when TRF is added after 2 days 
of culture rather than at culture initiation. In fact, even when given 
as late as 84 hrs after culture initiation, TRF still exerted 
substantial biolo g ical activity. This observation suggested that 
TRF facilitates the final stages of B cell differentiation followin g 
initial B cell activation by antigen and possibly macrophage derived 
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factors. Furthermore, TRF acts in an H-2 unrestricted manner, does 
not carry H-2 determinants and has a molecular weight of between 
25,000 and 35,000 daltons (Schimpl et al., 1977; Hubner et al., 1978). 
Purification of material present in culture supernatants of 
activated cells by ion exchange chromatography and isoelectrofocusing 
suggested that the various biological activities such as TRF activity 
in antibody responses, induction of :MLR in nude mouse cells, costimulator 
activity and T cell growth factor (TCGF) activity were all mediated 
by a family of closely related molecules with a molecular weight of 
about 30,000 daltons and isoelectric points of 4.3 or 4.9 (Farrar et al., 
1978; Watson et al., 1979a, b, c). The term interleukin-2 (IL-2) 
was suggested to describe this T cell derived molecule(s) with the 
biolo g ical activities above (Aarden et al. , 1979). 
Watson et al. (1979c) and Gillis et al . (1980) suggested that 
all the biological assays described above measure the clonal expansion 
of activated T cells. Even in antibody responses of nude or T cell 
depleted culture, IL-2 could act by driving the differentiation of 
pre-T cells into mature TH cells. This hypothes is is supported by the 
finding that (i) T cells but not B cells express r ecep tors for IL - 2 
(Bonnard et al ., 1979; Smith et al ., 1979), (ii) nude mice can be 
activated by IL-2 to manifest T cell alloreactivity (Gillis et al ., 1979; 
Wagner et al., 1980) and (iii) IL-2 containing supernatants can induce 
. + ( the differentiation of pre-T cells into Thy-1 T cells Jones -
Villeneuve et al ., 1980). 
However, others have shown that biolo gically active molecules 
with IL-2 properties act direc tly on B cells. A r ecent study found that 
B cells of DBA/2Ha mice do not respond to antigen induced TRF because of 
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the lack of an appropriate acceptor site (Tominaga et al., 1980), thus 
implying that TRF can act directly on antigen primed B cells. Additionally, 
Schimpl et al. (1980) were abl e to distinguish IL-2 and TRF on the basis 
of biochemical criterion, complete separation of these two molecules 
being achieved on the basis of affinity for Lentil lectin coupled 
Sepharose and isoelectric focusing behaviour in 4M urea with a pH 
gradient from 4-6. Moreover, TRF-containing preparations augmented 
antibody synthesis by the plasmacytoma MOPC 315 and since B cells do 
not possess IL-2 receptors, classical IL-2 could not be responsible 
for this effect. Together, these results sugge st that IL-2 and TRF 
are different molecules and that IL-2 acts on T cells and TRF on B cells. 
It must be kept in mind, however, that many TRF containing 
preparations probably contain IL-2 activity. As a result, thes e 
supernatants will exert helpe r activity on T cell dep l e ted cultures in 
two ways: TRF will directly stimulate B vells and IL-2 will r ecruit 
and cause proliferation of immature or remaining T cells, thus indirectly 
helping B c el ls. Swain and coworkers (1981) have, in fact, demonstrated 
synergy between IL-2 and TRF. 
In summary, a heterogeneous group of molecules perform the 
function of delivering an tigen -nonspecific helper signals to B ce lls. 
The AEF molecul e of Armerding et al. has some similarities to antigen -
specific helper factors as does the larger component of Delovitch's 
factor. It remains to be seen, however, whether the TCGF-like component 
isolated from AEF preparations (Delovitch et al ., 1981) is IL-2 which 
acts on T c e lls or is TRF. The TRF molecu l es are more s traight - forward 
in their action in that they ac t on already activated B cells and 
possibly provide the last si gna l required for antibody secretion . 
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Is there any relationship between the different T cell derived 
helper factors? The nonantigen specific helper factors, except for AEF, 
appear not to carry Ia antigenic specificities and are not MHC-restricted 
in their action . In contrast, the antigen-specific factors carry Ia 
determinants, but also are generally not H-2 restricted in their action. 
In terms of biological activity, all express T-cell replacing activity. 
It is possible that the Ia positive genetically restricted and/or 
antigen specific factors have a common lymphokine "backbone", such as 
IL-2, which is complexed with separate molecular component expressing Ia 
determinants and/or carrying antigen-binding capacity. Support for 
such an association comes from the work of Taniguchi and Takei (1980) who 
analysed an antigen-specific, I-J subregion restricted suppressor factor 
for B cells . The authors found that extracts prepared from a T cell 
+ hybridoma contained two separate molecules, one I-J and one KLH-
specific . Neither molecule alone expressed biological activity, but 
mixtures of the two were strongly suppressive for B cell responses. 
Hence antigen-specific and/or Ia bearing factors may in fact 
be the classical IL-2 molecule (or TRF, i.e. 30-35,000 daltons) coupled 
with a separate molecule carrying antigenic specificity and, if the Ia 
antigens are carbohydrate-define d (Howie e_;t CU.., 1979), coupled with a 
carbohydrate side-chain bearing Ia antigenicity. 
5 . 3 Macrophage-derived factors 
Mononuclear phagocytes release a variety of biologically active 
products, some of which influence the functional behaviour of lymphocytes. 
Secretory products include a numbe r of enzymes, complement components, 
interferon, growth factors and prostaglandins. The factors not affec ting 
lymphocytes have been reviewed elsewhere (Unanue e_;t al.., 1976a; Page 
~t al. . , 1978; Gordon, 1980) and will not be consid2red here. 
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Some of the molecules secreted by macrophages are potent 
stimulators of T and B cell proliferation and, moreover, are released 
following macrophage-lymphocyte interactions regulated by the MHC 
(Unanue et al., 1976b; Farr e.t a.1., 197/; 1979). The first clear 
demonstration of a mitogenic activity secreted by macrophages came from 
Gery and coworkers (Gery e.t a.1., 1972; Gery and Waksman, 1972). They 
described release of a "factor" from a 24-hour culture of human adherent 
cells which promoted the response of murine thymocytes to the T cell 
mitogen phytohaemagglutinin-A (PHA). The factor was named lymphocyt e -
activating factor (LAF). Following this demonstration, a large number 
of activities, defined in various assays have been attributed to factors 
derived from macrophages. These include such molecules as mitogen-
protein (Unanue and Kiely, 1977), T cell replacing factor III (Watson, 
1979), T cell replacing factor M (Hoffmann and Watson, 1979), helper 
peak-1 (Koopman e.t a.1., 1978), B cell activating factor (Wood, 1979), and 
B cell differentiation factor (Hoffmann e.t al., 1979). 
It appears now that all these activities are really manifestations 
of one (or one class of) molecule released by macrophages, possessing 
a wide range of biological effects . This molecule is defined as 
interleukin 1 (IL-1) (Aarden e.t al.., 1979). 
IL-1 (or LAF) is defined as an activity in macrophage culture 
supernatants that, when added to thymocytes together with or in the absence 
of PHA or Con A, increases, after 3-4 days of culture, their uptake of 
tritiated thymidine. The best evidence for IL-1 being a macrophage 
product is the fact that a macrophage line P388Dl r eleases this molecule 
(Mizel e.t al., 1978a, b). The most potent inducers of IL-1 secretion 
are immune T cells which must interact with macrophages in an antigen-
specific, I-A restricted manner (Farr e.t al., 1977, 1979; Ziegler and 
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Unanue, 1980), and bacterial lipopolysaccharide (LPS) which is often used 
as an inducer of Il-1 release (Me ltzer and Oppenheim, 1977). 
IL-1 is a protein with a molecular weight of 13,000-16,000 
daltons (Gery and Handschumacher, 1974; Calderon e..t al., 1975; Mizel, 
1979) and with pI values ranging from 4.5 to 6.5 (Economu and Shin, 
1978). High molecular forms of IL-1, which may be protein aggregates, 
have also been observed (Togawa e..t al., 1979). Furthermore, IL-1 
is not strain specific in its action and does not carry H-2 antigens 
(C alderon e..t al ., 1975). 
As already mentioned, IL-1-like molecules have been shown to 
enhance the generation of antibody-forming cells. There are two ways 
in which this can happen: IL-1 may stimulate T cells or precursor T 
cells which in turn help B cells and/or the monokine ~ay stimulate B 
cells directly. The next two sections will consider the - evi0ence for 
these two possibilities. 
5.3.1 Effects of IL-1 on T cells 
IL-1 has two major effects on T cells: one is associated 
with the prolife ration and maturation of immature T cells, the other 
deals with the induction of secretion of IL-2 by T cells which in turn 
stimulates the continuous cycling of immunocompetent T cells. 
There is no question that IL-1 affects thymocytes . Directly 
assaying proliferative activity (without PHA) established that peripheral 
T cells obtained from spleen or lymph nodes responded poorly to IL-1, 
whereas thymocyt e s we r e stimulated markedly by the monokine (G e ry e..t al ., 
1972; Calderon e..t al., 1975). The thymocytes also responded to IL-1 
by producing an augmented proliferative response to PHA whereas lymph 
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node T cells responded to IL-1 plus PHA but not as well as thymocytes 
(Gery et al., 1972). The direct mitogenic action of IL-1 requires 
a cell to be in an "activated" state, this state usually being induced 
in peripheral T cells by an antigen or a mitogen (Beller and Unanue, 
1979). Hence IL-1 is probably an important endogenous regulator of 
thymocyte differentiation in the thymus, exercising a powerful role in 
the intrathymic maturation of T cells. 
While Ih-1 enhances lect in-initiated thymocyte proliferation 
it does not support continuous T cell growth (Oppenheim et al., 1980). 
Several investigators have proposed that IL-1 enhances T cell growth 
not directly but through an enhancement of a T cell released and 
T cell specific growth factor (IL-2). A number of groups have provided 
support for this hypothesis (Smith et al.., 1979; Larsson et al., 1980; 
Shaw et al., 1980) reporting that in the absence of macrophages or IL-1 
T cell enriched populations release little or no IL-2. Additionally, 
IL-1 can convert the nonproducer T cell line (lAS cells) to a state 
where subsequent mitogen stimulation triggers production of IL-2 (Gillis 
and Mizel, 1981). Only a brief exposure (2-4 hrs) of these cells to IL-1 
was required for conversion to IL-2 production. Moreover, lAS cells 
could absorb IL-1 from cultures, suggesting the existence of IL-1 
r eceptors on potential IL-2 producer cells. The implications of these 
results are that IL-1 serves as an early signal for T cell proliferation 
by promoting the production of a second, T cell derived, soluble factor 
that actually mediates T cell proliferation and function. 
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5 . 3 . 2 Effects of IL-1 on B cells 
A number of investigators have obtained evidence which suggests 
that macrophage - derived factors can directly stimulate antigen-driven 
B cell differentiation. The molecule responsible appears to be similar 
if not identical to IL-1. 
Initially Schrader (1973) reported that spleen cells from 
athymic (nude)mice developed an antibody response if cultured with 
macrophage - conditioned medium, an observation supported by Calderon 
et al . (1975) . Supernatants from stimulated macrophages contained 
t his a ctivity even when the macrophages were first treated with anti-
Thy- 1 antibody plus complement, or were obtained from athymic mice . 
The results were taken to mean that a macrophage product in combination 
with antigen, directly stimulates the differentiation of B cells into 
antibody forming cells . However, the ability of a macrophage-derived 
product to do this seems puzzling. Athymic mice are known to have 
activated macrophages (Zinkernagel and Blanden, 1975) and yet do not 
respond well to T-dependent antigens. Why should the addition of a 
macrophage - derived factor (whose induction is T cell indepe ndent) 
alter this state? 
Supernatants from activated macrophages also have been shown 
to restore antibody responses to T-dependent antigens in T-cell-
depleted spleen cell cultures (Calde ron et al., 1975; Unanue et al., 1976b; 
Wood et al . , 1976). While this was also int e rpreted as the ability 
of IL-1 to directly affect B cells, another explanation is also feasibl e. 
IL-1 may be stimulating residual mature or immature T cells to secre t e 
IL-2 which in turn induces T cells to divide. The T cells and/or IL-2 
may then stimulate B cells; hence the IL-1 could be acting indirectl y 
on B cell differentiation . 
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Additional studies in the Kumuro-Boyse system (Hoffamnn et al., 
1976c, Hoffmann, 1980) clearly indicated that macrophage derived 
products can induce B cell differentiation from immature bone marrow 
cells into a state where they can enter the immune response. However, 
the macrophage factor responsible has not been characterized and hence 
may not be IL-1. 
Finally, a striking synergy between T cells and macrophage 
product(s) resulting in heightened antibody responses has been shown by 
a number of workers (Calderon et al., 1975; Hoffmann et al., 1979; 
Wood et al., 1976). Furthermore, Farrar and associates (1977) have 
demonstrated that MLC supematants contain a number of T-cell-replacing 
activities for an -<.YL vitJr.o anti-SRBC response. TRF activity was 
associated with molecules of an apparent molecular weight of 15,000 
and 40,000 daltons, which acted synergistically when added together. 
The 15,000 dalton molecule may well represent IL-1 (Koopman et a£., 1977). 
In support of this cooperativity, recent studies have indicated that 
macrophage products can enhance the activity of TRF preparations 
(Hoffmann and Watson, 1979; Hoffmann, 1980). However, these studies 
say nothing about whether the macrophage product directly acts on 
B cells. 
Controversy exists over the relationship between IL-1 and the 
molecule which stimulates B cells in culture. A number of studies 
indicated that the B cell stimulatory molecule, like IL-1, has a 
molecular weight of 15,000 daltons (Calderon et al., 1975; Wood et al.., 
1976; Wood, 1979). In one study, molecules having both activities 
chromatographed in the same position (Ca lderon et al., 1975) but this 
was not the case in studies using human material (Wood et al., 1976) 
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which indicated that thymocyte stimulatory activity and B cell 
stimulatory activity were mediated by separate molecules. Hence this 
question remains to be resolved. However, it is possible that the 
IL-1 molecule is responsible for multiple functions since it is 
known, for example, that IL-1 also acts as an endogenous pyrogen 
(Dinarello ~t al., 1977; Murphy ~ta.£., 1980b). 
In summary, evidence suggests that during the initial 
interaction of T cells with antigen on macrophage surfaces, macrophages 
may be stimulated to secrete IL-1 molecules which activate both T cells 
and B cells to differentiate. Whether IL-1 alone is enough to induce 
B cells to secrete antibody is uncertain, but the involvement of other 
T cell factors in antibody responses and the demonstration of H-2 
restricted interactions between T cells and B cells suggests that this 
is not so. 
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5.3 . 3 Genetically Restricted Factor (GRF) 
In addition to IL-1 or IL-1-like molecules, at least one other 
monokine has been shown to influence the generation of antibody 
responses . Erb and Feldman (1975 ) generated TH cells to KLH in a 
double-chamber culture where the macrophages were separated from T cells 
by a nucleopore filter. This suggested that macrophages operated by 
releasing a soluble mediator which is capable of activating T cells 
without cell contact . The soluble macrophage product was named 
" genetically restricted factor" (GRF) because it would only induce 
T cells with the same I - A haplotype as the macrophages which made it. 
Briefly, GRF is about 55,000 daltons, can be retained on an anti-I-A 
subregion irnmunoabsorbent (Erb ~t al. , 1976) and contained antigen, 
KLH (Puri and Lonai, 19 80). Hence, GRF appears to be a complex between 
Ia and antigen and apparently binds directly to TH cells but not B cells. 
This seems to be the only instance where T cells can be 
activated in absence of accessory cell. The prevailing evidence 
indicates that T cells must see Ia plus antigen on the macrophage cell 
surface (Unanue, 1981). On the other hand, it is possible that the 
presence of GRF reduces the number of macrophages needed for T cell 
activation. Thus in the system described above, the macrophage depletion 
of T cells was not absolute and the addition of GRF in the presence 
of a small number of macrophages and th e antigen resulted in T cell 
activation . 
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6 CONCLUDING REMARKS 
Since the original definition of T-B collaboration in the late 
1960's, many laboratories have attempted to further characterize this 
interaction. As with most biological systems, this interaction has 
proven to be much more complex than was originally thought. At least 
two different types of TH cells have been identified and T cells with 
suppressor, rather than helper properties have also been described. 
Furthermore, the regulation of inducti on of TH and Ts cells involves 
a number of complex interactions. All these findings lend support to 
the concept that induction of effector cells (e.g. plasma cells, Tc 
or TDTH cells) is tightly regulated by a complex network of cell-cell 
interactions. 
The demonstration that the HHC plays a key role in cell-cell 
interactions and antigen-recognition has provided a potential genetic 
and molecular basis for these processes. However, at the molecular 
level, th e mechanism of T-B collaboration is still not well understood. 
Obviously, soluble factors (non-specific and possibly antigen-specific) 
play an important role but the chemical nature of these factors and the 
way they interact with and activate target cells is still unknown. 
Furthermore, how MHC antigens are actually recognis ed by T cells and 
mediate MHC-restricted interactions between cells remains a mystery . 
Obviously the molecular basis of cell-cell communication in the immun e 
response represents a fascinating area of future research. 
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2 . 1 ANIMALS 
All animals were bred and maintained in the Animal Breeding 
Establishment of the John Curtin School of Medical Research. 
Inbred and outbred mice were watered and fed ad libitum with 
Mecon rat and mouse cubes (Fidelity Feeds, Murrumburrah). Donors of 
spleen cells were used between the ages of 6-14 weeks. The H-2 haplotypes 
of the inbred mouse strains used in this study are listed in Table 2.1 
(obtained from Klein et al., 1978). 
2 . 2 ANTIGENS 
Monomeric flagellin (MON), molecular weight 40,000 was prepared 
from the flagella of Salmonella typhimwr.ium SL 870 (Ada et al., 1964) 
Haemocyanin (HCY), a pentamer of molecular weight 450,000 daltons was 
recrystallized from the haemolyrnph of the South Australian crayfish 
]MU/2 lalandii (Moore et al., 1968) as described below. These proteins 
were dinitrophenyla ted according to the method of Eisen (1964) (see 
section 2.2.2), the conjugation ratios used being DNPl:l MON and 
DNP 26 _42 HCY. SRBC were stored in Alsevers solution and washed four 
times in normal saline before use. 
2 . 2 . 1 Purification of haemocyanin (HCY) 
Haemolymph was obtained from two crayfish and, clotted overnight 
serum was exhaustively dialysed against DDW at 4°c. The serum-
containing dialysis tubing was placed into buffer pH4.6, ionic streng th 
0.015 (containing 0.005M sodium acetate, 0 . 005M acetic acid and 
0.010~1 sodium buffer) which permits the crystallisation of HCY from 
the serum. Crystals obtained in 48 hrs were centrifuged (2,000 rpm, 5 min), 
TABLE 2.1 
H-2 haplotypes of the inbred mouse strains 
used in this study 
Strain 
K N A B 
CBA/H k k k k 
BlOBR k k k k 
Balb/c d d d d 
Bl0.D2 d d d d 
CJH.SW b b b b 
BlO b b b b 
BlO.A k k k k 
Bl0 . A(2R) k k k k 
Bl0.A(3R) b b b b 
BlO.A(SR) b b b b 
CJH.OL d d d d 
A.TL s ? k k 
A.TH s s s s 
H-2 Region 
.!_-Sub region 
J E 
k k 
k k 
d d 
d d 
b b 
b b 
k k 
k k 
b k 
k k 
d d 
k k 
s s 
C s 
k k 
k k 
d d 
d d 
b b 
b b 
d d 
d d 
d d 
d d 
d k 
k k 
s s 
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u D 
k k 
k k 
d d 
d d 
b b 
b b 
d d 
b b 
d d 
d d 
k k 
d d 
s d 
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washed in the buffer and subsequently dissolved in 1% w/v sodium 
bicarbonate solution. The HCY in this solution was recrystallised 
once more as described above, dissolved in 25 mls of 1% sodium bicarbonate 
and the protein content determined by spectrophotometer (OD 620 ) using 
coomassie dye method (Rylatt and Parish, 1982). The final concentration 
of HCY was 66mg/ml . 0 HCY was stored in 10ml aliquots at -20 C . 
2 . 2 . 2 Dinitrophenylation of MON and HCY 
MON at lOmg/ml and HCY at 20mg/ml were reacted with 20mg/ml . 
of K2co3 and 20mg/ml DNP-sulphonicacid at room temperature for about 
24 hrs protected from light . This solution was dialysed for 24 hrs 
against normal saline with multiple changes of saline. The number of 
DNP groups per molecule of HCY or MON was estimated on spectrophotometer 
(oc 360 ) using formula as follows: (given that HCY has a molecular 
weight of 450,000 daltons, POL 40,000 daltons and DWP 17,600 daltons) 
DNP groups/HCY molecule= 
OD360 x dilution protein concentration (mg/ml) 
17,600 I 450,000 
2 . 3 IMMUNIZATIONS 
DNP-MON and DNP-HCY were made particulate by absorption to 
bentonite as described by Gallily and Garvey (1968). Mice were given 
one intraperitoneal injection of hapt en-carrier coupled to bentonite 
every two weeks for a total of three inj ec tions. Each injection contained 
200 µg of protein in 0.2ml of saline . Mice were used as spleen cell 
donors 10 or more days after the last inj ec tion. 
Mice were primed to SRBC with one intravenous injection 
containing 10 µ l of packed SRBC in 200 µ l phosphate buffed saline (PBS). 
Spleens were us ed 7 or more days later. 
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NOTE : Spleen cells taken from mice primed to DNP-HCY in winter and 
summer months often showed no "memory", i.e. would not respond to DNP-HCY 
in culture . We finally overcame this problem by keeping these animals 
during and after the priming regime in a light, humidity and temperature 
0 (25 C) controlled room . Under these conditions, the majority of 
spleen cell preparations from the animals responded in culture and the 
animals remained primed for much longer periods. 
2 . 4 TISSUE CULTURE MEDIA 
Eagle's Minimal Essential Medium (EMEM) was prepared by 
dissolving 10g of medium powder (GIBCO, F-15) in 1 litre of double 
distilled deionized water (DDW) containing 42 mls of 5% sodium 
bi carbonate, lOOu/ml penicillin, 100 µ g/ml streptomycin and 100 µ g/ml 
neomycin. 
Dulbecco's Modified Eagle's Medium (DMEM) was prepared by 
dissolving 10g of medium powder (GIBCO, H-16) in 1 litre of DDW 
containing 72mls of 5% sodium bicarbonate; lOOu/ml penicillin, 100 µg/ml 
streptomycin and 100 µg/ml neomycin. RPMI was prepared by dissolving 
10g of medium powder (GIBCO) in 1 litre of DDW containing 45mls of 
5% sodium bicarbonate and antibiotics as for EMEM. 
EMEM, DMEM and RPMI were sterilised by filtration through a 
0 . 22 µm membrane (Millipore Corporation) and were stored for less than 
three weeks. 
2 . 4 . 1 Foetal Calf Serum (FCS) 
FCS (Flow laboratori e s, Stanmore, Australia) was selected for 
its ability to maintain Tc cells in culture. When indicated, heat 
inactivated foetal calf serum (HIFCS) was prepared by incubating sel e ct e d 
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0 
selected serum batches at 56 C for 30 minutes. FCS used in maintenance 
assay (kindly donated by Dr. Lafferty) was screened for its lack of 
mitogenic activity in this assay. 
2 . 4 . 2 Nucleic Acid Precursors (NAPs) 
100mg of each cytosine, uridine, adenosine and guanosine 
(SIGMA) were dissolved in lOOmls of DDW, autoclaved and stored at 4°c. 
For use in antibody cultures, 2mls of this stock were used per lOOmls 
of EMEM, giving a final concentration of 20 µg/ml. 
2 . 4 . 3 2-Mercaptoethanol (2-ME) 
2-ME (SIGMA, type 1) stock solution was made up at 0.lM in DDW 
and stored at -20°C. The stock was diluted 1:1,000 to give a final 
-4 
concentration of 10 M for use in cultures. 
2 . 5 CELL CULTURES FOR ANTIBODY RESPONSES 
Spleen cell suspensions were prepared by removing the organ 
aseptically and pressing spleen fragments through a fine stainless steel 
grid into culture medium containing EMEM, 5% FCS, 2-ME and NAPS . . The 
resulting cell suspension was washed, declumped and resuppended in this 
culture medium at a concentration of 2 x 106 cells/ml. 
Cell suspensions were cultured in 24-well Linbro trays (Hamden, 
Conn.) containing 2.5mls (5 x 106 cells) culture well. Each treatmen t 
was cultured in quadruplicate. 
Primary antitody responses were assayed after 3 days of culture 
in a humidified 10 % co 2 /7 %o 2 atmosphere and secondary responses after 
7 days of culture. Antigen was added at the beginning of the culture, 
FIGURE 2 . l TITRATION OF ANTIGENS IN ANTIBODY RESPONSES 
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200ng of DNP-MON in primary responses, 50ng/ml of DNP-MON, DNP-HCY 
and 2 x 10
6 
SRBC/ml in secondary culture. In preliminary experiments, 
these antigen concentrations were found to be the optimum (see Figure 2.1). 
Sugars were also added at the beginning of the culture at 5mg/ml (~20rnM). 
2.6 PREPARATION OF CELLS 
2.6.1 Anti-Thy 1.2 treated populations 
Monoclonal anti-Thy 1.2 antibodies were obtained from three 
sources for the studies described in this thesis, namely clone F7D5 
initially kindly supplied by Dr. P. Lake and subsequently purchased from 
Olac 1976, LTD, Brcester, Oxen., and clone 30H12, a rat anti-mouse 
monoclonal kindly supplied by Dr. I.F.C. McKenzie. 
7 Anti-Thy-1.2 antibody was added to spleen cells (4 x 10 cells/ml) 
at the optimum concentration for T cells lysis (previously determined 
by microcytotoxicity of lg cells) incubated on ice for 30-45 minutes, 
washed twice with EMEM, 5% FCS, 2ME, NAPs and incubated with a 1:2 
dilution of guinea pig complement for 15-30 minutes at 37°c. On average, 
25-35% of spleen cells were killed by this treatment as assessed by 
Trypan Blue exclusion method. 
2.6.2 lg-negative spleen cell populations 
Pure populations of lg-negative cells were obtained from spleen 
by a rosetting procedure which has been described previously by Parish 
and coworkers (1974). 
Spleen cell suspensions were prepared as described in section 2.5 
in E lEM, 5% FCS and 2-ME and kept on ice 7 at 4 x 10 cells/ml . 
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SRBC were coated with sheep anti-mouse lg as follows: 0.25mls 
of packed SRBC (washed 4 x with normal saline (N.S.)) was mixed with 
4mls of N.S. and 20 µl of sheep anti-mouse lg ( 125 mg/ml ). While 
this was mixing on vortex mixer, 0.3mls of 0.1% Crc1
3 
were added: this 
was left at room temperature for 5 minutes and the reaction stopped 
by the addition of 5mls of PBS. The SRBC coated with anti-mouse lg 
were centrifuged, supernatant discarded and the procedure repeated 
to remove the last traces of free antibody. The anti-mouse lg coated 
SRBC were resuspended in 2.25mls of culture medium (10% suspension) 
and were kept cold. 
The cold spleen cells and anti-mouse Ig-SRBC were mixed, 
centrifuged (1,500 rpm, 5 min 4°c) to formed rosettes, gently resuspended 
0 
and warmed up to 20 C. The suspension was layered on a cushion of 
lsopaque/Ficoll and centrifuged in MSE (4,000 rpm, 15 min, 20°c). The 
+ 
lg fraction moves to the bottom of the tube, the lg fraction remains 
on interphase between medium and Isopaque/Ficoll. lg fraction was 
harvested and washed 2 x to remove lsopaque/Ficoll. 7 -2-3 x 10 lg cells 
may be recovered per spleen. This lg population was used in anti-
Thy 1.2 titration and in MLR. 
2 . 7 DETECTION OF ANTI-DNP PLAQUE-FORMING CELLS (PFC) 
Cells secreting anti-DNP antibodies were estimated in glass slide 
chambers using the technique of Cunningham and Szenberg (1968) . SRBC 
were coupled with dinitrophenyla t ed rabbit anti-SRBC Fab (Strausbauch 
e.t al.,, 1970) the preparation of which is outlined below . Indirect 
PFC were detected in the presence of sheep anti-mouse lg developing 
serum (Wort is e.t a1. . , 196 8 ) . 
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In brief, cultured cells were harvested, pelleted by centri-
fugation and resuspended in 1ml of cold culture medium. 100 µl of 
cell suspension, 30 µ 1 of 15% DNP-SRBC, 15 µ 1 of guinea pig complement 
and/or 15 µl of developing serum were mixed to gether, placed into glass 
0 slide chambers, sealed with wax and incubated for 1 hour at 37 C. Cells 
secreting anti-DNP antibodies lyse DNP-coated SRBC around them, 
creating clear areas (plaques) which were enumerated under a dissecting 
microscope. 
2. 7. 1 Preparation of anti-SRBC-Fab for anti-DNP PFC assay 
Rabbits were injected intravenously twice a week for 3 weeks 
with 1ml of 25% washed SRBC in phosphate buffered saline (PBS). 
Seven days after the last challenge, the animals were bled and serum 
collected. Anti-SRBC antibody titres were assayed by a haemagglutination 
procedure (Langman, 1972) and were greater than 1:300. 
Rabbit anti-sheep IgG in the serum was precipitated with 
40% saturated ammonium sulphat: (NH4 ) 2so4 overnight at 4°c with constant 
stirring. The precipitated material was centrifuged (10,000 rpm, 
10 min, 4°C), supernatant discarded, and the pellet washed with 40 % 
(NH4 ) 2 so4 . The protein was redisolved in 20mls of O.lM phosphate 
buffer, pH 7.0, containing 0.01M cysteine and 0.002 M EDTA. The 
protein concentration measured at OD 280 was '\, 33m:3/,Y1 i.e. 660mg total. 
The rabbit anti-sheep IgG was than digested with papain to 
obtain Fab and Fe fragments of IgG. Papain was added at 1% by weight 
i.e. 6.?mg/660mg of protein; incubated at 37°c for 6 hrs and dialysed 
against PBS for 24 hrs at 4°c. The content of the dialysis bag was 
centrifuged (10,000 rpm, 20 min, 4°c) to pellet crystallised Fe 
fragments, and filtered to remove low density precipitate which did not 
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sediment. The supernatant was concentrated to 4mls by pressure 
dialysis and centrifuged again to remove newly crystallised Fe fragments. 
The supernatant was applied onto G-200 column 48cm x 5 cm (Pharmacia) 
and eluted with PBS (5ml fractions, lOmls/hr). Fab-containing fractions 
were detected at OD 280 , pooled, concentrated by pressure dialysis and 
the total protein concentration determined to be~ 2mg/ml (total protein 
~ 230mg). 
2. 7. 2 
0 Rabbit anti-SRBC Fabin PBS were stored at -20 C. 
Dinitrophenylation of Rabbit anti-SRBC Fab 
DNP was coupled to Fab fragments as described by Strausbauch 
et al. (1970). lOmls of Fab was mixed with 100mg DNP-sulphonic acid 
and 100mg sodium carbonate (pH 9.3), left to react at room temperature 
for 24 hours away from light and subsequently dialysed for 48 hours 
against normal saline. 0 Anti-SRBC DNP-Fab was stored at -20 C. 
2. 7. 3 Dinitrophenylation of SRBC 
SRBC were coated with DNP using dinitrophenylated rabbit anti-
SRBC Fab fragments as follows: 1ml of packed SRBC (washed 4 times with 
saline) was mixed with 9mls of PBS and 200 µl of DNP-Fab for 1 hr at 
37°c. DNP-SRBC were washed twice to remove free DNP-Fab and resuspended 
in Smls of culture medium to be used in PFC assay. 
2.7.4 Guinea Pig complement 
Outbred guinea pigs were bled by heart puncture, blood clotted 
0 and serum collected by centrifugation (2,000 rpm, 4 C). The serum was 
then mixed with SRBC (washed previously with saline) and kept on ice 
for 30 min to remove any anti-SRBC antibodies. The SRBC were then 
pelleted by centrifugation, serum collected, aliquoted in 0.5ml 
0 
aliquots and stored at -60 C. 
,. 
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2 . 8 SUGARS 
The sugars used and their source were as follows: L - fucose, 
a - methyl glucoside, D - galactose, a- methyl galactoside and 
a - methyl mannoside from Calbiochem, San Diego, Ca; N - acetyl - D -
gl ucosamine, N - acetyl - D - galactosamine and N - acetyl - D -
mannosamine from Sigma, St. Louis, Mo; D - mannose from Fluka, A. G. Buchs, 
Switzerland and D - glucose from Univar, Ajax Chemicals, Sydney. 
2 . 9 MIXED LYMPHOCYTE REACTIONS (MLR) ~n v~tko 
5 -A MLR was generated between 5 x 10 Ig A.TH spleen responder 
cells and 5 x 10
5 
2,000 X-irradiated A.TL stimulator cells in Linbro 
24 well trays, containing RPMl, 5% HIFCS, 2-ME. Cultures were incubated 
i n the presence of sugars at a concentration of 2mg/ml for 4 days in 
humidified 7%o2 /10%co 2 air (Woolnough et a.l . ,1979). 
The cultures were pulsed with 125 1 UDR (0.5 Ci/well) for 18 hrs, 
harvested onto glass fibre filter paper discs (Whatman, Grade GF/A) using 
a Titertek cell harvester. 
2 . 10 In v~tko PRIMARY CYTOTOXIC T CELL RESPONSE 
2 . 10 . 1 Generation of Tc cells 
Tc cells were generated by mixing 5 x 10 6CBA/H responder cells 
with 1.25 x 10
6 
2,000R-irradiated c60 co source) Balb/c stimulator 
spleen cells in 2 . 4ml medium in 24-well Linbro trays, each treatment 
in quadriplicate, as described previously (Woolnough et al, 1979). 
The cells were cultured in DMEM, 10%HIFCS, 2-ME for 5 days in 7%0
2
/ 
10%co2 air mixture at 37°c. Sugars were present throughout the culture 
of a concentration of 5mg/ml. The cells specific for H-2d antigens 
were assayed for killer activity against 51 cr-labelled P815 mastocytom 
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(H- 2d) target cells in a four-hour release assay (Lafferty ~t al., 1976) 
which is described below. 
2 . 10 . 2 Cytotoxic Assay 
The cell populations to be assayed for cytotoxicity were pelleted 
by centrifugation (1,200g, 5 min) and resuspended in EMEM containing 
10% HIFCS . 0 . 1ml of effect on cells were added to 0.1ml of labelled 
target cells in quadriplicat e wells of flat-bottomed microtitre plates 
(Linbro, 76 - 003 - 05). Spontaneou s lysis of the targets was determined 
by mixing 0 . 1ml of targets with 0.1ml of EMEM containing 10% HIFCS 
in quadriplicate . Total releasable chromium was determined by mixing 
0.1ml of targets with 0.9ml of distilled wat e r in plastic centrifuge 
t ubes (water lysis). All cell mixtures were incubated for 4 hours 
at 37°c in a humidified atmosphere of 10% co
2 
in air. 
0.1ml of supernatant was removed from microtitre wells without 
disturbing the cells. Water lysis tube s were vortexed, centrifuged 
at 1,200 for 5 min, and 0.5ml of the supernatant was removed. 
Supernatants were counte d for one minute in a Packard gamma scintillation 
spectrophotometer . 
Cytotoxic activity (% specific lysis) is expressed as: 
test lysis - spontaneous l ys is 
wat e r lysis - spontaneous lysis 
2 . 11 IvJAINTENANCE OF CELL LINES 
2 . 11 . 1 P815 masLocytoma as Tc cell targets 
P815 (strain origin DBA/2, Dunn and Po tt e r, 1957) cell line 
was maintained by passage in tissue culture every 3 o r 4 days about 
5 4 . 5 2 . 1 
. x 10 viable cel ls were subcultured into 2 cm tissue cu ture flasks 
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(Falcon, 3013) containing 5mls of DMEM and 10% HIFCS. Cells were 
incubated in a humidified atmosphere of 7% 0
2
/10% co
2 
air and were 
used as targets 24 hours after subculture. 
2 . 11 . 2 PUS . 18 macrophage cell line 
PU5.18 cell line (Ralph and Nakionz, 1977) of Balb/c origin, 
was maintained by passage in tissue culture every 3-5 days. About 
10
5 
viable cells were removed from the monolayer by trypsin and 
subcultured into 25cm2 tissue culture flasks containing 5mls of DMEM, 
10% HIFCS and O.lm L-asparagine. When monolayers were confluent, 
15 ~ l 1ml LPS W was added to the medium to induce IL-1 secretion. 
2 . 11 . 3 Embryo fibroblasts 
Primary cultures of embryo fibroblasts were prepared as 
described by Bellet and Younghusband (1979) from PVG rat and C57Bl/6 
mouse embryos, and were grown in Eagle's medium "Autopow" (Flow 
Laboratories) supplemented with 10% FCS in 75cm2 plastic tissue 
culture flasks. 
2 . 12 GENE RAT ION OF TRF-CONTAI NING SUPERNATANT 
Spleen cells from mice primed to DNP-HCY were cultured as 
described in section 2.5 for 5 days with antigen. Cultures were 
harvested, centrifuged (2,000 rpm, 5 min), supernatant retained and 
centrifuged a ga in to remove al l spleen cells. This superantant was 
used directly in TRF assays. 
Alternatively, primed spleen cells were cultured for 4 days 
as above, cells pelleted by centrifugation supernatant discarded, 
pellet resusp e nd ed in E EM containing 2-ME and antigen (no FCS), 
replaced in Linbro trays and cultured for 24 hrs more. This 24-hour 
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(day 4-5 of culture) supernatant was pelleted free of cells, and was 
concentrated 10-fold over a PM-10 membrane (Arnicon, Lexington, Mass.) 
0 
under N2 at -15 C. The concentrate d supernatant was sterilized by 
0 filtration through a 0.22 Wm Millipore membrane and stored at -60 C. 
The rationale for the second part of TRF generation was to obtain 
TRF-containing supernatants which were free of FCS and hence could be 
concentrated with ease. 
2.13 PREPARATION OF CONCANAVALIN-A ACTIVATED CULTURE 
SUPERNATANT (CON A CS) 
Con A CS was made using a modification of the method described 
by Talmage et al.., (1977). 10 8 mouse spleen cells were cultured in 15mls 
of serum-free EMEM containing 10-4M 2-ME and 5 Wg/ml Concanavalin A 
(Con A; SIGMA, Grade IV). Cultures were set up in 75cm2 tissue culture 
flasks (Falcon, 3024), gassed with 10% co
2
/7% o
2
, 83% N
2 
and incubated 
at 37°c for 2 hours. By this time most of the cells had adhered to the 
plastic substrate. The supernatant medium was discarded, and the cell 
monolayer was washed gently 3 times with 15mls of EMEM/2-ME to remove 
non-cell bound Con A. The monolayers were then flooded with 30mls of 
serum-free EMEM containing 10-4M 2-ME. The flasks were re gassed and 
incubated at 37°c for a further 16-20 hours. 
The supernatant medium was harvested, centrifuged to remove 
cells and concentrated 10-fold over a PM-10 membrane (Amicon, Lexing ton, 
Mass.), filtered through a 0 .22 wm Millipore membrane and stored at - 20°c. 
Con A CS prepared by this t echnique contained no detectable 
residual Con A, as determined by agglutination of sheep red blood cells 
(Lafferty et al.., 1981). 
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2 . 14 TRF ASSAY 
Spleen cells from primed mice were treated with anti-Thy 1.2 
antibody and complement as described in section 2.6.2, adjusted to 
~ 1.2 x 10 6 cells/ml and cultur-d with supernatants from antigen-
activated or Con A-activated spleen cells in the presence of antigen. 
The ability of these supernatants to restore anti-DNP PFC responses 
was assayed 6 or 7 days later if added at culture initiation, or 4 days 
later if added on day 2 of the culture. 
2 . 15 MAINTENANCE ASSAY 
This assay measures the ability of IL-2 or T cell growth factor 
(TCGF) to support the continual blasting of activated T cells in cultures. 
The assay consists of two parts: generation of activated T cells and 
the assay of supernatants for maintenance activity. 
2 . 15 . 1 Preparation of mouse T cell blasts 
Spleen cells from C57Bl/6 (H-2b) mice were washed , declumped and 
6 
adjusted to a concentration of 10 cells/ml in EMEM, 10% HIFCS, 2-ME. 
Con A was added to cells at 1 µg/ml and the cell suspensions were 
plated in 24-well Linbro trays at 1 ml/well, gassed with humidified 
0 7% 0 2 /10% CO 2 air and incubated for 3 days at 37 C. 
2.15 . 2 The Assay 
5 The activated T cells were washed and resusp e nd e d at 4 x 10 
cells/ml in DMDM, 10% HIFCS and 2-ME. Lymphokine containing sample 
(SO µl of cell susp _nsion was added to each well and trays incubated 
at 37°c in a humidified atmosphere -of 7% 0 2 /10 % CO 2 air. After 16-20 
3 hours of culture, 1-2 µ Ci of H-methyl thymidine (Arne rsham, specific 
activity SCi/mmol) were added to e ach we ll in 50 µ l of EMEM and the 
cultures were incubated for a furt he r 5 hours. 
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The cultures were harvested onto g lass fibre filter paper discs 
(Whatman, Grade GF/A) using a Titertek cell harvester. The amount of 
thymidine incorporated by the cultures was determined by placing the 
discs in scintillation fluid and counting on a Packard liquid 
scintillation spectrophometer. Maintenance activity was expressed as 
counts/minute (cpm) and was considered significant if it was more than 3 
standard deviations (SD) above the mean of 24 controls. 
2 . 16 INTERLEUKIN - 1 (IL-1) AS SAY 
IL-1 either in antigen-activated supernatants or in supernatants 
of LPS-stimulated PU-5-1.8 cell line was assayed on C3H.Hej thymocytes 
which are unreactive to LPS in the preparation. 
Cell suspensions of C3H.Hej thymocytes were prepared as in 
section 2.5 and adjusted to 2 x 10 7 cells/ml in EMEM, 10 % HIFCS, 2-ME. 
Con A at 1 µg/ml was added to the cell susp e nsion. 50 µ l of IL-1 
containing supernatant was then placed in each well of a 96-well flat-
bottomed tray in 2-fold dilutions out to 12 wells. 50 µ l of cell 
suspension was added to each well and the plate incubated for 48 hours 
at 37°c in humidified co2 air mixture. 24 control wells contained 
medium inst e ad of supernatant. 
48 hours lat e r, 1-2 µ Ci of 3H-menthy l thymidine was add e d to 
each well in 50 µ l of EMEM and culture d for a furtt e r 5 hours. Th e 
cultures were harve st e d and thymidine incorporation ass e ss e d as for 
IL-2 in section 2.15.2. 
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2.17 STATISTICAL ANALYSIS OF RESULTS 
The arithmetic mean and standard error (SE) or standard 
deviation (SD) of the mean were calculated by standard statistical 
methods. The Student's T-test was used to estimate the significance 
of the difference between the mean values of two groups. The 
difference between two groups was considered not significant (NS) if 
the p value was >0.05. 
CHAPTER 3 
Inhibition of se~ondary IgG responses 
by N-acetyl-D-galactosarnine 
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3 . 1 INTRODUCTION 
Evidence from a wide range of biological systems indicates that 
carbohydrates, usually expressed as gangliosides, can function as cell 
surface receptors for regulatory molecules. The best characterized 
receptor is the monosialoganglioside GM
1 
which binds cholera toxin and 
subsequently results in adenylate cyclase activation (Van Heyningen, 1974; 
Fishman and Brady, 1976). Gangliosides have also been implicated in the 
cell membrane receptors for tetanus toxin (Van Heyningen, 1974), 
interferon (Vengris e..t al.., 1976), thyroid stimulatory hormone (Mullin 
e..t al., 1978), and cell adhesion (Huang, 1978). At the immunological 
l evel, recent studies suggest that the receptor on macrophages for 
migration inhibition factor is also a ganglioside (Higgins e..t al.., 1978; 
L i u e..t a£ . , 1 9 82 ) . 
Recently, a family if l region-associated (Ia) antigens expressing 
carbohydrate-defined antigenic determinants have been described both 
in mouse (Parish e..t al.., 1977) and man (Sandrin e..t al., 1979). Since 
the carbohydrate-defined Ia antigens appear to be gang liosides, it seems 
likely that they may act as receptors for informational molecules between 
'., 
lymphoid cells. The observation that certain T cell-derived gangliosides 
can inhibit ,01 vi:ltr..o antibody responses (Esselman and Miller, 1977) is 
consistent with this idea. 
Additionally, a large body of evidence suggests that Ia antigen 
specificities are associated with a ran ge of immunore gulatory molecules 
or "factors" secreted by T cells. These factors mediate help (Armerding 
e..t al . , 1974; Munro and Taussig, 1975; Howie and Feldmann, 1977) and 
suppression (Tada e..t al.., 1976; Theze e..t al.., 1977) of antibody formation, 
contact hypersens itivity (Greene e..t al.., 1977) and mixed lymphocyte 
reactions (MLR) (Rich et af., 1977). At least some of these factors 
have been shown to carry carbohydrate-defined Ia specificities. Thus 
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L-Glu -L-Ala -L-Tyr (GAT) and poly-L-(Tyr, Glu)-poly-DL-Ala--poly-
L-Lys (T,G)A--L -specific helper factors appear to bear carbohydrate 
determinants (Howie et al., 1979). Similarly, a T cell-derived 
suppressor factor of delayed-type hyper-sensitivity also appears to 
carry carbohydrate-defined Ia antigens (Liew et al., 1980). 
If carbohydrate-protein interactions (possibly f-region controlled) 
do indeed play a role in the communication between lymphocytes, one 
would predict that certain monosaccharides should selectively inhibit 
in vitJr..o immune responses. This chapter describes studies which support 
this concept and suggests that N-acetyl-D-galactosamine (Gal NAC) inhibits 
secondary IgG respons es by blocking the collaboration between T and B 
lymphocytes. 
3.2 ~~TERIALS AND METHODS 
3.2.1 Animals 
CBA/H, A.TL, A.TH and Balb/c mice of either sex were used at 
5-16 weeks of age. Monomeric flagellin (MON) was prepared from the 
flagella of Salmonella typhimwr.ium SL 870, and haemocyanin (HCY) from 
]aJ.,U/2 lalandii crayfish as described in section 2.2. These prot e ins 
were dinitrophenylated with conjugation ratios of DNP
1
_
1
MON and 
DNP 42 HCY (see section 2.2). The sources of the monosaccharides are 
listed in section 2.8. 
3.2.2 Immunizations 
Mice were primed to DNP-MON and DNP-HCY as desc ribed in section 
2.3. Briefly, the anti gen was bound on be ntonit e and inj ec ted intra-
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peritoneally three times at two-week intervals. Animals were used 
2-6 weeks after last challenge. 
3.2.3 In v,i,t)[o Antibody responses 
6 Spleen cells were cultured at a concentration of 2 x 10 cells/ml 
-4 in EMEM, 5% FCS, 2-ME (10 M) in 24-well Linbro trays as described in 
Section 2.5. Primary antibody responses were assayed after 3 days of 
culture in a 10% co2 /7% o2 humidified atmosphere; secondary antibody 
responses after 7 days of culture. Sugars and antigen were added at 
the beginning of the culture. 
3.2.4 MLR 
A MLR was generated between 5 x 105 Ig · A. TH spleen responder 
cells and 5 x 105 2,000 rads-irradiated A.TL stimulator spleen cells 
in the presence of sugars at a concentration of 2mg/ml. After 4 days 
of culture, each treatment was pulsed for 18 hours with 0.5 µCi/well 
125 
of I-labelled deoxyuridine. Further details of the MLR are described 
in section 2.9. Results were expressed as counts/minute incorporated. 
3 . 2 . 5 In v,i,t)[o Primary Tc cell responses 
Tc cells were generated by culturing 5 x 10 6 CEA responder cells 
with 1.25 x 10
6 
gamma-irradiated Balb/c stimulator cells (see section 
2.10). Sugars were present throughout culture at a concentration of 
Smg/ml. The cultures were harvested on the fifth day and cytotoxic 
51 
activity assayed on Cr-labelled P815 mastocytoma target cells. For 
details see section 2.10.2. 
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3 . 2 . 6 Assay of PFC 
Antibody-secreting cells were enumerated using the technique 
of Cunningham and Szenberg (1968). To detect anti - DNP PFC, SRBC 
were coated with DNP. Indirect PFC were estimated in the presence 
of developing serum as described in section 2. 7. Different classes of 
indirect PFC were assayed with the use of monospecific anti-IgG
1
, 
IgG2a' IgG2b and IgA antisera (Litton Bionetics, Kensington, MD). 
Results were expressed as the mean of anti-DNP PFC/4 culture replicates. 
3.2 . 6 Generation and assay of supernatant with T cell 
r eplacing helper activity 
T cell replacing factor (TRF) was generated by culturing 
6 primed spleen cells (2 x 10 /ml) for 5 days with antigen and then 
harvesting the culture supernatant. TRF activity was assayed by adding 
2.5ml of supernatant to each well of primed spleen cells that had 
been cultured for 2 days with antigen and then T cell depleted by 
anti-Thy-1 . 2 and complement treatment (see section 2 . 6.1). The anti -
DP PFC response, assayed after an additional 5 days of culture, was 
a measure of helper activity. 
3 . 3 RESULTS 
3 . 3 . 1 Inhibition of ~n v~t~o i mmune responses by 
rnonosaccharides 
A prediction of the hypothesis that carbohydrate-protein 
interactions are involved in lymphocyte communication is that mono-
saccharides should ~elec tively inhibit immune responses. Thus, ten 
monosaccharides were screened for their effec t on a ran ge of -{.Y!. v~Uo 
immune responses. 
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The ten monosaccharides used in this study represent common 
sugars p r esent in mammalian carbohydrates. It should be not e d that 
amino sugars such as glucosamine could not b e used in ~n v~Vto cultures 
as it was found that they were highly toxic for lymphocytes, killing 
o r lysing all cells within 24 hours of culture. 
3 . 3 . 2 Primary ~n v~tko antibody responses 
In these studies, the primary ~n v~Uo anti-DNP PFC response 
induced by DNP-MON was examined. This antigen induces only IgM PFC 
in a primary response, the PFC peaking after 3 days of culture. In the 
experiment shown in Table 3.1, at Smg/ml (~ 20mM), D-mannose was 
inhibitory, suppressing the anti-DNP PFC response to background levels 
without noticeably affecting cell viability of the culture. A similar 
inhibitory effect with this sugar was observed in a number of experiments. 
3 . 3 . 3 Secondary ~n v~tfLo antibody responses 
I n v~Vto secondary anti-DNP antibody responses were examined 
using spleen cells from mice that had been primed with either DNP-MON 
or DNP-HCY, the levels of anti-DNP PFC being assayed after 7 days of 
culture . The secondary PFC responses consisted of both IgM and IgG-
secreting cells. However, with spleen cells from CBA mice, I gM peaked after 
3 days of culture and dec lined to very low levels by day 7, whereas 
IgG PFC peaked on day 6 or 7. Thus the n eg ligible day 7 IgM PFC r esponses 
are not include d in Tables 3.2 and 3.3. 
As in primary antibody respons e , D-mannose completely 
abrogated the secondary PFC r e sponses induced by both DNP-MO and 
D P-HCY . However, in contrast with the primary r esponse, Gal NAc 
EFFECT OF MONOSACCHARIDES ON PRIMARY .lli VITRO 
J\NTIBODY RESPONSE TO DNP-MON 
TREATMENT !GM DNP-PFC/CULTURE 
NO ANTIGEN 23 + 5 
NO SUGAR 2,160 + 133 
L-FUCOSE 1,732 + 65 
D-GLUCOSE 1,463 + 395 
N-ACETYL-D-GLUCOSAMINE 1,763 + 57 
aMETHYL GLUCOSIDE 1,770 + 72 
D-GALACTOSE 1,513 + 74 
N-ACETYL-D-GALACTOSAMINE 1,953 + 101 
aMETHYL GALACTOSIDE 1,600 + 198 
D-MANNOSE 18 + 12 
N-ACETYL-D-MANNOSAMI NE 1,970 + 65 
aMETHYL MANNOSIDE 1,953 + 83 
TABLE 3.1 
% INHIBITION 
100 (P=0.001) 
Ability of different monosaccharides to inhibit the ,{J1 v~~to 
primary anti - DP - MON antibody response of CBA/H spleen cells. 
Results are expressed as mean and standard e rror (n=4). 
~onosaccharide concentration= Srng/rnl D1P - PFC assayed after 3 days 
of culture . 
EFFE CT OF MONOSACCHARIDES Oi~ SECONDARY lli VITRO 
ANTIBODY RESPONSE TO DNP-MON 
TREATMENT 
NO ANTIGEN 
NO SUGAR 
L-FUCOSE 
D-GLUCOSE 
N-ACETYL-D-GLUCOSAMINE 
aMETHYL GLUCOSIDE 
D-GALACTOSE 
i~-ACETYL-D-GALACTOSAM INE 
aMETHYL GALACTOSIDE 
D-MANNOSE 
N-ACETYL-D-MAN NOS AM INE 
aMETHYL MANNOSIDE 
TABLE 3 . 2 
IGG DNP-PFC/ CULTURE 
0 
8) 825 + 324 
6)768 + 383 
6)325 + 388 
7)255 + 222 
- 7)940 + 386 
6)770 + 851 
849 ± 19 
7) 458 + 814 
10 ± 7 
6)528 + 310 
7)590 + 279 
% INHIBIT I ON 
90 (P=0.001) 
100 (P=0.001) 
Ability of different monosaccharides to inhibit the ,{J1 vdJr.o 
secondary anti - DNP - MON antibody response of CBA/H spleen cells . 
The results are expressed as means and atandard errors 
(n=4) . Monosaccharide concentration= Smg/ml; DNP - PFC assayed after 
7 days of culture . 
EFFECT OF MONOSACCHARIDES ON SECONDARY lli VITRO 
ANTIBODY RESPONSE TO DNP-HCY 
TREATMENT IGG DNP-PFC/CULTURE 
NO ANTIGEN 5 + 3 
NO SUGAR 14)450 + 2)147 
L-FUCOSE 4)705 + 1)425 
D-GLUCOSE 12)088 + 1)803 
N-ACETYL-D-GLUCOSAMINE 6)330 + 615 
aMETHYL GLUCOSIDE 14)723 + 528 
D-GALACTOSE 13)195 + 517 
N-ACETYL-D-GALACTOSAMINE 1)858 + 86 
aMETHYL GALACTOSIDE 15)200 + 966 
D-MANNOSE 3 + 3 
N-ACETYL-D-MANNOSAMINE 11)275 + 284 
aMETHYL MANNOSIDE 11)225 + 632 
TABLE 3. 3 
% INHIBITION 
67 (P=0,01) 
56 (P=0,01) 
87 (P=0,001) 
100 (p=0.001) 
Ability of different monosaccharides to inhibit the ,(YI, v~:f:Ao 
secondary anti-DNP-HCY antibody response of CBA/H spleen cells. 
Results are expressed as mean and standard error of our 
determinantions. Sugar concentration= 5mg/ml. PFC response was 
assayed after 7 days of culture. 
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inhibited about 90% of the IgG response to these two antigens 
(see Tables 3.2 and 3.3). Two other sugars consistently inhibited 
the response to DNP-HCY, although the blocking was not as striking as 
with Gal NAc. These sugars were N-acetyl-D-glucosamine (Glc NAc) and 
L-fucose (Fuc), inhibiting IgG levels by 56 and 67 % respectively 
(Table 3.2). Comparable results with DNP-HCY primed cells were 
obtained in additional experiments. In DNP-MON-primed cultures, Glc NAc 
and Fuc exerted significant inhibition in 2 out of 5 experiments. 
However, as depicted in Table 3.2 inhibition by these sugars was not 
always observed with this antigen. 
3 . 3 . 4 Responses to alloantiqens ~n vitko 
Two different responses to alloantigens were examined: 
a MLR against an inter - H-2 (!-region) difference and the Tc cells 
generated by complete incompatibility across the H-2 complex. As in 
both primary and secondary antibody responses ~n vilio, D-mannose 
completely inhibited both the MLR to I-region antigens (Table 3;4) and 
the generation of Tc cells (Table 3.5). However, Gal NAc exerted no 
inhibitory effect at all in these responses, nor did Glc NAc and Fuc, 
thus highlighting the specificity of these sugars for secondary antibody 
responses. 
3 . 3.5 Mode of inhibition by Gal NAc 
The data presen t ed above indicates that Gal NAc clearly 
selectively inhibits secondary antibody responses. A more detailed 
analysis of the mode of inhibition by this sugar was performed. The 
inhibitory effect of this sugar was concentration- dependent. As can be 
seen in Figure 3.1, significant inhibition was still seen at a concentration 
INHIBITION OF MIXED LYMPHOCYTE REACTION BY VARIOUS 
SUGARS 
RESPONDERS STIMULATORS SUGAR C.P.M. c125I UDR) (IG- SPLEEN) (2.,000R X-IRRAD. 2MG/ML 
SPLEEN) 
5xl05 A.TH 5xl05 A.TH 10.,965 + 840 
II 5xl05 A.TL 47.,759 + 1,037 
II II L-FUCOSE 39.,250 + 5.,932 
II II L-RHAMNOSE 47.,271 + 1.,315 
II II 
D-GALACTOSE 41.,817 + 896 
II II 
N-ACETYL-D-GALACTOSAMINE 45.,599 + 5.,911 
II II 
D-GLUCOSE 47.,306 + 2.,153 
II II 
N-ACETYL-D-GLUCOSAMINE 47.,112 + 1.,403 
II II D-MANNOSE 14.,009 + 1.,195 
II II 
N-ACETYL-D-MANNOSAMINE 40.,727 + 2.,846 
---- ---· - - --- -----------· --- ------------ --
---- ----- - · - ·-
TABLE 3.4 
Inhibition of ML R by d i f f e r ent s u gars . 
5 5 5 x 10 r e spond e r c e lls we r e mi xed with 5 x 1 0 2 ,000 r d 
X-irradiat e d stimulator s pl een ce ll s i n t he p r esen ce of 2mg/ ml of 
monosaccharide . The ext e nt of s timul a t ion was assayed aft e r 4 days of 
culture . 
Mean (n=3) s tan dar d e rro r. 
EFFECT OF SUGARS ON THE GENERATION 
OF CYTOTOXIC T CELLSa 
SUGARS (5 MG/ML) SPECIFIC LYSIS %b 
37.4 + 1,5 
L-FUCOSE 44,8 + 1.1 
D-GLUCOSE 44,8 + 106 
Glc NAc 30,6 + 2.8 
METHYL-a-D-GLUCOSIDE 44.1 + 4.7 
D-GALACTOSE 48,2 ± 2a3 
Gal NAc 42,7 ± 2a3 
METHYL-a-D-GALACTOSIDE 35,9 ± Dal 
D-MANNOSE 0 
a) CYTOTOXIC T CELLS WERE GENERATED BY INCUBATING 
1.2s x 106 IRRADIATED BALB/c SPLEEN CELLS WITH 
5 x 106 CBA/H SPLEEN CELLS 
b) MEAN (n = 4) + STANDARD ERROR 
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FIGURE 3.1 
Ability of different concentrations of Gal NAc to inhibit 
the secondary anti-DNP-HCY antibody response ,01 vilio. Dotted Line 
(·······; represents response in the absence of sugar. Results are 
means of the day 7 PFC responses. Vertical bars are standard errors 
of means (n=4). 
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of 0.7mM. In this context, the concentration of glucose in the EMEM 
culture medium is about SmM. Figure 3.1 also shows a residual response 
which was not inhibited even by high concentrations (24-48mM) of Gal NAc. 
This residual response varied between experiments, ranging from 5 to 
30% of the total anti-DNP PFC response in these studies. 
In the experiments described so far, Gal NAc was present 
throughout the 7 days of culture. It was important, therefore, to show 
the exact time in the response when Gal NAc exerted its inhibitory 
effect. One possibility was that this sugar inhibited both IgM and IgG 
responses. Furthermore, rat her than completely inhibiting the IgG 
response, Gal NAc may have shifted the peak of the IgG response away 
from day 7. 
A daily analysis of the secondary antibody response indicated 
that IgM peaked on day 3 and IgG on day 7 (Figure 3.2) . Similar peaks 
were obtained for DNP-HCY and DNP-MON primed cultures, although the 
IgM peak was higher with DNP-MON primed cells. 
A daily analysis of Gal NAc inhibition is depicted in 
Figure 3.2 and highlights the inability of this sugar to affect the 
IgM response but its very strong blocking of IgG production. It should 
be noted that in the presence of sugar, there appears to be no shift 
in the peak of the IgG response: in fact, very few IgG-producing cells 
were detected after 10 days of culture. A similar analysis of the secondary 
antibody response to DNP-MON revealed that Gal NAc had no effect on IgM 
PFC but inhibited the IgG production throughout a 10-day culture period. 
When plaques were develope d with monospecific antisera, it was seen that 
the IgG response consisted of approximately 90 % IgG
1 
and 10 % IgG
2
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FIGURE 3 . 2 
Kinetics of secondary anti-DNP-HCY antibody r esponse ~n V~Vi.O 
in the absence ( ) and in the presence ( 0) of Gal NAc . Solid 
line repres e nts IgG PFC l eve ls, broken line IgM PFC l evels . Each 
point r epresents the mean of 4 determinations . Ver tical bars are 
standard errors of means. 
antibody-forming cells. Gal NAc was equally inhibitory for both of 
these Ig classes (Table 3.6). There were no detectable IgG
2
b or 
IgA PFC. 
To determine the exact time at which Gal NAc exerted its 
inhibitory effect, this sugar was added and deleted from culture wells 
each day for 7 days of culture. Figure 3.3 indicates that Gal NAc 
acts over a short time interval, inhibiting only between days 3 and 4 
of culture. Furthermore, when Gal NAc was pulsed into cultures for 
24 hour periods throughout the 7 days of culture, inhibition by this 
sugar was again seen to predominantly occur on day 4 of the response (Fig 3.4). 
The inhibition on day 4 of culture observed in both of these experiments 
closely coincides with the first appearance of IgG PFC in this system 
(Figure 3 . 2) . 
3 . 3 . 6 Mode of inhibition by L-fucose 
Data presented in Table 3.3 shows that Fuc selectively 
inhibits secondary antibody responses to DNP-HCY. As with Gal NAc, 
a more detailed analysis of the mode of inhibition by Fuc was performed. 
Fuc did not inhibit IgG responses as acutely as Gal NAc. However, as 
can be seen in Figure 3.5, a daily analysis of Fuc-inhibition showed 
that this sugar did not shift the peaks of the antibody response and 
that IgG production was blocked significantly. 
As with Gal NAc, when Fuc was added and deleted from culture 
wells each day for 6 days of culture, this sugar exerted its 
inhibitory effect between days 2 and 4 of the culture (Figure 3.5). 
TABLE 3 . 6 
Isotype composition and Gal NAc inhibition 
of secondary IgG response to DNP-MON in CBA/H cultures 
(a) Isotype composition 
Isotype 
IgGl 
IgG2a 
IgG2b 
IgA 
day 7 PFC/culture* 
1,650 + 33 
245 + 19 
95 + 10 
53 + 18 
(b) Gal NAc inhibition of secondary IgGl and IgG2 response to 
DNP-MON in CBA/H cultures 
Treatment day 1 PFC/culture* 
IgGl I gG2 
Antigen only 
Gal NAc 
10,875 + 489 
4,068 + 528 
1,790 + 258 
1,095 + 88 
Plaques were de veloped with monospecific antisera on day 7 of culture. 
Gal NAc was present at 5mg/ml 
* mean and standard error of four determinations 
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Influence of the time of addition and deletion of Gal NAc 
on a secondary anti-DNP-MON antibody response ~n v~Uo. The sugar 
with either added (•)or deleted ( ) on each day of culture 
and all cultures assayed for anti-DNP PFC on day 7. Vertical bars 
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FIGURE 3 . 4 
Effect of pulsing cultures for 24-hour periods with Gal NAc 
on a secondary ,01 vi...tlr.o anti - DNP - MON antibody response. All cultures 
were assayed for anli -DrP -PFC on day 7. Each column represents the mean 
and standard error of 4 det e rminations. The bar on the ri gh t r ep r esents 
the respons e in absence of sugar . 
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L-fucose inhibition of secondary in vitro anti-DNP - HCY antibody 
response: 
(a) Kinetics of the antibody response in absence ( ) · and in 
presence ( ) of Fuc. Solid line represents IgG PFC levels, 
brokin line IgM PFC levels. Each point represents the me~n of 4 
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(b) Influence of the time o i 
addition and deletion of Fuc 
on the antibody response . 
Fuc was either added ( ) o 1 
deleted ( ) on each day of 
culture and all cultures 
assayed for anti - DNP PFC on 
day 6. Vertical bars are 
standard errors of mean (n=4) 
3 . 3 . 7 Inhibition of TRF activity 
A number of laboratories have demonstrated that mono-
saccharides block the interaction of lymphokines with target cells 
(Amsden ~t al.., 1978). Based on these findings, it seemed possible, 
t herefore, that Gal NAc was blocking the action of a helper factor, 
probably secreted by T cells . Table 3.7 presents the results of an 
experiment that tested this possibility. The experiment consisted 
of harvesting the supernatant from DNP-HCY-primed spleen cells cultured 
with antigen for 5 days and adding this supernatant to DNP-HCY primed· 
spleen cells that had been cultured for 2 days with antigen and then 
depleted of T cells. The data presented in Table 3.7 demonstrates 
t hat supernatants of 5-day cultures contained T cell replacing activity 
i . e . helped B cells to make antibody to a T-dependent antigen in the 
relative absence of T cells. This activity will henceforth be referred 
to as T cell replacing factor (TRF). It should be noted that supernatants 
from cultures without antigen stimulation lacked TRF activity. The 
TRF activity of this supernatant was completely abrogated by the addition 
of Gal NAc on day 2 of culture, suggesting that Gal NAc prevents an 
interaction between TRF and B cells. 
TABLE 3.7 
INHIBITION OF T-CELL REPLACif~G ACTIVITY 
BY N-ACETYL-D-GALACTOSAMir~E 
TREATMENT 
NO TRF 
TRF 
TRF + GAL l'~AC t 
IGG DNP-PFC/cuLTURE 
532 + 59 
11.,983 + 596 
336 + 119 
* 
SPLEEN CELLS FROM DNP-HCY PRIMED MICE., CULTURED FOR 
2 DAYS WERE TREATED WITH ANTI-THY-1,2 AND COMPLEMENT; 
AND RECONSTITUTED WITH DAY 5 CULTURE SUPERNATANT (TRF), 
TRF ABILITY WAS MEASURED AFTER ADDITIONAL 5 DAYS OF 
CULTURE, 
* MEAN AND STANDARD ERROR (N=4) 
t SUGAR AT 5 MG/ML 
3 . 4 DISCUSSION 
In this chapter, a range of monosaccharides were tested for 
their ability to inhibit a variety of in vi:vr.o immune responses. It 
was found that Gal NAc strongly inhibit ed the secondary IgG antibody 
response to both DNP-MON and DNP~HCY but had no effect on a primary 
antibody response, generation of Tc cells to alloantigens and MLR. 
This selective inhibition by Gal NAc had some additional unique 
features: 
(a) The sugar inhibited only IgG production and had no effect 
on either primary or secondary IgM levels. The 
inhibition studies depicted in Figure 2 also suggest 
that the initiation of IgG synthesis is independent 
of IgM shutdown. In addition, both classes of IgG 
detected in the in vi:vr.o responses, namely IgG
1 
and 
IgG2 a were equally inhibited by Gal NAc . 
(b) The secondary IgG responses could be blocked by the 
presence of Gal NAc over a very short time period. 
In fact, addition and deletion experiments (Figure 3), 
as well as the pulsing (Figure 4), show that Gal NAc 
needs to be present only on day 4 of the response to 
exert its inhibitory effect. Furthermore, the kinetic 
studies (Figure 2) indicate that this day coincides 
with the first appearance of I g G PFC in this system . 
(c) PresePce of Gal NAc in th e T cell-depleted cultures 
preve nt e d th e restoration of a normal IgG response by 
a culture-derived TRF. 
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Collectively, the data imply that Gal NAc inhibits the 
initiation of IgG synthesis. The TRF experiment (Table 3.7) indicates 
that Gal NAc has no effect on the induction of T helper cells but 
probably blocks the interaction of TRF for antibody synthesis with its 
target cell, probably a B cell. However, although unlikely, these 
experiments do not exclude the possibility that Gal NAc acts directly 
on the precursors of IgG PFC rather than blocking the interaction of 
TRF with B cells . 
Blocking of interaction between a factor and its target cell 
is by no means a new concept. The action of migration inhibition 
factor, macrophage chemotatic factor and neutrophil chemotactic 
factor can be inhibited by L-fucose and L-rharnnose (Higgins ~t al.., 
1978; Amsden ~t al . , 1978). Sugars have also been reported to be able 
to inhibit the ability of lymphokines to induce skin reactions to an 
antigen (Baba ~t al.., 1979). 
In this report, 3 other sugars were shown to have an effect 
on ~n v~tko immune responses. D-mannose completely inhibited all 
responses tested and hence was nonspecific in its action. It should 
be pointed out that this sugar was not toxic for cultured cells but 
appeared to inhibit their differentiation in response to antigen, 
(i.e . the number of viable cells in cultures containing D-mannose 
was the same as in cultures without added antigen). Studies in 
Chapter 6 suggest that D-mannose affects lymphocyte metabolism. 
Fuc and Glc NAc selectively inhibited secondary ~n v~uo antibody 
responses to DNP-HCY. Their occasional inability to inhibit DNP-MON 
primed cultures is difficult to explain, but may be due to the fact 
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that nuce are frequently preprimed to MON by the bacte rial flora of 
the gut or by natural pathoge ns such as P~ottu/2 ( Venning, 1974). 
Therefore it is possible that more primed TH cells and consequently 
more TRF is present in thes e responses and h e nce the difficulty in 
inhibiting the responses with Fuc and Glc NAc. Another possibility 
if that th ese two sugars are "poore r fit" i.e. they may b e of secondary 
importance in the structure these sugars are mimicking and hence do not 
always successfully block the binding of TRF to its targe t cell. In 
this context it should be noted that these two sugars were usually 
less effective inhibitors than Gal NAc. 
Glc NAc is a clos e analogue of Gal NAc and hence it is 
possible that it mimics the action of Gal NAc. However in subseque nt 
experiments Glc NAc proved to be an inconsistent inhibitor i.e. would 
b e significantly inhibitory in only about half of the experiments and 
hence it was not used further. 
Fuc, on the other hand, is structurally quite different 
from Gal NAc and therefo r e may have a different mechanism of inhibition. 
However, daily analysis of antibody inhibition by Fuc (Fi gur e 3.5) 
indicates that this sugar inhib its secondary antibody response ~n v~Uo 
in a manner similar to that exe rt ed by Gal NAc . 
Finall y , it could be argued that the inhibi tory sugars exe rt 
nonspe cific or osmotic effects on cell cultures. A number of observations 
make this supposition unlikely: 
the inhibitory sugars, Gal Ac, Glc Ac and Fuc showed 
specificity for secondary IgG responses ~n v~Uo only and 
no other r esponse tested was affected by these 3 sugars 
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the noninhibitory sugars were present in cultures at the 
same concentration as Gal NAc, yet had no apparent 
osmotic effects. 
Gal NAc exerts its inhibitory effect over a very short 
period of time, between day 3 and 4 of culture 
genetic analyses of IgG inhibition presented in Chapter 4 
demonstrate that the inhibition is under I region control 
and varies between mouse strains. 
Data presented in this chapter are consistent with the 
hypothesis that carbohydrate-determinants play a role in communication 
between lymphocytes, a point which will be discussed further in later 
chapters. 
9 1 
3 . 5 SUMMARY 
Evidence is presented that a number of monosaccharides 
inhibit secondary IgG responses ,in vi:br.o, but have no effect on primary 
,in vi:tAo antibody responses, MLR or the generation of Tc cells . 
The most striking specific inhibition was produced by Gal NAc . This 
sugar exerted its inhibitory effect on day 4 of the culture, the day 
when IgG PFC first appeared. Furthermore, Gal NAc could override the 
action of a TRF in T-cell-depleted cultures. Collectively, the data 
indicates that Gal NAc inhibits the initiation of IgG synthesis, 
possibly by blocking the interaction of a helper factor for IgG 
synthesis with its target cell. 
CHAPTER 4 
Inhibition of secondary IgG responses 
by monosaccharides: Evidence for ~-region control 
4 . 1 INTRODUCTION 
It is generally accepted that the murine MHC controls 
glycoproteins whose antigenic determinants reside in their protein 
portion . Recently, a second series of polymorphic antigens under 
I - region control have been described that are carbohydrate in nature. 
The role of Ia antigens has been implicated in many immunological phenomena 
such as T cell-macrophage interactions (Schwartz et al., 1978; Erb 
et al., 1980), T cell help (Hodes et al., 1980; Tada and Okumura, 1979) 
and T cell suppression (Tada and Okumura, 1979; Theze et al., 1977). -
However, the relative importance of the protein - defined and carbohydrate -
defined Ia antigen in these phenomena is unknown. 
In Chapter 3 data was presented which showed that some simple 
sugars selectively inhibit the secondary ~n v~tfco IgG responses of CBA/H 
spleen cells, probably by blocking the interaction of a T cell replacing 
helper factor (TRF) with a target cell, probably a B cell. These results 
suggest that carbohydrate recognition is involved in initiation of IgG 
synthesis, simple sugars blocking this interaction by mimicking the 
carbohydrate structure(s) involved. If carbohydrate - defined Ia antigens 
are the structures recognised, then, due to the great polymorphism of 
these antigens (Parish et al., 1982), it might be expected that the IgG 
response of mouse strains of different I-region haplotype would be 
inhibited by different suga rs. 
The experiments presented in this chapter examined sugar 
inhibition of secondary IgG responses in a range of mouse strains. The 
inhibitory sugars d i ffered between mouse strains as predicted and these 
differences were found to map within the I-re gion of the H-2 complex, 
specifically to the I-J and I-C subregions. These findings support the 
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concept that carbohydrate Ia antigens play a role in I-region controlled 
cell-cell interactions. 
4.2 MATERIALS AND METHODS 
4. 2. 1 Animals 
All mouse strains used and their H-2 haplotypes are presented 
in Table 2.1. Only females were used at 6-14 weeks of age. 
4.2.2 Antigens 
Haemocyanin (HCY) was recrystallized from the haemolymph of 
crayfish and dinitrophenylated as described in Section 2.2. The conjug-
ation ratio used was DNP
26
HCY. 
4. 2. 3 Sugars 
The source of monosaccharides is listed in section 2.8. All 
sugars were added at the beginning of culture and were used at a final 
concentration of Smg/ml in culture medium (~20mM). 
4 .2.4 Immunizations 
DNP-HCY was made particulate by adsorption to bentonite as 
described in section 2.3. Mice were given one i.p. injection of this 
antigen every two weeks for a total of three injections. Each dose 
contained 200 µg of protein in 0.2ml of phosphage-buffered saline. 
Animals were used ten or more days after the last injection. 
The priming of animals proved difficult at this stage . During 
the summer and winter months (in 2 successive years), very few animals 
responded in ~n v~Dl.o cultures, despite the three doses of DNP-HCY 
given ,{yz_ v~vo. Only 1 out of 3 or 1 in 4 "batches" of animals were primed 
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and these gave responses only if taken within a fortnight of the 
last challenge ,(YI. vivo. In spring and autumn, mice were primed more 
consistently. Administration of antibiotics proved unsuccessful as did 
the reduction of animals per cage. 
We finally solved the problem of priming by keeping and priming 
the mice in a temperature (25°c), light and humidity-controlled 
environment, but otherwise treated as described in section 2.3. Under 
these conditions, the majority of animals gave good responses consistently 
for up to 3 months after the last challenge (the longest interval tested). 
4 . 2 . 5 Cell Cultures 
Spleen cells were cultured in Linbro 24-well trays for 7 days 
in EMEM, 5% FCS, l0-4M 2-ME as described in section 2.5. Each well 
contained 5 x 10
6 
cells in 2.5ml medium and each treatment was cultured 
in quadriplicate. 
4.2 . 6 Assay of anti-DNP PFC response 
Cells secreting anti-Dr P antibodies were estimated at the peak 
of the IgG response (day 7), SRBC were coated with dinitrophenylated 
anti-SRBC Fab and indirect plaque-forming cells were estimated in the 
presence of developing serum. For more details of the assay, see 
section 2.7. 
4 . 3 RESULTS 
4 . 3 . 1 Analysis of sugar inhibition in different mouse strains 
Eight monosaccharides were tested for their ability to inhibit 
the secondary,(Y!. vi:tfr.o anti-DNP-HCY IgG responses of a number of different 
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mouse strains. Table 4.1 presents typical sugar inhibition data for six 
different mouse strains. Each strain was tested on at least two separate 
occasions with comparable inhibition data being obtained in each 
experiment. 
It can be seen in Table 4.1 that Gal NAc inhibited all strains 
tested. However, some sugars exhibited strain-specific inhibition. These 
differences appeared to be H-2 controlled, since the inhibition patterns 
were dependent upon the H-2 haplotypes rather than the non-H-2 
background of the mouse strains used. For example, BIO.BR 
and BlO.D2 cells that share the BlO background but are H-2 incompatible 
were inhibited by different sugars. Three monosaccharides emerged 
as H-2 haplotype-specific inhibitors. L-fucose (Fuc) only inhibited the 
k haplotype (CBA/H, BIO.BR) but not the d (Balb/c, BlO.D2) orb (C3H.SW, 
BlO) haplotypes, whereas D-galactose (Gal) and N-acetyl -D-rnannosamine 
(Man NAc) inhibited d and b haplotypes but had no inhibitory effect on 
the k haplotype. H-2s and H-2q haplotypes also showed strain specific 
sugar inhibit ion pattern identical to the d and b haplotype but since we 
had no appropriate recombinants within these haplotypes, they were 
not mapped further. 
4 .3.2 Sugar inhibition in H-2 recombinant mouse strains 
The next series of experiments attempted to map the region(s) 
in the H-2 complex controlling the differences in sugar inhibition by 
testing a range of k, ~ and d haplotype recombinants. The results of 
these experiments are collated in Table 4.2 and summarized schematically 
in Figure 4.1. 
TABLE 4 .1 Ability of Different Monosaccharides to Inhibit the Secondary IgG Response 
of Different Mouse Strains 
Mouse Strain 
Treatment 
CBA/H Bl0.BR BALBLc Bl0.02 C3H.SW 
H-2k H- 2k H-2d H-2d H-2b 
Background (no antigen} 5 ± 3 15 ± 12 960 ± 143 0 0 
Antigen only 14,450 ± 2,147 4,218 ± 295 55,050 ± 4,490 2,165 ± 243 13,390 ± 422 
L-fucose 4,705 ± 1,425* 282 ± 53** 52,470 ± 2,152 2,438 ± 126 13,933 ± 1,471 
D-glucose 12,088 ± 1,803 4,470 ± 580 53,350 ± 3,654 2,378 ± 169 12,588 ± 860 
a-methyl-D-glucoside 14,725 ± 528 n. ::1. 52,960 ± 4,101 2,757 ± 177 15,687 ± 1,504 
D-galactose 13,195 ± 517 4,488 ± 491 30,340 ± 2,797 * 638 ± 182* 5,133 ± 486** 
N-acetyl-S-D-galactosamine 1,858 ± 86** 418 ± 169** 15,550 ± 955** 278 ± 73** 845 ± 300** __ , .. ..,., 
- -
..... - - - ---
a-methyl-D-galactoside 15,200 ± 966 3,625 ± 350 48,970 ± 1,744 2,235 ± 71 13,010 ± 1,100 
N-acetyl-S-D-mannosamine 11,275 ± 284 3,847 ± 319 30,660 ± 1,712* 340 ± 174* 1,165 ± 596** 
a-methyl-D-mannoside 11,225 ± 632 4,018 ± 167 53,600 ± 2,058 n.d. 10,890 ± 1,417 
Results expressed as day 7 anti-DNP IgG PFC/culture± standard error of four 
deter mi nations. Significant inhibition indicated by: * (P < 0.01 > 0.001) 
and** (P < 0.001). 
Bl0 
H-2b 
0 
6,375 ± 823 
5,525 ± 1,154 
5,075 ± 175 
4,975 ± 396 
2,450 ± 589** 
-
1,725 ± 111** 
8,200 ± 549 
2,325 ± 390* 
-
4,900 ± 613 
Treatment 
Background (no antigen) 
Antigen only 
L-fucose 
D-glucose 
a-methyl-D-glucoside 
D-galactose 
N-acetyl-8-D-galactosamine 
a-methyl-D-galactoside 
N-acetyl-8-D-mannosamine 
a-methyl-D-ma nnoside 
TABLE 4-2 Ability of Different Monosaccharides to Inhibit the Secondary 
IgG Response of H-2 Recombinant Strains of Mice 
H- 2 Re combinant Strain 
BlO.A BlO.A (2R) BlO.A ( 4R) C3H.OL BIO.A (3R) 
10 ± 13 n.d. 50 ± 29 85 ± 26 15 ± 15 
6,625 ± 235 3,100 ± 248 12,125 ± 1,327 4,826 ± 404 10,800 ± 828 
3 , 6 50 ± 611* 1,000 ± 235** 13,500 ± 919 5,800 ± 266 11,750 ± 961 & Flftffi:C =• 
6,663 ± 306 2,875 ± 85 13,175 ± 1,355 5,083 ± 317 10,700 ± 762 
6,300 ± 438 2,700 ± 394 14,075 ± 1,448 4,995 ± 500 11,000 ± 286 
3,567 ± 120** 1,575 ± 217* 2,225 ± 293** 2,710 ± 247* 6,125 ± 466** --
-- -
_,., 
-
e m 
--1,350 ± 1,031** 100 ± 71** 1,975 ± 421** 2,150 ± 224* 1,975 ± 335** • v,n..._ 
- - -
7,700 ± 593 3,200 ± 268 10,600 ± 631 4,555 ± 191 n.d. 
3£400 ± 621* 800 ± 82** 5,175 ± 634* 2,760 ± 115* 3,275 ± 392** 
7,300 ± 1,108 2,650 ± 166 15, 250 ± 1,723 4,840 ± 373 11,100 ± 954 
Footnotes as in Table 1 
BlO.A(SR) 
5 ± 3 
7,100 ± 252 
3,263 ± 624* 
-
7,563 ± 434 
7,775 ± 726 
2,625 ± 583** 
1,650 ± 325** 
-
6,925 ± 518 
2,150 ± 985** 
-
7,113 ± 659 
MOUSE STRAIN H-2 COMPLEX 
K ~ 
A B J E C 
B10.BR CBA/H H-2k [ 
B10.D2 BALB/c H-2d 
B10 C3H.SW H-2 6 
B10.A 
B10.A(2Rl 
B10.Al4Rl 
C3H.OL 
B10.Al3Rl 
Bl0.Al5Rl 
FIGURE 4.1 
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Summary of the ability of different sugars to inhibit the secondary 
IgG antibody response in a range of mouse strains 
The genetic makeup of the mouse strains is repres ented by: 
D for the k haplotype 
~ for the d haplotype 
~ for the b haplotype 
- no inhibition by sugars 
+ significant inhibition 
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Fuc inhibited the secondary IgG response of k but not d orb 
haplotypes (Table 4.1). The fact that Bl0.A and Bl0.A(2R) were also 
inhibited by Fuc mapped the effect to the left of the I-C subregion, 
whereas the lack of inhibition of Bl0.A(4R) mapped the phenomenon to 
the right of I-A. The Fuc inhibition was directly mapped to the I-J 
subregion by inhibition being detected in Bl0.A(SR) but not in BIO.A (3R). 
In contrast to Fuc, Gal and Man NAc inhibited band d but not k 
haplotypes (Table 4.1). Gal and Man NAc inhibited Bl0.A and Bl0.A(2R) 
responses which mapped the inhibition to the right of I-E. The detection 
of inhibition by Gal and Man NAc in the C3H.OL strain mapped the effect 
to the IC subregion. 
4 . 4 DISCUSSION 
The sugar inhibition of secondary IgG responses shown in 
Chapter 3 was further analysed in this chapter and the data presented 
here shows that the effect is linked to the H-2 complex and maps within 
the I-region. 
Thus Fuc only inhibited responses in cell cultures of k haplotype 
and this inhibition mapped to the I-J subregion, whereas two other sugars, 
fan NAc and Gal inhibited d and b haplotype and this effect was shown 
to be under I-C subregion control. 
Gal NAc inhibited the secondary IgG response of all mouse strains 
tested and hence the genetic region controlling this inhibition could 
not be mapped . However, there is a close structural similarity between 
Gal Ac and Man Nae in that they share the N- acetyl-B-D-structure of the 
sugar while Gal shares the D-galactose portion of Gal Ac. It seems 
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likely, therefore, that inhibition by Gal NAc, like Man NAc and Gal, 
is controlled by the I-C subregion. 
It appears then, that the I-C subregion controls a carbohydrate 
structure involved in the interaction of TRF with target cells whose 
dominant sugar is Gal NAc, since this sugar was the most potent 
inhibitor of all monosaccharides tested (see Tables 4.1 and 4.2). The 
different patterns of inhibition seen ind and k haplotypes suggests 
that the linkage of Gal NAc in the carbohydrate structure differs 
between mouse strains. 
On the other hand, inhibition by Fuc was controlled by a 
completely different genetic region, namely the I-J subregion. It is 
possible that the I-J subregion in the d and b haplotypes also controls 
carbohydrate structures, but presumably inappropriate sugars were used 
in our experiments to demonstrate this point. 
Collectively, these data suggest that the I-J and 1-C 
subregions of the murine MHC control carbohydrate structures involved 
in the delivery of help for secondary IgG responses. Whether the I-J 
and I-C subregions control products (possibly glycosyltransferases) 
which make up a single carbohydrate structure akin to the complementarity 
described for protein Ia antigens (Jones et al., 1978; Lafuse et al., 1980), 
or whether these subregions control two separate carbohydrate structures 
involved in the activation of IgG synthesis requires further investigation. 
This is the first time to my knowledge that a helper function 
has been ascribed tc the I-C subregion. The I-J subregion, on the other 
hand, has been shown to control antigens expressed on helper T cells 
(Tada et al.., 1978) and on antigen - specific helper factors (Howie et al., 
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1979). More significantly, there is some evidence that both the I-J 
and I - C subregions control carbohydrate Ia antigens. Howie et a£. (1979) 
r aised the possibility that the I - J subregion determinants on an antigen-
specific helper factor were carbohydrate in nature, whereas Sandrin 
et al . (1981) recently detected I-C subregion controlled carbohydrate 
antigens on murine B lymphocytes. 
4 . 5 SUMMARY 
Certain monosaccharides selectively inhibit secondary IgG 
r esponses )yz_ vitJr..o. Genetic analyses described in this chapter revealed 
t hat the inhibitory sugars differed between mouse strains and these 
differences mapped to the I-J and I-C subreg ions of the murine MHC. 
These results imply that interaction between T and B lymphocytes can 
involve the recognition of l-region controlled carbohydrate structures. 
CHAPTER 5 
11 Further characterisation of a rnonosaccharide -
inhibi table T eel l replacing factor 11 
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5 . 1 INTRODUCTION 
In chapter 3, evidence was presented that supernatants from 
antigen-stimulated primed spleen cells contained T cell-replacing (TRF) 
activity which was abrogated by the addition of Gal NAc to the 
cultures. The active component(s) in these supernatants was tentatively 
assigned the acronym TRF because it was able to restore the antibody 
response of T cell depleted, DNP-HCY primed, spleen cells when added 
on the second day of a 6-day incubation period . 
This chapter represents an attempt to further characterise 
some functional and physical properties of this soluble TRF and 
to elucidate the inhibition of its activity by simple sugars. 
5 . 2 MATERIALS AND METHODS 
5 . 2 . 1 Animals 
Mice were bred and maintained at the J.C.S.M.R. and were 
used at 5-16 weeks of age. 
5 . 2.2 Antigens 
Dinitrophenylated haemocyanin from ]a/2U/2 laland,i_,i_ and MON 
from Salmon~lla typh,tmUJL,tUmwere prepared as described in section 2.2. 
SRBC were obtained from the same sheep for all experiments and were 
washed four times with normal saline before use. 
5 . 2 . 3 Immunizations 
Mice were primed to D P-HCY as described in section 2.3. 
Briefly,bentonite-bound antigen was injected intraperitoneally 
three times at two-weekly intervals. Mice were kept in a li g ht, 
temperature and humidity-controlled room and were used 2-12 weeks 
100 
after the last challenge. Mice primed to SRBC were given one dose of 
10
8 
SRBC (10 µl packed SRBC in 200 it l PBS) intravenously and were 
used 7-10 days later. 
5. 2 . 4 Sugars 
The source of sugars is listed in section 2.8. All sugars 
were added at the beginning of culture unless otherwise indicated, and 
were used at a final concentration of 5 mg/ml in culture medium 
(approximately 20rnM). 
5.2.5 Cell cultures 
Spleen cells were cultured in Linbro 24-well trays for 6 or 
7 days in EMEM, 5% FCS, 2-ME and NAPs as described in section 2.5. 
Antigen concentrations were 2 x 106 cells/ml for SRBC and 50 ng/ml 
for DNP-HCY, DNP-MON, HCY and MON. 
5.2.6 Preparation of cells 
Spleen cells were separated into lg + and lg subpopulations 
b . + y rosetting the lg cells and fractionating the rosetting and non-
rosetting cells on an lsopaque/Ficoll gradient as described in 
section 2.6. The lg cells were then cultured as usual. 
Thy-1 spleen cell populations were generated by treating 
the spleen cells with monoclonal anti-Thy 1.2 and complement as 
described in section 2 .6. The spleen cells were either treated 
at the beginning or after two days of culture. The Thy 1.2 
population was subse quently cultured as usual. 
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Serious problems were encountered with the anti-Thy 1.2 
and complement (C') treatment of spleen cell populations, these 
treated cells at times giving substantial PFC responses in the absence 
of TRF. In fact, at times these "controls" gave larger PFC responses 
than complement-treated or untreated cell cultures suggesting a 
preferential elimination of suppressor T cells. These high background 
PFC levels occurred despite the fact that anti-Thy-1 treatment 
r eproducibly killed 30-40% of spleen cells. Furthermore, when primed 
cells from a number of different strains were treated concurrently in -
an identical manner, some cell cultures had very low background PFC 
responses whereas others exhibited a high level of activity. 
Increasing the amount of anti-Thy 1.2 antibodies or the incubation 
time with antibody and complement had no effect. These differences could 
be due to a ran ge of factors such as low Thy-1 density on highly primed 
T cells and bacterial infections contaminating spleen cells with LPS . 
However, the high background PFC levels often made modest 
PFC responses due to TRF addition difficult to evaluate. 
5 . 2 .7 Detection of PFC 
. . increases in 
Cells secreting anti-DNP antibodies were assayed after 6 
or 7 days of culture on DNP-SRBC monolayers in the presence of 
complement and/or developing serum. Cells secreting anti-SRBC 
antibodies were assays on SRBC monolayer. For more details see 
section 2.7. 
5 . 2 . 8 Generation of TRF 
G~neration of TRF either by antigen or Con A-stimulation is 
described in sections 2.12 and 2.13. Supernatants containing TRF 
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generated by culturing DNP-HCY-primed cells with antigen were either 
used immediately or were concentrated ten fold and frozen. Con A 
generated supernatants (CS) were always concentrated ten fold and 
frozen. TRF containing supernatants were assayed for activity by 
adding them to Thy-1 spleen cells either at the beginning of culture 
or after 2 days of cultures. 
The maJor problem with TRF generated from antigen-stimulated 
cultures was its lability. Whereas the day 5 supernatant always 
contained TRF activity (providing mice were primed), the majority 
of preparations lost their TRF activity when concentrated and 
0 
frozen at -60 C . Procedures such as concentration by pressure 
dialysis rather than over Amicon membranes, freeze drying, freezing 
unconcentrated or adding FCS to preparations were all unsuccessful 
in retaining the activity of the supernatants. 
5 . 2 . 9 Assay for IL-1 and IL-2 
An IL-1 containing supernatant was made by stimulating the 
macrophage cell line PU-5-1.8 with LPSW (section 2.11.2). Supernatants 
were concentrated 10-fold and stored at -20°C. The supernatants were 
assayed for their ability to initiate CJH.Hej thymocyte proliferation 
as described in section 2.16. 
Supernatants were assayed for their content of IL-2 on 
activated T cells in a maintenance assay as described in section 2.15. 
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5 . 2 . 11 gel Filtration of TRF activity 
Sephacry 1 200 ( ) column containing 270 mls of gel was 
-4 packed at room temperature at 40 ml/hour with EMEM and 10 M 2-ME 
for 24 hours. 3 ml sample of 10 - fold concentrated superantant 
containing TRF activity was applied to the column and filtered with 
EMEM, 2- ME at 4°c using peristaltic pump at a rate of 40 mls/hour. 
100 fractions (50 drops or 3.25 mls/fraction) were collected on 
fraction collector, individually sterilised with millipore filters 
and assayed for protein content by coomassie blue method (Rylatt and 
Parish, 1982) and for TRF activity on T cell depleted primed spleen 
cells. 
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5.3 RESULTS 
5 . 3 .1 Detection of TRF activity in culture supernatants 
Table 3.7 presented in chapter 3 demonstrated that the 
supernatants from secondary DNP-HCY cultures could restore the anti-
DNP PFC response of anti-Thy 1.2 + C' treated, DNP-HCY primed, spleen 
cells. In the next series of experiments this culture supernatant 
was concentrated ten-fold by Amicon filtration and then a range of 
dilutions tested for TRF activity . The two experiments in Table 5.1 
demonstrate that the supernatant contained TRF activity over a one 
hundred-fold concentration range, exhibiting plateau-like activity. 
It should be noted, however, that the PFC response of TRF containing 
cultures was at times not as high as intact (i.e. non-anti-Thy 1.2-
treated) spleen, e.g. experiment 1 in Table 5.1. Furthermore, many 
supernatants from DNP-HCY-primed cultures lacked TRF activity after 
concentration and freezing. 
In an attempt to overcome this variability, three different 
types of culture supernatants were assayed for TRF activity, namely 
(i) culture supernatants derived from the fourth and fifth day of 
incubation from antigen-activated DNP-HCY primed spleen cells, 
the supernatant being tested for TRF activity immediately after 
harvesting; 
(ii) the above supernatant which was concentrated 10-fold over an 
0 Amicon PMlO membrane and stored at -60 C, thawing once only and 
(iii) culture supernatants of Con A activated unprimed spleen cells 
which were 10 x concentrated and stored at -20°c. 
Table5.1 Titration of TRF activity in culture supernatants 
of DNP-HCY primed spleen cells 
Treatment of Spleen Cells 
Experiment 1 
Complement (CI ) alone 
Anti-Thy 1.2 + C' 
Experiment 2 
Complement (CI) alone 
Anti-Thy 1.2 + C' 
TRF 
( % ) 
12.5 
10 
5 
2.5 
15 
5 
1.5 
0.15 
DNP PFC/Culture+ SE 
IgM IgG 
1,425+240 37,325+1,848 
75+18 550+128 
43+8 4,345+546 
65+25 3,907+336 
83+34 4,383+510 
135+39 5,903+773 
103+22 • 9,707+276 
650+66 4,928+346 
115+29 · 11,746+913 
205+67 12,235+2,943 
393+106 19,564+2,943 
480+42 14,569+1,643 
Anti-Thy 1.2 and complement-treated CBA/H spleen cells were cultured 
for 7 days with DNP-HCY and varying doses of DNP-HCY-generated, lOx 
concentrated CBA/H TRF. Results are expressed as means and standard 
errors of four determinations. 
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As can be seen from Table 5.2 all three supernatants could 
reconstitute a PFC response in DNP-HCY primed anti-Thy 1.2 + c' treated 
spleen cell cultures and, moreover, all three contained TRF activity 
which could be inhibited by Gal NAc. Interestingly, Con A generated 
supernatants were consistently more active and retained TRF activity 
during storage better than antigen-stimulated supernatants. 
Additional experiments revealed that supernatants from DNP-HCY 
primed and stimulated lg spleen cells contained TRF activity (Table 
5 . 3), a r esult which suggested that the TRF was T cell derived . 
Furthermor e, TRF - containing supernatants could be generated by 
stimulating DNP-HCY primed spleen cells with HCY alone (Table 5 .4). 
5 . 3 . 2 Properties of TRF 
Chapter 4 of this thesis presented evidence that the sugar 
inhibition of secondary IgG responses to T-dependent antigens was 
strain-specific and controlled by !-region genes. Thus the response 
k 
of the H- 2 haplotype was inhibited by Fuc but not by Gal or Man NAc, 
whereas the response of H-2b and H- 2d haplotypes was inhibited by 
Gal and Man NAc but not by Fuc. 
Since Gal NAc inhibited TRF activity (Table 5.2) it seemed 
likely that the sugar inhibition of TRF activity would also be 
strain specific . As can be seen from Table 5.5, CEA (H-2k)-derived 
TRF was inhibited by Fuc but not by Gal and Man NAc in CEA spleen 
cell cultures, whereas C57Bl/6 (H-2b)-derived TRF activity was 
inhibited by Gal and Man NAc but not by Fuc in C57El/6 cultur e s. 
Gal NAc inhibited both TRF syst ems wh e r e as D-g lucose had no e ffect on 
the PFC responses. Hence the inhibitio n of TRF activity is analog ous 
Expt. 
1. 
2 • 
3. 
Table 5.2 Assessment of Different Culture Supernatants for TRF Activity 
Source of TRF TRF 
None added 
DNP-HCY stimulated secondary culture 20% unconcentrated 
None added 
DNP-HCY stimulated secondary cultures 0.5% lOx concentrated 
None added 
ConA-activated spleen cells 0.5% lOx concentrated 
IgG DNP PFC/Culture 
No Sugar 
532+59 
11,923+596 
5,925+486 
14,000+1,087 
55+38 
1,930+332 
GalNAc 
336+119 
5,875+553 
585+143 
Supernatants containing TRF activity were added to anti-Thy 1.2 + C' treated DNP-HCY primed CBA/H splee 
cells at the beginning of the culture. GalNAc was added on day Oat 5 mg/ml. DNP PFC responses were 
assayed after 7 days of culture and expressed as means and standard errors of four determinations. 
Table5.3 Evidence that DNP-HCY primed Ig spleen cells produce 
TRF when cultured with antigen 
Treatment IgG DNP PFC/culture 
No TRF added 
Ig spleen cell derived CBA TRF (0.5%) 
Ig spleen cell derived C57Bl/10 TRF (0.6%) 
55 + 38 
500 + 127 
1,210 + 250 
TRF-containing supernatant was generated by culturing Ig CBA or 
C57Bl/10 spleen cells with DNP-HCY for 5 days and l0x concentrated. 
TRF was added to anti-Thy 1.2 + C' treated DNP-HCY primed BALB/c 
spleen cells at the beginning of culture. Results are expressed as 
means and standard errors of day 6 PFC response. 
TableS.4 Evidence that HCY alone can induce DNP-HCY primed 
spleen cells to produce TRF 
Concentration of HCY generated 
TRF added 
None 
60 
30 
15 
IgG DNP PFC/Culture 
173 + 94 
1,970 + 101 
1,455 + 192 
638 + 82 
TRF was generated by culturing DNP-HCY-primed spleen cells with 
50 ng/ml of HCY for 5 days. Unconcentrated supernatant was added 
to anti-Thy 1.2 + C' treated DNP-HCY primed BALB/c spleen cells 
and cultured for 7 days. 
Treatment 
No TRF 
TRF (0.5 %) 
II 
II 
II 
II 
II 
Table5.5 Ability of different monosaccharides to inhibit the activity 
of C57Bl/10 (H-2b) and CBA (H-2k) derived TRF 
Sugar IgG DNP-PFC/Cul-ture 
( 5mg/ml) C57Bl/10 (H-2b) CBA (H-2k) CBA (H-2k) 
- 1,680+346 155+66 675+75 
-
-
. 
- 4,087+667 2,760+81 18,210+1,215 
D-glucose 5,212+301 3,373+291 N.D. 
L-fucose 4,027+238 1,195+187 ( 5 7) 11, 110+5-7 6 (40) 
D-galactose 2,053+343 ( 5 0) N.D. 19,200+781 
GalNAc 1,700+345 ( 5 9) 1,187+89 ( 5 7) 4,470+273 (75) 
ManNAc 1,985+174 (52) 2,838+132 17,708+448 
Antigen-generated, lOx concentrated supernatant from CBA cultures was added to anti-Thy 1.2 + C'-
treated CBA spleen cells and TRF from C57Bl/10 cultures was added to anti-Thy 1.2 + C' treated C57Bl/10 
spleen cells at the beginning of the culture. Tesults are expressed as the means and standard errors 
of day 7 PFC response (n=4). Values in brackets represent% inhibition and PFC responses which represent 
significant inhibition are enclosed. 
to the strain-specific inhibition of IgG responses by sugars in 
unfractionated spleen cell cultures seen in chapter 4. 
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Although the sugar inhibition of TRF activity was H-2 haplotype-
specific, the delivery of help by TRF was not strain specific. 
Thus it was found (Table 5.6) that TRF preparations from CBA/H (H-2k), 
BALB/C (H-2d) and C57Bl/6 (H-2b) mice could readily help CBA/H and 
BALB/C primed spleen cells to respond to DNP-HCY, indicating that 
the TRF can act across H-2 differences. 
Preliminary experiments also suggest that the TRF lacks 
antigen specificity. Culture supernatants containing TRF from DNP-
HCY primed spleen could help anti-Thy 1.2 + c' treated spleen cells 
primed to SRBC (Table 5.7) to respond to SRBC, indicating that TRF 
is not antigen specific, a notion supported by the fact that supernatants 
from Con-A activated unprimed spleen cells contain TRF activity for 
anti-DNP-HCY responses (Table 5.2). 
Absorbtion experiments also revealed that the TRF activity 
in the supernatant of DNP-HCY cultures could be absorbed by normal 
spleen cells at o
0
c, but not at 37°c (Table 5.8), suggesting that 
the TRF interacts with cell surface structures. 
Finally, in an attempt to semi-purify TRF, Con-A generated 
supernatant was fractionated by ge l filtrati on on a Sephacryl 200 
column. The peak of 1RF activity, as assayed by anti-DNP PFC 
responsiveness, was eluted in the void volume of the column indicating 
that the biologically active TRF molecules have a molecular weight of 
Table 5.6 Lack of strain specificity in TRF action 
TRF source IgG DNP-PFC/Culture 
CBA (H-2k) cells BALB/c (H-2d) cells 
No TRF added 1,228 + 253 1,603 + 220 
-
-
CBA (H-2k) 3,595 + 337 3,285 + 512 
-
-
BALB/c (H-2d) 5,528 + 198 3,673 + 263 
-
-
C57Bl/6 (H-2b) 4,500 + 551 2,700 + 07 
-
-
l0x concentrated TRF from DNP-HCY stimulated cultures of 3 mouse 
strains were added to anti-Thy 1.2 + C' treated, DNP-HCY-primed 
spleen cells at the beginning of culture. Results are expressed as 
the means and standard errors of day 6 PFC responses (n=4). 
Table5.7 Lack of antigen specificity of TRF 
Source of TRF Anti-SRBC IgG PFC/Culture 
No TRF added 5,858 + 638 
CBA (H-2k) 10,958 + 873 
C57Bl/10 (H-2b) 8,700 + 564 
TRF from DNP-HCY stimulated cultures was added at the 
beginning of culture with antigen (SRBC) to anti-Thy 1.2 + C' 
treated CBA/H spleen cells primed to SRBC. Results are 
expressed as the means and standard errors of day 6 anti SRBC 
PFC response (n=4). 
Table 5.8 Ability of spleen cells to absorb TRF activity 
Treatment 
No TRF 
TRF (0.5 %) unabsorbed 
TRF absorbed at o0 c 
TRF absorbed at 37°c 
IgG DNP-PFC/Culture 
4,928 + 346 
15,235 + 1,083 
2,664 + 357 
16,983 + 453 
TRF-containing supernatant was generated by culturing DNP-
HCY primed CBA/H spleen cells with DNP-HCY for 5 days. The 
lOx concentrated supernatant was added to anti-Thy 1.2 + C' 
treated DNP-HCY primed CBA/H spleen cells and pfc assayed 7 
days later. TRF was absorbed by incubating TRF with 10 8 
normal CBA/H spleen cells for 90 min either on ice or at 37°c. 
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more than 100,000 daltons. In an attempt to avoid aggregation, the 
column was run in the presence of 2-ME (Figure 5.1). The size of 
antigen -nonspecific, H-2 unrestricted TRF is reported to be about 
30,000 daltons (Hubner~t al. , 1978) and hence is inconsistent with the 
above result. The differences may be due to aggregation of molecules 
as a result of the concentration procedure or the use of Sephacry 1 
200 since it seems unlikely that TRF described here and in the 
literature are different molecules. 
5 . 3 . 3 Mode of interaction of TRF with target cells 
A hypothesis presented earlier in this thesis proposed that 
the interaction of TRF with its target cells involved carbohydrate 
recognition, analogous to a lectin binding an oligosaccharide. Thus, 
in the presence of the appropriate sugar, the binding of TRF to target 
cells is blocked and consequently the helper signal aborted. 
Since the sugar inhibition of TRF is strain specific (Table 
5.5) but the delivery of TRF activity is unrestricted by mouse 
haplotype (Table 5.6), it is possible to determine whether the TRF 
molecule is a lectin recognising carbohydrate structures on target 
cells or whether a lectin on target cells interacts with a carbohydrate 
moiety on TRF. The experimental protocol was to take H-2b haplotype 
k TRF and establish which sugars inhibited its activity on H-2 haplotype 
cells. If the sugar inhibition correlates with the source of the 
target cell (i.e. H-2k haplotype), then the lectin is on the target 
cells and TRF carries the carbohydrate moiety, whereas if the sugar 
inhibition correlates with the source of the TRF (i.e. H-2b haplotype) 
FIGURE 5.1 
Aldolase Albumin Cytochrome C 
158,000 68,000 12,500 
+ /] + + 6 Chymotrypsin 25,000 
r! + 100 
. 5 
E 
'----0) 
80 ::i. 4 
C 
0 
·.;:: 
0 
L. 
-C 6 3 Q) u 
C 
0 
u 
C 
Q) . 
-0 40 2 L. 0.. 
I .. f .h 1 .... , .. f•····· \ . ···J I 
....... 1-, .................. I 20 ~l i ···• .. 1·····1··········· I 1 ·---r 
10 20 30 40 50 60 70 
Fraction number 
Gel filtration of ConA stimulated supernatant on Sephacry\ 200.Fractions were assayed 
for the total protein content (-) and for TRF activity represented as day 7 anti-DNP 
lgG PFC response ( ............. ). The migration distance of protein standards are indicated by 
arrows.The bar on the right represents response in absence of antigen. PFC 
response is represented as means and standard errors (n =4). 
(0 
G) 
0 
z 
" 
" 
,, 
n 
'----() 
C 
..... 
C 
.., 
(1) 
>< 
0 
c..> 
108 
then the TRF is a lectin and the carbohydrate receptor is on the 
target cells. 
Table 5.9 demonstrates that TRF derived from H-2b haplotype 
spleen cells delivered the helper signal to CEA (H-2k) cells and that 
this activity was inhibited by sugars which inhibit IgG synthesis by 
b k 
H-2 but not by H-2 haplotype cells, i.e. Gal and Man NAc but not by 
Fuc . Thus the pattern of sugar inhibition correlates with the source 
of the TRF implying that the TRF is a lectin which interacts with a 
carbohydrate structure on target (B) cells. 
5 . 3 . 4 Time of TRF action 
Sugar inhibition data presented in chapter 3 (figure 3. 
suggested that Gal NAc which is proposed to inhibit TRF action had to 
be present on the third and the fourth days of culture to exhibit its 
inhibitory effects. In an attempt to determine the time interval 
during which TRF must be present in the cultures to exhibit activity, 
a TRF containing supernatant was pulsed into cultures between 48 and 
144 hours or between 48-96 hours. Data in Table 5.10 indicated that 
TRF only had to be present during the 48 hour period between the third 
and the fourth day of the culture to exert substantial helper activity 
in spleen cell cultures. 
A number of observations in the literature also indicat e 
that TRF is more effective when added to cultures on the second day 
of the culture period which presumably would not allow sufficient 
time for the TRF-containing supernatants to act indirectly via the 
activation of T cells. In an attempt to explor e this point, primed 
Table5.9 Sugar inhibition of TRF activity is related to source 
of TRF rather than nature of target cells 
Treatment IgG DNP PFC/Culture 
Bl0 TRF ( % ) C57Bl/6 TRF (0.5%) 
None 1,480 + 114 465 + 91 
-
-
TRF only 4,373 + 406 1,670 + 219 -
-
TRF + D-glucose 4,033 + 178 1,745 + 128 
-
-
TRF + L-fucose 4,273 + 399 1,527 + 58 
-
-
TRF + D-galactose 1,867 + 345 ( 5 7) 855 + 202 (49) 
-
-
TRF + GalNAc 1,680 + 106 ( 6 2) 680 + 85 ( 6 0) 
-
-
Bl0 TRF was generated by culturing DNP-HCY primed C57Bl/10 spleen 
cells with DNP-HCY for 5 days and concentrating 10-fold. C57Bl/6 TRF 
was a l0x concentrated ConA-generated supernatant from normal C57bl/6 
spleen cells. TRF was added at the beginning of culture to an t i-
Thy 1.2 + C' treated DNP-HCY primed CBA spleen cells. Results are 
expressed as means and standard errors of day 6 PFC response. Values 
which represent significant inhibition are enclosed. 
Table5.1O Effect of time of addition of TRF to 
cultures on antibody responsiveness 
Treatment 
No TRF 
TRF (20 %) days 2-6 
TRF (20%) days 2-4 
IgG DNP-P FC/Culture 
173 + 94 
1,463 + 135 
975 + 66 
TRF was generated by culturing DNP-HCY primed CBA/H 
cells with antigen for 5 days. Unconcentrated 
supernatant was added to DNP-HCY primed CBA/H spleen 
cells treated with anti-Thy 1.2 + C' on day 2 of 
culture. The response, assayed on day 6, is expressed 
as means and standard errors (n=4). 
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spleen cells were treated with anti-Thy 1.2 + c' either on day O and/or 
day 2 of the culture and TRF added on day O or day 2. The results 
presented in Table 5 . 11 indicate that 
(i) when T cells are removed at the beginning of the culture, 
TRF is more active if added on day 2 rather than on day 0 
of the culture; 
(i i) if T cells are removed on day O and then again on day 2, 
TRF will exert little activity in these cultures; 
(iii) however, if T cells are removed after 2 days of culture, 
the addition of TRF will result in the largest PFC response. 
This suggests that for optimal antibody formation to hapten-carrier 
conjugates, intact T cells are required early and TRF later in the 
response. 
5 . 3 .5 Relationship between IL-1, IL-2 and TRF 
Recent reviews suggest that IL-1 and IL-2 (see section 1) are 
capable of acting as helper factor in antibody responses, probably 
indirectly by inducing recruitment and proliferation of TH cells. Since 
the antigen-generated and Con A-activated supernatants contain both 
IL-1 and IL-2 besides TRF, it was important to determine whether 
these molecules could act as helper factors in T cell depleted spleen 
cell cultures and, more significantly, whether these activities could 
be inhibited by sugars. 
It was sho1-m in Table 5.2 that Con A activated spl ee n cell 
supernatants, which containIL-2 activity, exh ibited TRF activity in 
T cell depleted cultures and this activity was inhibited by Gal NAc . 
In a similar manner, IL-2 (d e rived from a macrophage cell line) was 
Table 5.11 Effe~t of time of T cell depletion on TRF activity 
Anti-Thy-l.2+C' 
treatment 
day 0 
day 0 and 2 
day 2 
TRF 
addition 
Nil 
day 0 
day 2 
Nil 
day 0 
day 2 
Nil 
day 2 
DNP-PFC/Culture 
IgM 
23+14 
38+28 
23+14 
8+8 
8+8 
38+38 
520+95 
450+121 
IgG 
38+14 
420+0 
840+102 
68+39 
53+53 
128+51 
795+192 
2,340+270 
TRF was a l0x concentrated ConA generated supernatant (0.5%) from 
BALB/c spleen cells. BALB/c spleen cells primed to DNP-HCY were 
either treated with anti-Thy 1.2 + C' at the beginning of the 
culture and/or after 2 days of culture. PFC responses, determined 
after 7 days of culture, are expressed as means+ standard errors 
(n=4) . 
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assayed for TRF activity in cultures of T cell depleted CJH.Hej (LPS 
unresponsive) spleen cells primed to SRBC. As can be seen from 
Table 5.12 the addition of the IL-1 containing macrophage supernatant 
could restore PFC responsiveness and the TRF activity was also 
inhibited by Gal NAc . However, both IL-1 and IL-2 may act by 
recruiting T cell precursors or activating low Thy- 1.2+ T cells and 
hence could indirectly affect TRF production. 
On the basis of the above proposal it was important to 
determine whether the ability of IL-1 and IL-2 to induce and support 
T cell proliferation was inhibited by monosaccharides. Table 5.13 
r eveals that the activity of neither IL-1 or IL-2 was inhibited by 
any of the sugars tested. 
5 . 4 DISCUSSION 
In this chapter, the general properties of a TRF activity 
that reconstituted secondary IgG responses and was inhibited by simple 
sugars was examined. The major findings of the chapter can be 
summarised as follows: 
(i) TRF activity which was inhibited by Gal NAc, was not only 
Jetected in the culture supernatants of ~n v~tfr._o secondary 
antibody responses but was also found in supernatants of 
Con-A activated normal spleen cells (Table 5.2) 
(ii) the TRF showed the same strain-specific pattern of sugar 
inhibition as intact spleen cell cultures, namely Fuc inhibiting 
the action of H-2k haplotype derived TRF in H- 2k spleen cell 
cultures and Gal and Man NAc inhibiting H- 2b- der ived TRF 
Table5j2 Assay for TRF activity in IL-1 preparations 
Treatment anti-SRBC PFC/Culture 
Experiment 1 
No IL-1 
IL-1 (2%) 
Il-1 (2%+GalNAc) 
Experiment 2 
No Il-1 
IL-1 (2%) 
IL-1 (2%+GalNAc) 
IgM 
53+33 
1,463+163 
405+108 
2,250+468 
5,680+812 
5,005+903 
IgG 
15+15 
5,205+285 
765+228 
3,885+586 
12,000+467 
6,610+378 
l0x concentrated Il-1 containing supernatant was obtained by 
LPS W stimulation of the macrophage cell line PU-5-1.8. IL-1 
was added at the beginning of culture to SRBC-primed anti-Thy 
1.2 + C' treated C3H/HeJ spleen cells and cultured for 6 days 
with SRBC. Results are expressed as means and standard errors 
of 4 determinations. 
TableS.13 Ability of different monosaccharides to inhibit IL-1 
and IL-2 (TCGF) activities 
Treatment CPM 
IL-1 IL-2 
No interleukin added 3,833+279 935+49 
No sugar 25,287+2,417 33,726+2,209 
D-glucose 40,880+8,062 32,010+2,039 
L-fucose 32,766+6,032 32,082+907 
G/c NAc 22,049+4,259 31,065+1,288 
G/c Met 26,131+1,755 30,512+1,989 
D-galactose 27,767+1,640 27,138+3,287 
GalNAc 27,747+5,142 34,942+2,443 
GalMet N.D. 33,608+2.014 
ManNAc 33,594+3,682 31,962+3,682 
ManMet N.D. 31,718+863 
A supernatant containing IL-1 activity was added to C3H.HeJ thymo-
cytes in the presence of ConA and in the presence of sugar (5mg/ml). 
A supernatant from ConA activated spleen cell cultures (containing 
IL-2) was added to 3-day old Con A activated B/6 spleen cells 
together with sugar at 5mg/ml. Results are expressed as CPM of 
3 h "d" . d H-t ymi ine incorporate . For further details of the assays see 
section 2.15 and 2.16. 
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activity in H-2 spleen cell cultures (Table 5.5). 
(iii) In contrast to the sugar inhibition results, the TRF was not 
H-2 restricted in its action (Table 5.6). Furthermore, the 
factor lacked antigen specificity (Table 5.7), was probably 
secreted by T cells (Tables 5.3 and 5.4) and could be absorbed 
by normal spleen cells (Table 5.8). 
(iv) The TRF acted late in the IgG response, needing only to be 
present between the third and the fourth days of culture to 
induce IgG synthesis (Table 5.10). On the other hand, optimal _ 
antibody formation required intact T cells early in the 
response and the addition of TRF later (Table 5.11). 
(v) The pattern of sugar inhibition of C57Bl/6 (H-2b)-derived TRF 
k 
activity in CBA/H H-2 cultures demonstrated that the TRF 
is a lectin which interacts with carbohydrate structures on 
target cells (Table 5.9). 
(vi) Finally, the inability of monosaccharides to inhibit the 
action of IL-1 and IL-2 on T cells discriminated the TRF 
from these activities (Table 5.13). 
The observation that TRF is H-2 unrestricted in its action, 
but can be inhibited by sugars in a H-2-specific manner may a t first 
glance be paradoxical. However, the ability of specific su gars to 
block TRF from different strains suggests that the TRF's (or lectins) 
differ in their fine specificity of sugar recognition. Thus, as 
demonstrated in Table 5.5, CBA derived TRF binds Gal NAc and Fuc whereas 
C57Bl/6 TRF lectin binds Gal NAc, Man NAc and Gal. It should be 
emphasised however, that Gal NAc was always a strong inhibitor of 
TRF action, and, therefore, it is likely that carbohydrate acceptor 
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sites on target cells are sufficiently alike for these lectins to 
bind in a cross-reactive manner, resulting in TRF activity being 
H-2 unrestricted. It is possible, however, that if enough mouse 
strains differing in H-2 were screened, some may have carbohydrate 
acceptor sites sufficiently different for certain TRF's to be unable 
to bind. Alternatively, the carbohydrate acceptor on target cell 
may be a relatively conserved structure and any TRF would be active 
in all mouse strains. One way to analyse the similarity between the 
carbohydrate acceptors on cells differing at H-2 would be to titrate 
k TRF from one haplotype, e.g. H-2 for its relative ability to 
reconstitute the PFC responses of syngeneic and allogeneic cells. 
If the affinity for self-receptors is higher than for non-self, then 
the TRF should be active to a higher titre in syngeneic than allogeneic 
cell culture. 
What is the nature of the target cell for the TRF described 
in this chapter? It is not possible to predict this from data 
presented here, although an absroption on purified B cells rather 
than on whole spleen (Table 5.8) may provide the answer. As discussed 
in chapter 1 the proliferating B cell is presumably the immedia t e 
target cell of TRF . This conclusion is supported by a number of 
observations including the fact that TRF preparations produced by a 
T cell line which secretes TRF but not IL-2 induce long-t erm cultures 
of B cells or the B cell reoplastic line BCL
1 
to synthesise immuno g lobulin 
(Howard ~t al.., 1981; Pure ~t al.., 1981). 
At this point it should be reemphasised tha t data presented 
in chapter 4 indicate that the sugar inhibition of TRF is controlled 
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by genes in the I-region. These observations suggest that the TRF 
binding of carbohydrate receptors on B cells is I-region controlled and 
raises the possibility that the TRF molecule is also MHC encoded. 
These possibilities could be verified experimentally by measuring the 
ability of anti-Ia sera to either block the absorbtion of TRF to 
spleen cells or to remove TRF activity from culture supernatants. 
Data presented in Tables 5.2 and 5.12 demonstrate that IL-2 
and IL-1 containing supernatants can restore the PFC response of T 
cell depleted spleen cell cultures to D P-HCY and that these activities, 
like that of TRF,rtre inhibited by Gal NAc. However, neither IL-1 
activity in the tbyrnocyte proliferation assay, nor IL-2 activity in 
the maintenance assay was inhibited by any of the sugars tested 
(Table 5.13). This suggests that IL-1 and IL-2 act by recruiting 
TH cells which subsequently secrete TRF and thus indirectly serve as 
"helper" factors. Some evidence, discussed in chapter 1, suggests 
that B cells may be the direct target for IL-1 activity, although only 
in the early stages of activation. The bulk of the evidence indicates 
that T cells are the more likely tar get cells for IL-1 and IL-2 
(reviewed by Farrar and Hilfiker, 1982). 
The ability to inhibit the TRF activity by specific simple 
sugars and their apparent lack of effect on IL-1 and IL-2 may provide 
a useful tool for functional distinction between these factors. More-
over, it may be possible to selectively bind and elute TRF from 
Gal (Ac coupled columns, although the recent availability of T cell 
lines which secrete TRF but not IL-2 (Takatsu e__t al ., 1980; Swain 
e__t ~t., 1981) makes this method for TRF purification less attractive. 
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Finally, it should be noted that TRF-containing supernatants 
did not usually totally reconstitute the PFC response of T-cell-
depleted spleen cell cultures to normal levels. This incomplete 
reconstitution is probably due to the requirement of intact T cells 
(or their antigen-specific products) for early B cell activation 
(Table 5.11), whereas TRF acts late in the response, supplying the 
final signal for differentiation of B cells into antibody forming 
cells. It could be argued that in instances where TRF completely 
reconstituted the PFC response (Table 5.1) either the supernatant 
contained sufficient IL-1 and/or IL-2 to recruit enough T cells for 
early B cell activation or a residue of TH cells remained after 
anti-Thy 1.2 + c' treatment and supplied the early activation signals. 
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5 . 5 SUMMARY 
This chapter describes an analysis of a TRF activity that 
reconstituted the secondaru IgG response of T cell-depleted spleen 
cell cultures and whose activity was inhibited by Gal NAc. It was 
found that this TRF activity was present in Con A supernatants from 
normal spleen cells as well as in supernatants from antigen-activated 
spleen cell cultures. Although the TRF was not strain-specific in 
its action it showed the same strain specific pattern of sugar 
inhibition as intact spleen cell cultures. Furthermore, the TRF 
lacked antigen specificity, was probably secreted by T cells, could 
be absorbed by normal spleen cells and acted late in IgG induction. 
Evidence is also presented which indicates that the TRF 
molecule is a lectin which interacts with a carbohydrate receptor 
on tar ge t cells. The inability of sugars to inhibit IL-1 and IL-2 
activity also indicates that the TRF is distinct from these activities. 
CHAPTER 6 
Analysis of inhibition of 
immune responses by D-mannose 
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6 . 1 INTRODUCTION 
In chapter 3 of this thesis data was presented which demonstrated 
that a number of ~n vitlr.o immune responses could be completely inhibited 
by the addition of D-mannose to the cultures. Unlike Gal NAc and Fuc, 
D-mannose inhibited all in vitlr.o immune responses examined, namely 
primary and secondary antibody response to T-dependent antigens, the 
generation of primary Tc cells to alloantigens and proliferative 
responses to alloantigens (MLR). This chapter further analyses the 
inhibition of immune responses by D-mannose and presents evidence that 
D-mannose inhibits lymphocyte proliferation, possibly by interfering 
with cellular metabolism. 
6.2 MATERIALS AND METHODS 
6.2.1 Animals 
Mice of both sexes were used at 6-16 weeks of age. The 
haplotypes of the various strains used are defined in Table 2.1 . 
6 . 2 . 2 Antigens 
MON was prepared from the flagel la of Salmon~lla typhimUJLium 
S1870, and HCY was recrystallised from the haemolymph of JcwU/2 lalandii . 
The description of these preparative methods and the dinitrophenylation 
of these proteins is described in more detail in section 2.2. TNP was 
coupled to LPS (E. coli 055:135 Difeo Lab.) according to the method 
described by Quintas and Lefkovits (1976). DNP was coupled to Ficoll 
(Pharmacia, Sweden) and polyacrylamide Bio-Gel Pl0 beads as described 
by Inman (1975). 
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6 . 2 . 3 Sugars 
The sugars used and their source were as follows: D-mannose 
N-acetyl-D- mannosamine (ManNAc), D-mannitol and mannan from Sigma, 
St . Louis, Miss. and a - methyl-mannoside from Calbiochem, San Diego, Ca . 
6. 2 . 4 Immunisations 
Mice were primed to DNP-MON and DNP-HCY as described in 
section 2 . 5 . Briefly, the antigen was bound onto bentonite and 
injected i.p . three times at 2-weekly intervals. Animals were used 
2- 10 weeks after the last challenge . 
6 . 2 . 5 I n v~tko antibody responses 
The ~n v~Uo culturing procedures are described in section 2.5. 
Briefly, spleen cells were cultured with EMEM, 5% FCS, 2-ME (l0-4M) and 
NAPs at a concentration of 2 x 10 6 cells/ml in Linbro trays ln a 
10% CO2 , 7% o2 , air mixture . Primary antibody responses were cultured 
for 3 days and secondary responses for 7 days. Anti-DNP-PFC were 
assayed using SRBC coated with DNP (see section 2.7). 
6 . 2 . 6 In v~tko primary cytotoxic T cell responses 
Tc cells were generated by mixing 5 x 10 6 CBA responder spleen 
cells with 1.25 x 10
6 
gamma-irradiated Balb/c stimulator spleen cells. 
The cultures were harvested after 5 days and Tc cells specific for 
H-2d antigens assayed against 51 cr-labelled P815 mastocytoma targe t 
51 
cells . Results are expressed as % Cr release ( for details see 
section 2.10). 
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6 . 2 . 7 Cell lines 
The fibroblasts either from a rat or a mouse were cultured in 
Autopow supplemented with L-glutamine and buffered with IM tris as 
described in section 2.11.3. P815, EL-4, NS-1 and WEHI-3 cell lines 
were grown in Falcon flasks in DMEM and 10% HIFCS in a 10% CO
2
, 
7% o2 atmosphere. These cell lines were maintained in the John Curtin 
School of Medical Research, either in the Department of Microbiology 
or the Department of Immunology. 
6.3 RESULTS 
6 . 3 . 1 Ability of D-mannose to inhibit a range of ~n v~t~o 
immune responses 
Amongst the data presented in chapter 3 was the observation that 
D-mannose inhibited ~n v~Uo primary and secondary antibody responses to 
the hapten-carrier conjugates DNP-MON and DNP-HCY, ~n v~Uo proliferative 
responses to alloantigens and the ~n v~Uo generation of primary Tc 
cells to alloantigens. In addition, data presented in Table 6.1 
demonstrates that D-mannose inhibited responses of unprimed spleen cells 
to three different T-cell-independent antigens, namely DNP-Ficoll, 
DNP-polyacrylamide beads and TNP-LPS. However, while D-mannose 
inhibited antibody responses to T-cell dependent antigens and responses 
to alloantigens to background levels (see chapter 3), the responses to 
T-independent antigens were inhibited only partially (50-80%) despite 
the use of the same sugar concentration (Table 6.1). 
Additional experiments reveal e d that the inhibitory effect of 
D-mannose was concentration-dependent. As can be seen in Figure 6 .1 
significant inhibition of a primary lg 1 response and the generation 
of Tc cells to alloantigens was still seen at a concentration of 
TABL E 6.1 
INHIBITION OF IN VITRO T-CELL INDEPENDENT ANTIBODY 
RESPONSES BY D-MANNOSE 
ANTIGEN 
DNP-FICOLL 
TNP-LPS 
DNP-BEADS 
DNP PFC/CULTURE 
No SUGAR 
1)163 + 45 
1)648 + 177 
948 + 70 
D-MANNOSE 
220 + 36 
768 + 18 
460 + 61 
(% INHIBITION) 
81 
53 
52 
D-MANNOSE (5MG/ML) WAS PRESENT THROUGHOUT CULTURE. ANTI-
DNP-PFC WERE ASSAYED AFTER 3 DAYS OF CULTURE. RESULTS ARE 
EXPRESSED AS MEANS AND STANDARD ERRORS OF FOUR 
DETERMINATIONS. THE RESPONSE OF CONTROL CULTURES TO WHICH 
NO ANTIGEN WAS ADDED WAS 50 + 5 PFC/CULTU RE. 
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0.15 mg/ml (~ 0.6mM). Figure 6.1 also shows that complete inhibition 
of the Tc cell response required only 2.5mM D-mannose whereas a higher 
concentration (l0mM) of the monosaccharide was needed to completely 
suppress a primary IgM response. 
6.3.2 Inhibition of immune responses by D-mannose-related 
sugars 
A number of monosaccharides structurally related to D-mannose 
were tested for their ability to inhibit the immune responsiveness o_f 
CBA/H spleen cells m V~Vr.o. Three innnune responses were tested: 
a primary IgM anti-DNP-MON antibody response, a secondary anti-DNP-MON 
IgG response and the generation of primary Tc cells to alloantigens. 
As can be seen from the data presented in Table 6.2, D-mannose 
completely inhibited all of these responses, a result consistent with 
earlier experiment described in chapter 3. On the other hand, 
D-mannitol, Man NAc and Man Met had no effect on the three responses. 
The additional sugar which was inhibitory was mannan, although this 
sugar was not as potent an inhibitor as D-mannose. At this point it 
should be noted that mannan is a polymer of D-mannose and hence would 
be expected to act in a manner similar to D-mannose. To eliminate the 
possibility that the inhibitory activity of the mannan preparation 
was due to free D-mannose residues rather than the polymer, mannan was 
dissolved in E~IBM and dialysed for 24 hours against EMEM. The resulting 
solution was equally inhibitory as undialysed mannan (Table 6 . 2), 
indicating that the polymer was responsible for the inhibition. 
6.3.3 Strain specificity of D-mannose inhibition 
Since the inhibition of secondary antibody respons es by Fuc and Gal 
1Ac - related sugars was highly strain-dependent (chapter 4), it was 
TREATMENT 
No ANTIGEN 
ANTIGEN ONLY 
D-MANNOSE 
MANNAN 
DIALYSED MANNAN 
D-MANNITOL 
MAN NAc 
MAN MET 
TABLE 6,2 
INHIBITION OF IMMUNE RESPONSES BY D-MANNOSE AND D-MANNOSE-RELATED SUGARS 
a 
ANTIBODY RESPONSE m VITRO (PFC/CULTURE) 
PRIMARY ANTI-DNP-MON 
!GM PFC/cuLTUREb 
18 + 12 
1)513 + 99 
8 + 8 
363 + 118 
320 + 51 
1)493 + 84 
1)413 + 74 
1)453 + 97 
SECONDARY ANTI-DNP-MON 
IGG PFC/cuLTUREc 
13 + 9 
3)875 + 75 
15 + 6 
337 + 26 
ND 
4)025 + 293 
3)900 + 71 
3)780 + 178 
CYTOTOXIC RESPONSE 
IN VITRO 
% 51 CR RELEASE/CULTUREd 
ND 
47,5 + 2.4 
1.1 + 0,2 
25,7 + 0.9 
ND 
48.0 + 1,7 
39.8 + 0.6 
45.7 + 0.8 
LEGENDS TO TABLE 6.2 
aMANNAN WAS DIALYSED AGAINST EMEM FOR 24 HOURS TO REMOVE 
CONTAMINATING D-MANNOSE RESIDUES. 
bPRIMARY ANTI-DNP-MON !GM RESPONSE OF CBA/H SPLEEN CELLS 
WAS ASSAYED AFTER 3 DAYS OF CULTURE (CBA/H). 
CSECONDARY ANTI-DNP-MON IGG RESPONSE OF CBA/H SPLEEN CELLS 
WAS ASSAYED AFTER 7 DAYS OF CULTURE. IGM RESPONSE WAS 
<100 PFC. 
aABILITY OF PRIMARY Tc CELLS (GENERATED IN CBA/H ANTI-BALB/c 
MLR) TO LYSE Sl(R LABELLED P815 TARGETS WAS ASSAYED AFTER 5 
DAYS OF CULTURE. 
SUGARS WERE PRESENT THROUGHOUT THE CULTURE PERIOD AT 5MG/ML. 
RESULTS ARE EXPRESSED AS MEAN AND STANDARD ERRORS OF FOUR 
DETERMINATIONS. 
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necessary to determine whether D-mannose exhibited any strain 
specificity in its inhibition. In order to test this possibility an 
,U1 vdlr.o secondary anti-DNP-MON antibody response was examined. Data 
presented in Table 6.3 demonstrated that D-mannose inhibited the 
generation of anti-DNP-PFC in four mouse strains differing in both 
their H-2 haplotypes and background genes . Hence the antibody responses 
k b d s 
of BlO.BR (H-2 ), C57Bl/6 (H-2 ), Balb/c (H-2 ), and SJL (H-2 ) spleen 
cells were inhibited to background levels when the cells were cultured 
with D-mannose for 7 days. A similar lack of strain specificity in -
D-mannose inhibition was observed when a primary IgM antibody response 
to DNP-MON was examined. 
6.3.4 Timing of D-mannose inhibition 
In the experiments described so far, D-mannose was present 
throughout the culture period. It was important, therefore, to show 
the time in the response when D-mannose exerted its inhibitory effect . 
To determine this, the sugar was added and deleted from culture wells 
each day either for 7 days in the case of the IgG response to DNP-HCY 
or for 5 days in the generation of Tc cells to alloantigens. Figure 
6.2 reveals that in the generation of Tc cells, the majority of 
D-mannose inhibition occurred on the second, third and fourth day of 
culture, no significant inhibition being observed when D-mannose was 
present during only the first 24 hours of culture. For the secondary 
IgG response, the adding and deleting data indicates that D-mannose 
exhibited its inhibitory activity on the third day of culture. 
The data presented in Figure 6.2 suggests that D-mannose has 
no effect on the induction of immune responses if only present during 
the first 24 hours of the culture. However, in a number of experiments 
TABLE 6.3 
LACK OF STRAIN SPECIFICITY OF D-MANNOSE INHIBITION 
IN SECONDARY ANTI-DNP-MON ANTIBODY RESPONSES IN VITRO 
MousE STRAIN 
BlO.BR 
C57B/6 
BALB/c 
SJL 
HAPLOTYPE 
k 
b 
d 
s 
ANTI-DNP-PFC/cuLTURE 
No SUGAR 
2)517 + 172 
2)928 + 243 
5)400 + 665 
2)150 + 225 
D-MANNOSE 
(5MGIML) 
14 + 8 
57 + 20 
15 + 6 
8 + 5 
PFC RESPONSE WAS ASSAYED AFTER 7 DAYS OF CULTURE. 
RESULTS ARE EXPRESSED AS MEANS AND STANDARD ERRORS OF 
FOUR DETERMINATIONS, 
50 
40 
a, 30 
en 
co Q) 
~ ~ 20 
() 
.,... 
LO 
~ 
10 
FIGURE 6.2 
0 1 2 3 4 5 
DAY 
Influence of the time of addition and deletion of D-mannose 
on the generation of Tc cells in vitro The sugar was either added ( f) 
or deleted ( ~) on each day of culture and all cultures assayed for Tc 
activity on day 5 Vertical bars are standard errors of means (n=4) 
4 
("') 3 r ,,,,,1 0 
T'9 
)( 
..,,,,, ' Q) \ ~ ::J .... 
::J 
' 
(.) 2 
......... 
() 
LL 
a.. 
<.? 
0) 
1 
0 1 2 3 4 5 6 7 
DAY 
Influence of the time of addition and deletion of D-mannose on a 
secondary anti-DNPP PFC DNP MON antibody respon~e in vitro 
The suqar was either added (I) or deleted 1 ~ ,on each day of culture 
and all cultures assayed for anti-DNP PFC on day 7. 
121 
(two out of five for IgG responses and one out of three Tc cell 
responses) pulsing of D-mannose into culture between 0-24 hours 
resulted in a very large enhancement of the response (see Table 6.4). 
The reason for this effect is unclear but may be due to suppressor 
T cells being selectively eliminated by D-mannose early in the 
response. 
Figure 6.3 presents the results obtained in an experiment 
where D-mannose was pulsed into Tc cell cultures for 24 hour periods. 
D-mannose had no effect on Tc cell generation during the first 24 hours 
of culture and exhibited most inhibition between 24 and 72 hours of 
culture , although there was still significant inhibition on the fourth 
and fifth days . This data is in general agreement with the addition 
and deletion experiment depicted in Figure 6.2. 
6.3.5 Inhibition of growth of cell lines by D-mannose 
Since immune responses represent a series of complex cell-cell 
interactions it was important to determine whether D-mannose interfered 
with cell-cell communication or merely acted as a metabolic inhibitor. 
One means of distinguishing between these two possibilities was to 
determine the effect of D-mannose on the growth of lymphoid and 
nonlymphoid cell lines ~n v~:ur.o. 
A number of cell lines were grown for two days in medium 
containing either Smg/ml of D-glucose as a control for non-specific 
osmotic effects or Smg/ml of D-mannose. The cell lines examined 
were primary and secondary fibroblasts obtained from rat and mouse 
embryos, the P815 mastocytoma, the WEHl-3 monocyte line, the EL-4 
thymoma and the NS-1 B cell lymphoma. D-mannose had no effect on the 
TABLE 6.4 
ENHANCEMENT OF IMMUNE RESPONSE IN VITRO BY A 
24 HOUR PULSE OF D-MANNOSE 
ANTIBODY RESPONSE 
IGG DNP PFC/CULTURE 
No SUGAR D-MANNOSE 
21600 + 92 14)168 + 11478 
-
24)155 + 1)106 90) 325 + 2) 063 
3) 375 + 504 6; 250 + 755 
2) 608 + 270 31 065 + 250 
15;465 + 1)100 13; 600 + 943 
CYTOTOXIC T CELL RESPONSE 
% 51cR RELEASE 
No SUGAR D-MANNOSE 
57 .1 + 1. 0 88 I 8 + 4 I 4 
-
59 I 2 + 0 I 8 56 I 3 + 3 I 2 
47.6 + 1.2 49 I 8 + 2 11 
38 I 5 + 1. 0 39.2 + 0.7 
D-MANNOSE (5MG/ML) WAS PULSED INTO CULTURES BETWEEN 0-24 HOURS~ 
IGG PFC WAS DETERMINED AFTER 7 DAYS OF CULTURE; % SlCR RELEASE 
AFTER 5 DAYS OF CULTURE. RESULTS ARE EXPRESSED AS MEANS AND 
STANDARD ERRORS OF FOUR DETERMINATIONS. 
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growth of any fibroblasts. In contrast, variable effects were obtained 
with lymphoid cell lines, the growth of the thymoma EL-4 being 
completely inhibited by D-mannose whereas the B cell line NS-1 being 
barely affected (Table 6.5). At face value, this result suggests a 
selective inhibition of T-lymphocyte, rather than B lymphocyte growth 
by D-mannose, a conclusion supported by the partial inhibition of 
T-independent antibody respons es by D-mannose (Table 6 .1 ). However, 
when several murine T cell and B cell lines were examined for their 
D-mannose susceptibility by Dr. Alan Harris (Walter and Eliza Hall 
Institute) no consistent pattern emerged, i.e. there were T cell 
and B cell lines that were either resistant or susceptible to D-mannose 
inhibition of growth (personal communication). Table 6.5 also shows 
that in the presence of D-mannose, the growth of P815 was strongly 
inhibited, but WEHI-3 was not. 
6.3.6 Ability of D-glucose to override D-mannose inhibition 
Since D-mannose inhibits the growth of certain cell lines 
~n v~tko, one possibility is that D-mannose perturbs D-glucose 
metabolism either by blocking D-glucose uptake or by interfering with 
D-glucose utilisation. If this is true, then high concentrations of 
D-glucose should override D-mannose inhibition. Figure 6.4 depicts 
an experiment where cells were cultured with decreasing concentrations 
of D-mannose in the presence of D-glucose (5mg/ml) or in the presence 
of a -menthyl-mannoside (5grn/ml). It can be seen th at D-mannose was, 
in terms of concentration, a 4-8 fold less effective inhibitor when 
mixed with D-glucose than when added alone. Thus D-glucose overrides 
D-mannose inhibition, whereas a -methyl-mannoside had no effect. 
TABLE 6.5 
ABILITY OF D-MANNOSE TO INHIBIT THE GROWTH OF CELL LINES 
CELL LINE CELL NUMBER/CULTURE 
D-GLUCOSE D-MANNOSE STARTING 
INOCULUM 
PRIMARY RAT FIBROBLASTS 5xlO8 5.2xlO 8 5xlO5 
SECONDARY MOUSE FIBROBLASTS l.9xlO8 l.8xlO8 5xlO5 
P815 (MASTOCYTOMA) l.2xlO7 3.3xlO5 5xlO5 
WEHI-3 (MONOCYTE) 6xlO6 3xlO6 lxlO5 
EL-4 (THYMOMA) 3xlO6 lxlO5 lxlO5 
NS-1 (B CELL LYMPHOMA) 6xlO5 3.6xlO5 lxlO5 
CELL LINES WERE SEEDED INTO SMALL FLASKS IN THE PRESENCE OF 
GLUCOSE OR MANNOSE (5MG/ML) AND ALLOWED TO GROW FOR 48 HOURS, 
RESULTS ARE EXPRESSED AS THE MEAN CELL NUMBER PER FLASKS 
BASED ON FOUR DETERMINATIONS, 
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6 . 4 DISCUSSION 
In this chapter, the inhibition of immune responses by 
D-mannose was investigated. D-mannose inhibited all ~n vitJr..o immune 
responses tested, namely primary IgM and secondary IgG responses to 
T-dependent antigens, the generation of MLR and primary Tc cells to 
alloantigens and IgM responses to T-cell-independent antigens. 
Inhibition by this sugar was concentration-dependent, significant 
inhibition of immune responses being obtained with as little as 0.6mM 
(Figure 6.1). Furthermore, inhibition by D-mannose was not strain 
specific (Tabl e 6.3) and, except for mannan, a polymer of D-mannose, 
a range of D-mannose-related sugars were not inhibitory (Table 6.2). 
Addition, deletion and pulsing data (Figure 6.2 and 6.3) 
indicated that D-mannose did not exhibit its inhibitory effect in the 
first 24 hours of culture but produced greatest inhibition during the 
second and third days of culture. This suggests that D-mannose 
does not interfere with the initial recognition and activation of 
lymphocytes by antigen but inhibits subsequent proliferation of these 
antigen-reactive cells. In support of this concept was the observation 
that the proliferation of certain cell lines in vitJr..o was completely 
inhibited by D-mannose (Table 6.5). These data also imply that D-mannose 
does not block cell-cell interactions between lymphoid cells. Howev e r, 
since some cell lines are not inhibited by D-mannose, lymphomye loid 
cells must be heterogeneous in their response to D-mannose. 
The findings presented here indicat e that D-mannose in some 
way perturbs the metabolism of lymphoid cells. This notion is further 
supported by the observation that the inhibit ory activity of D-mannose 
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was overridden by D- glucose (Figure 6 . 4) . An interesting feature of 
this experiment is that D- glucose needed to be in a substantial molar 
excess to overcome D-mannose inhibition, i.e. D-mannose still 
completely inhibited immune responses when an equimolar concentration 
of D- glucose was present (Figure 6 . 4). 
Thus D- mannose probably interferes with the metabolism of 
D-glucose by cells . There are two possible ways in which this could 
occur. First, D- mannose could bind and block the D-glucose carrier 
on the surface of cells. This seems unlikely, since D-mannose is 
readily transported into rat thymocytes (Hume ~t al. . , 1981) hamster 
cells ( Dahl and Morse, 1979) and human cells (Ganda ~t al. . , 1979) by 
the D- glucose carrier . It is possible, however, that mannan inhibits 
immune responses by blocking D- glucose uptake, although there is the 
additional possibility that mannan is hydrolysed to D-mannose by 
enzymes released by cells analogous to the cleavage of maltose by 
disaccharidases released by rat t hymocytes (Hume ~t ~£ . , 1981) . 
Secondly, D- mannose may interfere with cell metabolism. 
lannose is phosphorylated by mannokinase and then converted to glucose-6-
phosphate by an isomerase (Slein, 1950). This possibility could be 
tested by comparing the metabolism of D-mannose and D-glucose in cell 
lines that are either susceptible or resistant to D- rnannose inhibition. 
This was, in fact, done by Dahl and Morse (1979) who compared two 
chinese hamster ce 11 lines : CHO-Kl derived from ovary and resistant 
to D-mannose inhibition and V79 from foetal lung whose growth was 
inhibited by D-mannose. The authors found no difference in the upt ake 
of D-mannose by the two cell lines, no defect in the pathway of energy 
......... 
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metabolism either using D-mannose as substrate or in the presence of 
D-glucose and no defect in DNA synthesis. However, V79 was not able to 
hydrolyse complex D-mannose-containing polysaccharides due to a lack 
of the appropriate mannosidases and cell death probably resulted from 
accumulation of these polysaccharides inside the cell. Whether this 
explains the inhibitory effect of D-mannose on lymphocyte proliferation 
remains to be determined . 
Nevertheless, it is somewhat surprising that D-mannose inhibits 
the proliferation of lymphomyeloid cells since human cells of brain, 
adipose tissue, liver and pancreas utilise D-mannose as an energy source 
as readily as D-glucose. However, free D-mannose would not be normally 
available to these cells since it is poorly transported across the 
intestine (Ganda ~t al., 1979). Nonetheless, D-mannose appears to 
exert a profound effect on lymphomyeloid proliferation in the mouse 
giving rise to two possible uses: firstly, it may act as a selective 
immunosuppressive agent and secondly, it may have a use in chemotherapy 
of tumors since it affects a number of cell lines and has been reported 
to have an antitumor effect in mice when administered orally or by 
intraperitoneal inoculation (Gonzales and Amos, 1977). 
The literature contains several other reports of the inhibitory 
effects of D-mannose and D-mannose-related sugars on cellular processes. 
Thus D-mannose blocked the binding of glycoproteins by alveolar 
macrophages (Stahl ~t al., 1978), mannose-6-P inhibited the uptake of 
lysosomal enzymes into human fibroblasts (Kaplan ~t ~t., 1977), 
D-mannose blocked the cytotoxicity of natural killer (NK) cells against 
solid tumors in mice (Stutman ~t al., 1980) and mannose-6-P inhibited 
human NK cell activity ,01 v~tAo (Forbes ~t ai., 19 81) . These phenomena 
11 
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are unlikely to be related to the inhibition of immune responses 
reported here since they appear to deal with the blocking of recognition 
structures on the surfaces of cells rather than inhibiting cell 
metabolism. However, Muchmore ~t ~e, (1980) have also reported that 
D-mannose inhibits ,i_n v~br.o immune responses although the significance 
of these observations was not discussed. 
6 . 5 SUMMARY 
Data presented in this chapter and chapter 3 indicates that 
D-mannose inhibits a variety of immune responses ~n v~VLO, such as 
primary and secondary antibody responses to T cell dependent antigens, 
primary antibody responses to T cell-independent antigens, MLR and 
generation of Tc cells to alloantigens. D--mannose also inhibited the 
growth of some lymphomyeloid cell lines and lacked strain specificity 
in its inhibition. These results combined with the timing of D-mannose 
inhibition and the ability of D-glucose to overcome the effects of 
D-mannose indicated that unlike Gal NAc, Fuc and Gal, D-mannose 
inhibits responses by interfering with cell metabolism. 
....... 
CHAPTER 7 
Summary and Conclusions 
.......... 
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The work described in this thesis was undertaken to test the 
hypothesis that cell-cell collaboration can be mediated by MHC-controlled 
carbohydrate-protein interactions . As a first step (chapter 3), a 
variety of simple sugars were tested for their ability to inhibit a 
number of immune r esponses in vibe.a. Gal NAc, Fuc and Glc Nae 
inhibited IgG responses to hapten- carrier conjugates in CBA/H 
cultures, but had no effect on any other in vibe.a response tested. 
In contrast to sugars which specifically inhibited IgG responses 
~n vibe.a, D-mannose completely inhibited all in vibe.a immune responses 
tested in all mouse strains examined (chapter 6). Hence, D-mannose 
was a nonspecific inhibitor and in fact did not block cell-cell 
interaction, but interfered with cellular metabolism . In this 
context, it is important to rule out nonspecific effects when sugar 
inhibition of immune responses is analysed, since, in our hands, a 
number of other sugars (e . g. amino-sugars, D-ribose) proved to be 
n onspecific inhibitors. 
A range of monosaccharides were subsequently tested for their 
inhibitory effects on the in vibe.a IgG responses of a variety of 
mouse strains. (Chapter 4) a number of strain-specific inhibitors 
emerged and the inhibition of IgG levels by these sugars was found to 
be controlled by the I-J and/or the I-C sugregions of the H-2 complex. 
The simplest explanation for these observations is that induction of 
IgG responses involves carbohydrate structure s, recognition of which 
is controlled by the I-J and/or I-C subregions. 
A detailed analysis of the mechanism by which Gal NAc inhibited 
IgG responses supported the concept that the sugars were blocking 
interactions that were r equired for IgG secretion, Adding, deleting 
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and pulsing Gal NAc and Fuc in the cultures revealed that these 
sugars needed to be present in a short time period just before IgG 
was secreted in order to exert their inhibitory effect. Moreover, 
Gal NAc exerted its effect during this short time period by abrogating 
the ability of antigen-generated TRF to restore the antibody response 
of T cell-depleted cultures (chapter 3). 
Other strain-specific inhibitors (i.e. Fuc, Man NAc and Gal) 
also exerted their effect in this manner. The activity of the TRF, 
which was active across H-2 barriers, was inhibited by Fuc in H-2k 
strains, and by Man NAc and Gal in H-2b and H-2d strains (chapter 5), 
a pattern identical to that seen in the unfractionated spleen cell 
cultures (chapter 4). This observation again supported the view that 
an interaction between TRF and its target B cell, resulting in an 
IgG response, occurs via H-2-controlled carbohydrate-lectin binding 
and that the addition of appropriate sugars to the cultures 
competitively inhibited lectin binding. 
The next step was to determine whether the lectin was 
expressed on the surface of the target B cell, or was the TRF molecule 
itself. (N.B. A lectin is defined here simply by its ability to bind 
sugar molecules; whether it is also capable of a gglutinating cells 
is unknown.) Using TRF from H-2b culture s and T cell-de pleted spl een 
cells from antigen-primed H-2k mice, it was found that Gal and Man _Ac 
but not Fuc inhibited the reconstitution of the IgG response. Sinc e 
b Gal and Man Ac were H-2 specific inhibitors (i.e. they blocke d H-2 b 
--
TRF) then it follows that the H-2b TRF was a lectin and th e TRF mol e cul e 
mediated its effect by interacting with carbohydrate structures on 
target B cells. Moreover, since the inhibition by Gal and Man NAc was 
controlled by the I-C subregion, the lectin (TRF) is e ither cod e d for 
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or controlled by gene(s) in the I-C subregion. By corollary, the TRF 
k 
from H-2 cells is a lectin controlled by the I-J and/or I-C subregion 
and is specific for Fuc and Gal NAc. Since Gal NAc inhibited TRF 
from all mouse strains and was the strongest inhibitor, TRF must be 
primarily specific for Gal NAc. It should be noted that inhibition of 
TRF in H-2k strains appears to be controlled by two subregions - I-J 
and I-C. Whether these regions together control/or code for a 
single lectin, or two separate lectins, both of which are involved in 
IgG responses, could not be resolved. 
From the work presented in this thesis, very little can be 
deduced about the nature of the carbohydrate-defined receptors on the 
target B cells. It is likely that Gal NAc or a structurally similar 
monosaccharide is the dominant component of the TRF receptor on all 
target cells. Furthermore, Fuc may be an additional component of 
k 
this rec eptor on H-2 cells. At le ast two possibilities exist in 
terms of H-2b and H-2d target cell receptors: either they contain 
Gal NAc, Gal and Man NAc as components, (an unlikely possibility 
since Man NAc is believed to be absent from mammalian carbohydrates), 
or Gal Ac is linked to its subterminal sugar in such a way as to 
sterically resemble Man NAc and Gal. One way to analyse carbohydrate-
defined TRF receptors would be to treat B cells with various 
g lycosidas es and then determine their ability to absorb out TRF 
0 molecules, since TRF can be absorbed on whole spleen cells at 4 C 
(chapter 5). 
An interesting finding in this th esis is th e fact that 
although the TRF activity is inhibit ed by strain-specific sugars, it 
is nonetheless capable of helping B cells to r espond to antigen 
irrespective of their strain of ori gin. The simplest explanation is that 
---
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despite the lectins possessing different sugar specificities, the 
carbohydrate receptors on the target B cells of different strains 
are sufficiently alike for the lectin to bind crossreactively to all 
receptors. 
Data presented in this thesis indicates that the lectin (TRF) 
is either coded for or controlled by I-C and/or I - J subregions. Whether 
the carbohydrate receptor on the target cell is also an I-region-
c ontrolled structure is a matter of speculation made possible by 
t he demonstration that some I-C subregion molecules on B cells are 
carbohydrate-defined antigens (Sandrin et al..,1982) . 
At this point it should be noted that Roseman suggested in 
1970 that cellular interactions important for the regulation of 
biological phenomena may be mediated by highly specific protein-
carbohydrate recognition . He proposed that such interactions might 
occur via recognition of an appropriate carbohydrate determinant or 
substrate on one cell by a glycosyltransferase on another cell, and 
that after the attachment of a new monosaccharide residue , the 
enzyme substrate complex would dissociate and the cells separate. The 
subsequent demonstration of glycosyltransferases on the surface of 
intact cells of many kinds has added support to the concept that th ese 
enzymes mediate interactions between cells, particularly where 
carbohydrate recognition has been implicated (reviewed by Pierce et a1-., 
1980). 
With evidence for the existence of both carbohydrat e -defined 
and protein-defined H-2 anti gens (O'Neill et al . , 1981a, Hig g ins 
et al ., 1980) as well as the need for the involvement of g ly cosy l-
transferases in the synthesis of the carbohydrate antigens, it is 
......... 
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possible that responses controlled by H-2 genes are mediated by H-2 
controlled protein-carbohydrate-interactions. In fact, several 
recent articles have speculated on how MHC controlled 
glycosyltransferases could mediate antigen-specific and antigen-
nonspecific interactions by lymphoid cells (Parish ~t al ., 1981, 1982). 
As informational molecules, carbohydrates have considerable 
scope, particularly in their ability to exist in a variety of 
spatial configurations, to be linked in a number of different ways 
(e.g. a and B linkages) and their ability to readily form branched 
structures. There are, 24 for example, 10 possible structures for 
a twelve-residue oligosaccharide of three mannose, three Glc NAc, 
three galactose and three sialic acid residues (weir, 1980). On the 
basis of these calculations it is possible to envisage subtle changes 
in the structure of carbohydrate rec ep tor for TRF on target B cells 
of different mouse strains. 
The activity of a number of other lymphokines have also been 
shown to be blocked by monosaccharides (reviewed by Rocklin ~t al., 
1980) . The best defined of thes e is the macrophage migration inhibition 
factor (MIF). MIF activity in guinea pigs is specifically blocked 
by a -L-Fucose (Liu ~t al . , 1981). Furthermore, guinea pig and human 
macrophages treated with fucosidase no longer respond to MIF. These 
findings suggest that MIF is a lectin which reco gnis es L-fucose and 
that L-fucose is a part of a MIF rec ep tor, which may be a gangloiside. 
~!urine macrophage activation factor (MAF), which is 
indistinguishab l e from MIF, is also blocked by a monosaccharide, in 
this case by D-mannose. The macrophage receptor for ~1AF could be 
destroyed by mannosidase trea t ment indicating that MAF is a l ectin 
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recognising D-mannose and that this sugar is an essential component 
of the receptor (Yamamoto and Tokunaga, 1981). Although MIF/MAF are 
active across species barriers, it would be interesting to determine 
whether species or strain specific sugars could be found to inhibit 
the activity of these lymphokines and whether these effects could 
be mapped to the MHC. 
The activity of leucocyte-migration inhibitory factor (LIF) 
which is distinct from MIF (reviewed by Rocklin ~t ~e., 1980) could 
also be inhibited by sugars and L-fucose and Glc NAc have both been 
postulated to be important parts of the LIF receptor. 
Additionally, the activity of a number of other lymphokines 
could be inhibited by monosaccharides although the mode of inhibition 
is less well defined. Amongst these are lymphokines inducing skin 
reactions to antigens (Baba ~t al., 1979, Amsden ~t al., 1978), 
mitogenic factor (Geczy, 1977) and interferon, (Vengri s ~t al.,1976). 
Hence, in addition to an H-2-controlled carbohydrate-lectin 
interaction resulting in IgG synthesis described in this thesis, a 
number of other lymphokines appear to be l ec tin-like molecules 
which interact with their target cells via carbohydrate-defined 
receptors. Whether these interactions are H- 2 controlled remains to 
be seen. 
A number of other features warrant brief discussion. Firstly, 
the TRF described in this work r esembles that of other workers in 
that it is non-antigen-specific, ~on-H-2-restricted in its action, 
and is lat e -acting , presumably supplying the final signal which 
results in IgG secretion by antigen-activated B cells (Schimpl and 
Wecker, 1972). However, the TRF described here is coded for or 
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controlled by the I-J and/or I-C subregions; yet the TRF previously 
described in the literature does not appear to carry Ia antigens. 
To reconcile this difference it could be argued that the 
I-J and/or I-C subregion-controlled structures on TRF are either 
serologically silent or very weakly immunogenic. The difficulty 
in raising antibodies against, and identifying I-C subregion-
controlled determinants (Sandrin ~t al. . , 1981) supports this notion. 
Secondly, the demonstration that IgM synthesis in both 
primary and secondary antibody responses was not inhibited by any 
of the sugars which were good inhibitors of IgG responses implies that 
the IgM and IgG responses are activated by different mechanisms. 
Finally, the inhibition of TRF activity by monosaccharides 
offers a means of functionally distinguishing between TRF and IL-l/IL-2 
molecules in culture supernatants. Hence, if the helper activity 
in a culture supernatant is due to expansion of precursor T cells 
by IL-l/IL-2 molecules, then the sugar inhibition of IgG synthesis 
will be specific for the H-2 haplotype of the cultured cells, not of 
the origin of the supernatant. In contrast, if the "help" is due 
to TRF molecules, then the sugar inhibition pattern will follow the 
origin of the supernatant rather than that of the cultured cells. 
In conclusion, data presented in this thesis support the 
concept that MHC-controlled carbohydrate recognition is important 
in IgG responses to hapten-carrier conjugates. Whether these 
observations can be extended to other immune responses awaits 
further investigation. 
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